Amedeo Smart

Free Medical Literature Service


 

Amedeo

COVID-19

  Free Subscription

Articles published in
Clin Infect Dis
    September 2022
  1. HOGAN JI, Duerr R, Dimartino D, Marier C, et al
    Remdesivir resistance in transplant recipients with persistent COVID-19.
    Clin Infect Dis. 2022 Sep 26. pii: 6717535. doi: 10.1093.
    >> Share

  2. FLOREA A, Sy LS, Qian L, Ackerson BK, et al
    Effectiveness of mRNA-1273 vaccine booster against COVID-19 in immunocompetent adults.
    Clin Infect Dis. 2022 Sep 22. pii: 6711079. doi: 10.1093.
    >> Share

  3. SCHERER EM, Backer M, Carvajal K, Danziger-Isakov L, et al
    The COVID-19 Pandemic Unmasked the Challenges Faced by Early-Stage Faculty in Infectious Diseases: A Call to Action.
    Clin Infect Dis. 2022 Sep 22. pii: 6710388. doi: 10.1093.
    >> Share

  4. NAJJAR-DEBBINY R, Gronich N, Weber G, Khoury J, et al
    Effectiveness of Molnupiravir in High Risk Patients: a Propensity Score Matched Analysis.
    Clin Infect Dis. 2022 Sep 20. pii: 6708264. doi: 10.1093.
    >> Share

  5. SIANGPHOE U, Baden LR, El Sahly HM, Essink B, et al
    Associations of Immunogenicity and Reactogenicity After SARS-CoV-2 mRNA-1273 Vaccine in COVE and TeenCOVE Trials.
    Clin Infect Dis. 2022 Sep 20. pii: 6708263. doi: 10.1093.
    >> Share

  6. ONO S, Michihata N, Yamana H, Uemura K, et al
    Comparative effectiveness of BNT162b2 and mRNA-1273 booster dose after BNT162b2 primary vaccination against the Omicron variants: A retrospective cohort study using large-scale population-based registries in Japan.
    Clin Infect Dis. 2022 Sep 18. pii: 6696997. doi: 10.1093.
    >> Share

  7. BOULWARE DR, Murray TA, Proper JL, Tignanelli CJ, et al
    Impact of SARS-CoV-2 vaccination and booster on COVID-19 symptom severity over time in the COVID-OUT trial.
    Clin Infect Dis. 2022 Sep 17. pii: 6702474. doi: 10.1093.
    >> Share

  8. DONLAN AN, Mallawaarachi I, Sasson JM, Preissner R, et al
    Dupilumab use is associated with protection from COVID-19 mortality: A retrospective analysis.
    Clin Infect Dis. 2022 Sep 15. pii: 6698736. doi: 10.1093.
    >> Share

  9. ALONSO-NAVARRO R, Cuesta G, Santos M, Cardozo C, et al
    Qualitative Subgenomic RNA to Monitor the Response to Remdesivir in Hospitalized Patients with COVID-19: impact on the length of hospital stay and mortality.
    Clin Infect Dis. 2022 Sep 13. pii: 6696600. doi: 10.1093.
    >> Share

  10. CUOMO RE, Li Z, Purushothaman V, Basavapatna-Shankar C, et al
    Predictors of Time to COVID-19 Infection in the National Basketball Association: A Retrospective Case-Control Study.
    Clin Infect Dis. 2022 Sep 13. pii: 6696551. doi: 10.1093.
    >> Share

  11. KAKIUCHI S, Livorsi DJ, Perencevich EN, Diekema DJ, et al
    Days of Antibiotic Spectrum Coverage: A Novel Metric for Inpatient Antibiotic Consumption.
    Clin Infect Dis. 2022;75:567-576.
    >> Share

  12. MAGNUS MC, Haberg SE, Carlsen EO, Kwong JC, et al
    Pregnancy status at the time of COVID-19 vaccination and incidence of SARS-CoV-2 infection.
    Clin Infect Dis. 2022 Sep 8. pii: 6693880. doi: 10.1093.
    >> Share

  13. KOJIMA N, Klausner JD
    Usage and awareness of antiviral medications for COVID-19 among individuals at risk for severe COVID-19, March 2021 to 1 August 2022.
    Clin Infect Dis. 2022 Sep 7. pii: 6693563. doi: 10.1093.
    >> Share

  14. GOLAN Y, Campos JAS, Woolson R, Cilla D, et al
    Favipiravir in patients with early mild-to-moderate COVID-19: a randomized controlled trial.
    Clin Infect Dis. 2022 Sep 6. pii: 6692456. doi: 10.1093.
    >> Share

  15. BHIMRAJ A, Morgan RL, Shumaker AH, Baden L, et al
    Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients with COVID-19.
    Clin Infect Dis. 2022 Sep 5. pii: 6692369. doi: 10.1093.
    >> Share

  16. SWANK Z, Senussi Y, Manickas-Hill Z, Yu XG, et al
    Persistent circulating SARS-CoV-2 spike is associated with post-acute COVID-19 sequelae.
    Clin Infect Dis. 2022 Sep 2. pii: 6686531. doi: 10.1093.
    >> Share

    August 2022
  17. WIRTH KE, Edwards JK, Feinstein L, Breskin A, et al
    When emulating a trial, do as the trialists do: Missteps in estimating relative effectiveness of a SARS-CoV-2 vaccine booster dose.
    Clin Infect Dis. 2022 Aug 30. pii: 6679241. doi: 10.1093.
    >> Share

  18. HARRIGAN SP, Wilton J, Chong M, Abdia Y, et al
    Clinical severity of Omicron SARS-CoV-2 variant relative to Delta in British Columbia, Canada: A retrospective analysis of whole genome sequenced cases.
    Clin Infect Dis. 2022 Aug 30. pii: 6679248. doi: 10.1093.
    >> Share

  19. YIP TCF, Lui GCY, Lai MSM, Wong VWS, et al
    Impact of the use of oral antiviral agents on the risk of hospitalization in community COVID-19 patients.
    Clin Infect Dis. 2022 Aug 29. pii: 6678124. doi: 10.1093.
    >> Share

  20. LOHSE ZM, Shapiro JJ, Lednicky JA, Cash MN, et al
    Persistence of SARS-CoV-2 omicron variant in children and utility of rapid antigen testing as an indicator of culturable virus.
    Clin Infect Dis. 2022 Aug 27. pii: 6677545. doi: 10.1093.
    >> Share

  21. FISHER BT, Boge CLK, Xiao R, Shuster S, et al
    Multicenter Prospective Study of Biomarkers for Diagnosis of Invasive Candidiasis in Children and Adolescents.
    Clin Infect Dis. 2022;75:248-259.
    >> Share

  22. KLOMPAS M, Baker MA, Rhee C
    Coronavirus Disease 2019's Challenges to Infection Control Dogma Regarding Respiratory Virus Transmission.
    Clin Infect Dis. 2022;75:e102-e104.
    >> Share

  23. KLEIN B, Harris DA
    Examining the Robustness of 3 Versus 6 Feet of Physical Distancing in Schools: A Reanalysis of van den Berg et al.
    Clin Infect Dis. 2022;75:e310-e311.
    >> Share

  24. FERNANDEZ-DE-LAS-PENAS C
    Are Patients Exhibiting Post-Coronavirus Disease (COVID) Symptoms at 12 months the Same at 5 or 9 Months? The Fluctuating Nature of Post-COVID.
    Clin Infect Dis. 2022;75:e1208.
    >> Share

  25. ADVANI SD, Sickbert-Bennett E, Moehring R, Cromer A, et al
    The Disproportionate Impact of COVID-19 Pandemic on Healthcare-Associated Infections in Community Hospitals: Need for Expanding the Infectious Disease Workforce.
    Clin Infect Dis. 2022 Aug 23. pii: 6673939. doi: 10.1093.
    >> Share

  26. GANATRA S, Dani SS, Ahmad J, Kumar A, et al
    Oral Nirmatrelvir and Ritonavir in Non-hospitalized Vaccinated Patients with Covid-19.
    Clin Infect Dis. 2022 Aug 20. pii: 6672670. doi: 10.1093.
    >> Share

  27. WIEMKEN TL, McGrath LJ, Andersen KM, Khan F, et al
    COVID-19 severity and risk of subsequent cardiovascular events.
    Clin Infect Dis. 2022 Aug 19. pii: 6671924. doi: 10.1093.
    >> Share

  28. NASREEN S, Febriani Y, Velasquez Garcia HA, Zhang G, et al
    Effectiveness of COVID-19 vaccines against hospitalization and death in Canada: A multiprovincial test-negative design study.
    Clin Infect Dis. 2022 Aug 17. pii: 6668859. doi: 10.1093.
    >> Share

  29. DELAHOY MJ, Munoz F, Li K, Arriola CS, et al
    SARS-CoV-2 testing and detection during peripartum hospitalizations among a multi-center cohort of pregnant persons, March 2020-February 2021.
    Clin Infect Dis. 2022 Aug 12. pii: 6663759. doi: 10.1093.
    >> Share

  30. PECK H, Anbumurali N, McMahon K, Freeman K, et al
    Detection of influenza in managed quarantine in Australia and the estimated risk of importation.
    Clin Infect Dis. 2022 Aug 12. pii: 6663754. doi: 10.1093.
    >> Share

  31. FJELLTVEIT EB, Blomberg B, Kuwelker K, Zhou F, et al
    Symptom burden and immune dynamics 6 to 18 months following mild SARS-CoV-2 infection -a case-control study.
    Clin Infect Dis. 2022 Aug 12. pii: 6663664. doi: 10.1093.
    >> Share

  32. KARABA AH, Zhou W, Li S, Aytenfisu TY, et al
    Impact of Seasonal Coronavirus Antibodies on SARS-CoV-2 Vaccine Responses in Solid Organ Transplant Recipients.
    Clin Infect Dis. 2022 Aug 12. pii: 6663288. doi: 10.1093.
    >> Share

  33. QASMIEH SA, Robertson MM, Teasdale CA, Kulkarni SG, et al
    Estimating the period prevalence of SARS-CoV-2 infection during the Omicron (BA.1) surge in New York City (NYC), January 1-March 16, 2022.
    Clin Infect Dis. 2022 Aug 12. pii: 6662085. doi: 10.1093.
    >> Share

  34. MOESTRUP KS, Reekie J, Zucco AG, Jensen TO, et al
    Readmissions, post-discharge mortality and sustained recovery among patients admitted to hospital with COVID-19.
    Clin Infect Dis. 2022 Aug 8. pii: 6658187. doi: 10.1093.
    >> Share

  35. FOPPIANO PALACIOS C, Tucker EW, Travassos MA
    COVID-19 burden among unaccompanied minors in United States custody.
    Clin Infect Dis. 2022 Aug 5. pii: 6656047. doi: 10.1093.
    >> Share

  36. AWASTHI M, Golding H, Khurana S
    SARS-CoV-2 hyperimmune intravenous human immunoglobulins neutralizes Omicron subvariants BA.1, BA.2, BA.2.12.1, BA.3 and BA.4/BA.5 for treatment of COVID-19.
    Clin Infect Dis. 2022 Aug 4. pii: 6655744. doi: 10.1093.
    >> Share

  37. KLEYNHANS J, Walaza S, Martinson NA, Neti M, et al
    Household transmission of SARS-CoV-2 from adult index cases living with and without HIV in South Africa, 2020-2021: a case-ascertained, prospective observational household transmission study.
    Clin Infect Dis. 2022 Aug 4. pii: 6655792. doi: 10.1093.
    >> Share

  38. ZAMBRANO LD, Newhams MM, Olson SM, Halasa NB, et al
    BNT162b2 mRNA Vaccination Against COVID-19 is Associated with Decreased Likelihood of Multisystem Inflammatory Syndrome in U.S. Children Ages 5-18 Years.
    Clin Infect Dis. 2022 Aug 4. pii: 6655523. doi: 10.1093.
    >> Share

  39. PRAY IW, Grajewski B, Morris C, Modji K, et al
    Measuring work-related risk of COVID-19: comparison of COVID-19 incidence by occupation and industry - Wisconsin, September 2020-May 2021.
    Clin Infect Dis. 2022 Aug 4. pii: 6655522. doi: 10.1093.
    >> Share

  40. ARASHIRO T, Arima Y, Muraoka H, Sato A, et al
    COVID-19 vaccine effectiveness against symptomatic SARS-CoV-2 infection during Delta-dominant and Omicron-dominant periods in Japan: a multi-center prospective case-control study (FASCINATE study).
    Clin Infect Dis. 2022 Aug 3. pii: 6653543. doi: 10.1093.
    >> Share

  41. VIHTA KD, Pouwels KB, Peto TE, Pritchard E, et al
    Omicron-associated changes in SARS-CoV-2 symptoms in the United Kingdom.
    Clin Infect Dis. 2022 Aug 3. pii: 6653436. doi: 10.1093.
    >> Share

  42. KRISHNA BA, Metaxaki M, Wills MR, Sithole N, et al
    Reduced incidence of Long COVID referrals to the Cambridge University Teaching Hospital Long COVID clinic.
    Clin Infect Dis. 2022 Aug 1. pii: 6652885. doi: 10.1093.
    >> Share

  43. ATCHISON CJ, Moshe M, Brown JC, Whitaker M, et al
    Validity of self-testing at home with rapid SARS-CoV-2 antibody detection by lateral flow immunoassay.
    Clin Infect Dis. 2022 Aug 1. pii: 6652878. doi: 10.1093.
    >> Share

    July 2022
  44. MONTEJANO R, de la Calle-Prieto F, Velasco M, Guijarro C, et al
    Tenofovir Disoproxil Fumarate/Emtricitabine and Baricitinib for Patients at High Risk of Severe COVID-19: The PANCOVID Randomized Clinical Trial.
    Clin Infect Dis. 2022 Jul 30. pii: 6652179. doi: 10.1093.
    >> Share

  45. SINE K, Appaneal H, Dosa D, LaPlante KL, et al
    Antimicrobial Prescribing in the Telehealth Setting: Framework for stewardship during a period of rapid acceleration within primary care.
    Clin Infect Dis. 2022 Jul 30. pii: 6652160. doi: 10.1093.
    >> Share

  46. KERTES J, David SSB, Engel-Zohar N, Rosen K, et al
    Association between AZD7442 (tixagevimab-cilgavimab) administration and SARS-CoV-2 infection, hospitalization and mortality.
    Clin Infect Dis. 2022 Jul 29. pii: 6651663. doi: 10.1093.
    >> Share

  47. LEHRNBECHER T, Sack U, Speckmann C, Groll AH, et al
    Longitudinal Immune Response to Three Doses of mRNA Vaccine Against COVID-19 in Pediatric Patients Receiving Chemotherapy for Cancer.
    Clin Infect Dis. 2022 Jul 28. pii: 6651274. doi: 10.1093.
    >> Share

  48. LI H, Gao M, You H, Zhang P, et al
    Association of nirmatrelvir/ritonavir treatment on upper respiratory SARS-CoV-2 RT-PCR negative conversion rates among high-risk patients with COVID-19.
    Clin Infect Dis. 2022 Jul 23. pii: 6649232. doi: 10.1093.
    >> Share

  49. ESPARCIA-PINEDO L, Yarci-Carrion A, Mateo-Jimenez G, Ropero N, et al
    Development of an effective immune response in adults with Down Syndrome after SARS-CoV-2 vaccination.
    Clin Infect Dis. 2022 Jul 23. pii: 6649074. doi: 10.1093.
    >> Share

  50. MALAHE SRK, Hoek RAS, Dalm VASH, Broers AEC, et al
    Clinical characteristics and outcome of immunocompromised patients with COVID-19 caused by the Omicron variant: a prospective observational study.
    Clin Infect Dis. 2022 Jul 23. pii: 6649068. doi: 10.1093.
    >> Share

  51. HUYGENS S, Munnink BO, Gharbharan A, Koopmans M, et al
    Sotrovimab resistance and viral persistence after treatment of immunocompromised patients infected with the SARS-CoV-2 Omicron variant.
    Clin Infect Dis. 2022 Jul 22. pii: 6648554. doi: 10.1093.
    >> Share

  52. ROTHBERG MB, Kim P, Shrestha NK, Kojima L, et al
    Protection Against the Omicron Variant Offered by Previous SARS-CoV-2 Infection: A Retrospective Cohort Study.
    Clin Infect Dis. 2022 Jul 22. pii: 6648553. doi: 10.1093.
    >> Share

  53. HATFIELD KM, Baggs J, Wolford H, Fang M, et al
    Effectiveness of COVID-19 vaccination against SARS-CoV-2 Infection among Residents of US Nursing Homes, Before and During the Delta variant Predominance, December 2020 - November 2021.
    Clin Infect Dis. 2022 Jul 20. pii: 6646955. doi: 10.1093.
    >> Share

  54. VIEL KR
    Response to 'Reduced Cell Surface Levels of C-C Chemokine Receptor 5 and Immunosuppression in Long Coronavirus Disease 2019 Syndrome'.
    Clin Infect Dis. 2022 Jul 12. pii: 6640218. doi: 10.1093.
    >> Share

  55. HUNYADY P, Streller L, Ruther DF, Groba SR, et al
    Secondary sclerosing cholangitis following COVID-19 disease: a multicenter retrospective study.
    Clin Infect Dis. 2022 Jul 9. pii: 6637421. doi: 10.1093.
    >> Share

  56. MIGUERES M, Dimeglio C, Mansuy JM, Abravanel F, et al
    The influence of the nasopharyngeal viral load on the spread of the Omicron BA.2 variant.
    Clin Infect Dis. 2022 Jul 7. pii: 6633281. doi: 10.1093.
    >> Share

  57. SANDERS JSF, Lianne Messchendorp A, de Vries RD, Baan CC, et al
    Antibody and T-cell responses 6 months after COVID-19 mRNA-1273 vaccination in patients with chronic kidney disease, on dialysis, or living with a kidney transplant.
    Clin Infect Dis. 2022 Jul 7. pii: 6633280. doi: 10.1093.
    >> Share

  58. MAPONGA TG, Jeffries M, Tegally H, Sutherland A, et al
    Persistent SARS-CoV-2 infection with accumulation of mutations in a patient with poorly controlled HIV infection.
    Clin Infect Dis. 2022 Jul 6. pii: 6632801. doi: 10.1093.
    >> Share

  59. MURISON KR, Grima AA, Simmons AE, Tuite AR, et al
    Severity of SARS-CoV-2 Infection in Pregnancy in Ontario: A Matched Cohort Analysis.
    Clin Infect Dis. 2022 Jul 6. pii: 6632524. doi: 10.1093.
    >> Share

  60. DANIEL KELLY J, Lu S, Anglin K, Garcia-Knight M, et al
    Magnitude and determinants of SARS-CoV-2 household transmission: a longitudinal cohort study.
    Clin Infect Dis. 2022 Jul 5. pii: 6631204. doi: 10.1093.
    >> Share

  61. COHEN JM, Carter MJ, Ronny Cheung C, Ladhani S, et al
    Lower Risk of Multisystem Inflammatory Syndrome in Children (MIS-C) with the Delta and Omicron variants of SARS-CoV-2.
    Clin Infect Dis. 2022 Jul 5. pii: 6631205. doi: 10.1093.
    >> Share

  62. BAGGS J, Rose AN, McCarthy NL, Wolford H, et al
    Antibiotic Resistant Infections among COVID-19 Inpatients in U.S. Hospitals.
    Clin Infect Dis. 2022 Jul 2. pii: 6627591. doi: 10.1093.
    >> Share

  63. SAMSON ME, Still WL, Mark-Carew M, Jarris DK, et al
    Utility of a Test to Return Strategy to Identify Individuals with COVID-19 in the Pre-Kindergarten through Grade 12 School Setting - District of Columbia, January 2022.
    Clin Infect Dis. 2022 Jul 1. pii: 6625819. doi: 10.1093.
    >> Share

    June 2022
  64. GOOD MK, Czarnik M, Harmon KG, Aukerman D, et al
    SARS-CoV-2 Infections and Reinfections among Fully Vaccinated and Unvaccinated University Athletes - 15 States, January - November 2021.
    Clin Infect Dis. 2022 Jun 30. pii: 6623463. doi: 10.1093.
    >> Share

  65. MOORING EQ, Newell K, Castrodale L, Tompkins M, et al
    Increased Mortality among Persons with Symptomatic COVID-19 During the Period of SARS-CoV-2 B.1.617.2 (Delta Variant) Predominance-Alaska, November 2020-October 2021.
    Clin Infect Dis. 2022 Jun 29. pii: 6619623. doi: 10.1093.
    >> Share

  66. GLATMAN-FREEDMAN A, Feldman SF, Hershkovitz Y, Kaufman Z, et al
    Vaccine coverage associated with ending a SARS-CoV-2 wave: a retrospective longitudinal analysis.
    Clin Infect Dis. 2022 Jun 28. pii: 6619125. doi: 10.1093.
    >> Share

  67. TAM AR, Zhang RR, Lung KC, Liu R, et al
    Early treatment of high-risk hospitalized COVID-19 patients with a combination of interferon beta-1b and remdesivir: a phase 2 open-label randomized controlled trial.
    Clin Infect Dis. 2022 Jun 28. pii: 6619124. doi: 10.1093.
    >> Share

  68. MOLINE HL, Keaton A, Rice W, Varghese J, et al
    Effectiveness of COVID-19 mRNA vaccines against infection during an outbreak of SARS-CoV-2 Beta (B.1.351) variant in a skilled nursing facility - Virginia, March-April 2021.
    Clin Infect Dis. 2022 Jun 27. pii: 6618595. doi: 10.1093.
    >> Share

  69. IDOKO OT, Usuf E, Okomo U, Wonodi C, et al
    SARS-CoV-2 in Africa: current considerations and future projections.
    Clin Infect Dis. 2022 Jun 25. pii: 6617636. doi: 10.1093.
    >> Share

  70. OH DY, Holzer M, Paraskevopoulou S, Trofimova M, et al
    Advancing Precision Vaccinology by Molecular and Genomic Surveillance of SARS-CoV-2 in Germany, 2021.
    Clin Infect Dis. 2022 Jun 25. pii: 6617635. doi: 10.1093.
    >> Share

  71. BORAH BF, Pringle J, Flaherty M, Oeltmann JE, et al
    High Community Transmission of SARS-CoV-2 Associated with Decreased Contact Tracing Effectiveness for Identifying Persons at Elevated Risk of Infection - Vermont.
    Clin Infect Dis. 2022 Jun 24. pii: 6617336. doi: 10.1093.
    >> Share

  72. ARNALDO P, Mabunda N, Young PW, Tran T, et al
    Prevalence of SARS-CoV-2 antibodies in the Mozambican population: a cross-sectional Serologic study in three cities, July-August 2020.
    Clin Infect Dis. 2022 Jun 24. pii: 6617331. doi: 10.1093.
    >> Share

  73. KUTTY PK, Stuckey MJ, Koumans EH
    Vaccines, Variants, and Vigilance: Strengthening the COVID-19 Public Health Response through Partnerships and Collaborations.
    Clin Infect Dis. 2022 Jun 24. pii: 6617337. doi: 10.1093.
    >> Share

  74. CHOI D, Nielsen J, Waller LA, Patel SA, et al
    The US COVID-19 surveillance environment: An ecological analysis of the relationship of testing adequacy in the context of vaccination.
    Clin Infect Dis. 2022 Jun 24. pii: 6617111. doi: 10.1093.
    >> Share

  75. MORROCCHI E, Pighi C, Pascucci GR, Cotugno N, et al
    Perinatally HIV-infected adolescents and young adults demonstrate distinct BNT162b2 mRNA COVID-19 vaccine immunogenicity.
    Clin Infect Dis. 2022 Jun 23. pii: 6615389. doi: 10.1093.
    >> Share

  76. OHLSEN EC, Yankey D, Pezzi C, Kriss JL, et al
    COVID-19 vaccination coverage, intentions, attitudes and barriers by race/ethnicity, language of interview, and nativity, National Immunization Survey Adult COVID Module, April 22, 2021-January 29, 2022.
    Clin Infect Dis. 2022 Jun 23. pii: 6614630. doi: 10.1093.
    >> Share

  77. BOUTON TC, Atarere J, Turcinovic J, Seitz S, et al
    Viral dynamics of Omicron and Delta SARS-CoV-2 variants with implications for timing of release from isolation: a longitudinal cohort study.
    Clin Infect Dis. 2022 Jun 23. pii: 6614634. doi: 10.1093.
    >> Share

  78. BOUCAU J, Uddin R, Marino C, Regan J, et al
    Characterization of virologic rebound following nirmatrelvir-ritonavir treatment for COVID-19.
    Clin Infect Dis. 2022 Jun 23. pii: 6614635. doi: 10.1093.
    >> Share

  79. TEMTE JL, Barlow S, Temte E, Goss M, et al
    SARS-CoV-2 co-detection with influenza A and other respiratory viruses among school-aged children and their household members- March 12, 2020, to February 22, 2022, Dane County, Wisconsin.
    Clin Infect Dis. 2022 Jun 23. pii: 6614626. doi: 10.1093.
    >> Share

  80. LEVY R, Cohen R, Lev-Shalem L, Eisenkraft A, et al
    A Retrospective Database Analysis of Before and After Social Distancing in Relation to Pediatric Infection Rate and Healthcare Services Usage During the COVID-19 Pandemic.
    Clin Infect Dis. 2022 Jun 20. pii: 6611849. doi: 10.1093.
    >> Share

  81. BROSH-NISSIMOV T, Hussein K, Wiener-Well Y, Orenbuch-Harroch E, et al
    Hospitalized patients with severe COVID-19 during the Omicron wave in Israel - benefits of a fourth vaccine dose.
    Clin Infect Dis. 2022 Jun 20. pii: 6611845. doi: 10.1093.
    >> Share

  82. ZIPFEL CM, Paul P, Gowler CD, Reddy SC, et al
    Modeling the effectiveness of healthcare personnel reactive testing and screening for the SARS-CoV-2 Omicron variant within nursing homes.
    Clin Infect Dis. 2022 Jun 20. pii: 6611848. doi: 10.1093.
    >> Share

  83. STARGEL A, Taylor MM, Zansky S, Spencer K, et al
    Case Investigation and Contact Tracing Efforts from Health Departments in the United States, November 2020-December 2021.
    Clin Infect Dis. 2022 Jun 20. pii: 6611688. doi: 10.1093.
    >> Share

  84. CARLIN AF, Clark AE, Chaillon A, Garretson AF, et al
    Virologic and Immunologic Characterization of COVID-19 Recrudescence after Nirmatrelvir/Ritonavir Treatment.
    Clin Infect Dis. 2022 Jun 20. pii: 6611663. doi: 10.1093.
    >> Share

  85. ROSKOSKY M, Moni G, Kawakami V, Lambert J, et al
    SARS-CoV-2 Transmission Associated with an Indoor Music Event That Required Proof of Full Vaccination Against COVID-19 Prior to Entry-Seattle, July 2021.
    Clin Infect Dis. 2022 Jun 20. pii: 6611550. doi: 10.1093.
    >> Share

  86. SABLEROLLES RSG, Rietdijk WJR, Goorhuis A, Postma DF, et al
    Durability of immune responses after boosting in Ad26.COV2.S-primed healthcare workers.
    Clin Infect Dis. 2022 Jun 20. pii: 6611568. doi: 10.1093.
    >> Share

  87. VU DM, Vu DTB, Do TTT, Olmsted AE, et al
    Presence of SARS-CoV-2 Antibodies among Vietnamese Healthcare Workers by Dosing Interval for ChAdOx1 nCoV-19 Vaccine.
    Clin Infect Dis. 2022 Jun 20. pii: 6611567. doi: 10.1093.
    >> Share

  88. KEATING P, Sell J, Chen J, Ackelsberg J, et al
    Delayed Recognition of COVID-19 in New York City: A descriptive analysis of COVID-19 illness prior to February 29, 2020.
    Clin Infect Dis. 2022 Jun 20. pii: 6611571. doi: 10.1093.
    >> Share

  89. KLAASSEN F, Chitwood MH, Cohen T, Pitzer VE, et al
    Population immunity to pre-Omicron and Omicron SARS-CoV-2 variants in US states and counties through December 1, 2021.
    Clin Infect Dis. 2022 Jun 20. pii: 6611479. doi: 10.1093.
    >> Share

  90. GOLD JAW, Ahmad FB, Cisewski JA, Rossen LM, et al
    Increased deaths from fungal infections during the COVID-19 pandemic-National Vital Statistics System, United States, January 2020-December 2021.
    Clin Infect Dis. 2022 Jun 19. pii: 6611491. doi: 10.1093.
    >> Share

  91. CZECH-SIOLI M, Gunther T, Robitaille A, Roggenkamp H, et al
    Integration of sequencing and epidemiological data for surveillance of SARS-CoV-2 infections in a tertiary-care hospital.
    Clin Infect Dis. 2022 Jun 19. pii: 6611489. doi: 10.1093.
    >> Share

  92. STRID P, Zapata LB, Tong VT, Zambrano LD, et al
    COVID-19 Severity among Women of Reproductive Age with Symptomatic Laboratory-Confirmed SARS-CoV-2 by Pregnancy Status - United States, Jan 1, 2020 - Dec 25, 2021.
    Clin Infect Dis. 2022 Jun 19. pii: 6611488. doi: 10.1093.
    >> Share

  93. RICHARDSON VL, Franco MAC, Marquez AB, Valdez LM, et al
    Vaccine effectiveness of CanSino (Adv5-nCoV) COVID-19 vaccine among childcare workers - Mexico, March-December 2021.
    Clin Infect Dis. 2022 Jun 19. pii: 6611492. doi: 10.1093.
    >> Share

  94. HALASA NB, Spieker AJ, Young CC, Olson SM, et al
    Life-Threatening Complications of Influenza versus COVID-19 in U.S. Children.
    Clin Infect Dis. 2022 Jun 19. pii: 6611483. doi: 10.1093.
    >> Share

  95. ROTTENSTREICH A, Zarbiv G, Oiknine-Djian E, Vorontsov O, et al
    Kinetics of maternally-derived anti- SARS-CoV-2 antibodies in infants in relation to the timing of antenatal vaccination.
    Clin Infect Dis. 2022 Jun 19. pii: 6611486. doi: 10.1093.
    >> Share

  96. FREE H, Luckhaupt SE, Billock RM, Groenewold MR, et al
    Reported exposures among in-person workers with SARS-CoV-2 infection in 6 states, September 2020-June 2021.
    Clin Infect Dis. 2022 Jun 19. pii: 6611490. doi: 10.1093.
    >> Share

  97. RANGANATH N, O'Horo JC, Challener DW, Tulledge-Scheitel SM, et al
    Rebound Phenomenon after Nirmatrelvir/Ritonavir Treatment of Coronavirus Disease-2019 in High-Risk Persons.
    Clin Infect Dis. 2022 Jun 14. pii: 6607746. doi: 10.1093.
    >> Share

  98. MONGE S, Rojas-Benedicto A, Olmedo C, Martin-Merino E, et al
    Effectiveness of a second dose of an mRNA vaccine against SARS-CoV-2 Omicron infection in individuals previously infected by other variants.
    Clin Infect Dis. 2022 Jun 10. pii: 6605647. doi: 10.1093.
    >> Share

  99. WEGRZYN RD, Appiah GD, Morfino R, Milford SR, et al
    Early detection of SARS-CoV-2 variants using traveler-based genomic surveillance at four US airports, September 2021- January 2022.
    Clin Infect Dis. 2022 Jun 10. pii: 6605116. doi: 10.1093.
    >> Share

  100. LIND ML, Schultes OL, Robertson AJ, Houde AJ, et al
    Testing Frequency Matters | An Evaluation of the Diagnostic Performance of a SARS-CoV-2 Rapid Antigen Test in United States Correctional Facilities.
    Clin Infect Dis. 2022 Jun 10. pii: 6605088. doi: 10.1093.
    >> Share

  101. LIM SY, Park S, Kim JY, Kim S, et al
    Comparison of Waning Neutralizing Antibody Responses Against the Omicron Variant 6 Months After Natural SARS-CoV-2 Infection (With/Without subsequent COVID-19 Vaccination) Versus 2-dose COVID-19 Vaccination.
    Clin Infect Dis. 2022 Jun 10. pii: 6605068. doi: 10.1093.
    >> Share

  102. RUHLAND A, Fell A, Holzbauer SM, D'Heilly P, et al
    Exposure Outcomes in Fully Vaccinated Healthcare Personnel with Known SARS-CoV-2 Exposure-Minnesota, January-August 2021.
    Clin Infect Dis. 2022 Jun 10. pii: 6605065. doi: 10.1093.
    >> Share

  103. MILLER MJ, Himschoot A, Fitch N, Jawalkar S, et al
    Association of Trends in SARS-CoV-2 Seroprevalence and State-Issued Nonpharmaceutical Interventions- United States, August 1, 2020 - March 30, 2021.
    Clin Infect Dis. 2022 Jun 10. pii: 6605073. doi: 10.1093.
    >> Share

  104. BUSCH MP, Stramer SL, Stone M, Yu EA, et al
    Population-weighted seroprevalence from SARS-CoV-2 infection, vaccination, and hybrid immunity among U.S. blood donations from January-December 2021.
    Clin Infect Dis. 2022 Jun 10. pii: 6605072. doi: 10.1093.
    >> Share

  105. LI ZN, Liu F, Jefferson S, Horner L, et al
    Multiplex Detection of Antibody Landscapes to SARS-CoV-2/Influenza/Common Human Coronaviruses Following Vaccination or Infection with SARS-CoV-2 and Influenza.
    Clin Infect Dis. 2022 Jun 10. pii: 6605070. doi: 10.1093.
    >> Share

  106. MILLER AD, Yousaf AR, Bornstein E, Wu MJ, et al
    Multisystem Inflammatory Syndrome in Children (MIS-C) During SARS-CoV-2 Delta and Omicron Variant Circulation- United States, July 2021 - January 2022.
    Clin Infect Dis. 2022 Jun 10. pii: 6605071. doi: 10.1093.
    >> Share

  107. TOP KA, Chen RT, Levy O, Ozonoff A, et al
    Advancing the Science of Vaccine Safety during the COVID-19 Pandemic and Beyond: Launching an International Network of Special Immunization Services.
    Clin Infect Dis. 2022 Jun 9. pii: 6605049. doi: 10.1093.
    >> Share

  108. WAN EYF, Chui CSL, Ng VWS, Wang Y, et al
    mRNA (BNT162b2) COVID-19 vaccination increased risk of Bell's palsy: a nested case control and self-controlled case series study.
    Clin Infect Dis. 2022 Jun 8. pii: 6604461. doi: 10.1093.
    >> Share

  109. BART SM, Curtiss CC, Earnest R, Lobe-Costonis R, et al
    SARS-CoV-2 Outbreak at a College with High COVID-19 Vaccination Coverage-Connecticut, August-September 2021.
    Clin Infect Dis. 2022 Jun 8. pii: 6604453. doi: 10.1093.
    >> Share

  110. LEWIS NM, Self WH, Gaglani M, Ginde AA, et al
    Effectiveness of the Ad26.COV2.S (Johnson & Johnson) COVID-19 Vaccine for Preventing COVID-19 Hospitalizations and Progression to High Disease Severity in the United States.
    Clin Infect Dis. 2022 Jun 8. pii: 6604454. doi: 10.1093.
    >> Share

  111. LEUNG NHL, Cheng SMS, Martin-Sanchez M, Au NYM, et al
    Immunogenicity of a third dose of BNT162b2 to ancestral SARS-CoV-2 & Omicron variant in adults who received two doses of inactivated vaccine.
    Clin Infect Dis. 2022 Jun 8. pii: 6604400. doi: 10.1093.
    >> Share

  112. DOYLE TJ, Kiros GE, Schmitt-Matzen EN, Propper R, et al
    Maternal and perinatal outcomes associated with SARS-CoV-2 infection during pregnancy, Florida, 2020-2021: A retrospective cohort study.
    Clin Infect Dis. 2022 Jun 8. pii: 6604396. doi: 10.1093.
    >> Share

  113. ALHABBAB RY, Algaissi A, Mahmoud AB, Alkayyal AA, et al
    MERS-CoV infection elicits long-lasting specific antibody, T and B cell immune responses in recovered individuals.
    Clin Infect Dis. 2022 Jun 8. pii: 6604398. doi: 10.1093.
    >> Share

  114. NACHEGA JB, Sam-Agudu NA, Machekano RN, Rosenthal PJ, et al
    Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection and Pregnancy in Sub-Saharan Africa: A 6-Country Retrospective Cohort Analysis.
    Clin Infect Dis. 2022 Jun 8. pii: 6603567. doi: 10.1093.
    >> Share

  115. NACHEGA JB, Sam-Agudu NA, Siedner MJ, Rosenthal PJ, et al
    Prioritizing Pregnant Women for Coronavirus Disease 2019 Vaccination in African Countries.
    Clin Infect Dis. 2022 Jun 8. pii: 6603568. doi: 10.1093.
    >> Share

  116. STRAUS W, Urdaneta V, Esposito DB, Mansi JA, et al
    Analysis of Myocarditis Among 252 Million mRNA-1273 Recipients Worldwide.
    Clin Infect Dis. 2022 Jun 6. pii: 6603291. doi: 10.1093.
    >> Share

  117. RICHTERMAN A, Behrman A, Brennan PJ, O'Donnell JA, et al
    Durability of SARS-CoV-2 mRNA Booster Vaccine Protection Against Omicron Among Health Care Workers with a Vaccine Mandate.
    Clin Infect Dis. 2022 Jun 6. pii: 6603294. doi: 10.1093.
    >> Share

  118. LIN Y, Yue S, Yang Y, Yang S, et al
    Nasal Spray of Neutralizing Monoclonal Antibody 35B5 Confers Potential Prophylaxis Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants of Concern (VOCs): A Small-scale Clinical Trial.
    Clin Infect Dis. 2022 Jun 6. pii: 6603292. doi: 10.1093.
    >> Share

  119. NAJJAR-DEBBINY R, Gronich N, Weber G, Khoury J, et al
    Effectiveness of Paxlovid in Reducing Severe COVID-19 and Mortality in High Risk Patients.
    Clin Infect Dis. 2022 Jun 2. pii: 6599020. doi: 10.1093.
    >> Share

    May 2022
  120. MARRA AR, Miraglia JL, Malheiros DT, Guozhang Y, et al
    Effectiveness of heterologous COVID-19 vaccine booster dosing in Brazilian healthcare workers, 2021.
    Clin Infect Dis. 2022 May 27. pii: 6594056. doi: 10.1093.
    >> Share

  121. NASH D, Rane MS, Robertson MM, Chang M, et al
    SARS-CoV-2 incidence and risk factors in a national, community-based prospective cohort of U.S. adults.
    Clin Infect Dis. 2022 May 27. pii: 6594058. doi: 10.1093.
    >> Share

  122. ZHAO M, Slotkin R, Sheth AH, Pischel L, et al
    Serum Neutralizing Antibody Titers 12 months after COVID-19 mRNA Vaccination: Correlation to Clinical Variables in an Adult, US-Population.
    Clin Infect Dis. 2022 May 26. pii: 6593314. doi: 10.1093.
    >> Share

  123. PETROS BA, Turcinovic J, Welch NL, White LF, et al
    Early introduction and rise of the Omicron SARS-CoV-2 variant in highly vaccinated university populations.
    Clin Infect Dis. 2022 May 25. pii: 6591846. doi: 10.1093.
    >> Share

  124. GRIMA AA, Murison KR, Simmons AE, Tuite AR, et al
    Relative Virulence of SARS-CoV-2 Among Vaccinated and Unvaccinated Individuals Hospitalized with SARS-CoV-2.
    Clin Infect Dis. 2022 May 25. pii: 6591845. doi: 10.1093.
    >> Share

  125. RIDDELL AC, Kele B, Harris K, Bible J, et al
    Generation of novel SARS-CoV-2 variants on B.1.1.7 lineage in three patients with advanced HIV disease.
    Clin Infect Dis. 2022 May 25. pii: 6591841. doi: 10.1093.
    >> Share


  126. Correction to: Investigation of a Suspect Severe Acute Respiratory Syndrome Coronavirus-2 and Influenza A Mixed Outbreak: Lessons Learned for Long-Term Care Facilities Nationwide.
    Clin Infect Dis. 2022 May 24. pii: 6591404. doi: 10.1093.
    >> Share


  127. Correction to: Clinical Experience With Severe Acute Respiratory Syndrome Coronavirus 2-Related Illness in Children: Hospital Experience in Cape Town, South Africa.
    Clin Infect Dis. 2022 May 24. pii: 6591403. doi: 10.1093.
    >> Share

  128. EPSI NJ, Richard SA, Lindholm DA, Mende K, et al
    Understanding 'hybrid immunity': comparison and predictors of humoral immune responses to SARS-CoV-2 infection and COVID-19 vaccines.
    Clin Infect Dis. 2022 May 24. pii: 6591282. doi: 10.1093.
    >> Share

  129. KIM DY, Lin MY, Jennings C, Li H, et al
    Duration of replication-competent SARS-CoV-2 shedding among patients with severe or critical coronavirus disease 2019 (COVID-19).
    Clin Infect Dis. 2022 May 24. pii: 6590994. doi: 10.1093.
    >> Share

  130. CORRADINI P, Agrati C, Apolone G, Mantovani A, et al
    Humoral and T-cell immune response after three doses of mRNA SARS-CoV-2 vaccines in fragile patients: the Italian VAX4FRAIL study.
    Clin Infect Dis. 2022 May 24. pii: 6590993. doi: 10.1093.
    >> Share

  131. LOFGREN E, Naumova EN, Gorski J, Naumov Y, et al
    How drivers of seasonality in respiratory infections may impact vaccine strategy: a case study in how COVID-19 may help us solve one of influenza's biggest challenges.
    Clin Infect Dis. 2022 May 24. pii: 6590989. doi: 10.1093.
    >> Share

  132. EYAL N, Gheaus A, Gosseries A, Magalhaes M, et al
    COVID vaccine prioritization in low- and middle-income countries may justifiably depart from high-income countries' age priorities.
    Clin Infect Dis. 2022 May 24. pii: 6590988. doi: 10.1093.
    >> Share

  133. LAGOUSI T, Papadatou I, Strempas P, Chatzikalil E, et al
    PAVING THE WAY TOWARDS PRECISION VACCINOLOGY: THE PARADIGM OF MYOCARDITIS AFTER COVID-19 VACCINATION.
    Clin Infect Dis. 2022 May 24. pii: 6590985. doi: 10.1093.
    >> Share

  134. SHAPIRO JR, Sitaras I, Park HS, Aytenfisu TY, et al
    Association of frailty, age, and biological sex with SARS-CoV-2 mRNA vaccine-induced immunity in older adults.
    Clin Infect Dis. 2022 May 24. pii: 6590987. doi: 10.1093.
    >> Share

  135. ROTTENSTREICH A, Vorontsov O, Alfi O, Zarbiv G, et al
    Maternal and Neonatal SARS-CoV-2 Omicron Variant Neutralization after Antenatal mRNA Vaccination.
    Clin Infect Dis. 2022 May 24. pii: 6590984. doi: 10.1093.
    >> Share

  136. DELAHOY MJ, Ujamaa D, Taylor CA, Cummings C, et al
    Comparison of influenza and COVID-19-associated hospitalizations among children < 18 years old in the United States-FluSurv-NET (October-April 2017-2021) and COVID-NET (October 2020-September 2021).
    Clin Infect Dis. 2022 May 20. pii: 6589788. doi: 10.1093.
    >> Share

  137. LEVIN-RECTOR A, Firestein L, McGibbon E, Sell J, et al
    Reduced Odds of SARS-CoV-2 Reinfection after Vaccination among New York City Adults, July-November 2021.
    Clin Infect Dis. 2022 May 20. pii: 6589783. doi: 10.1093.
    >> Share

  138. TENFORDE MW, Self WH, Zhu Y, Naioti EA, et al
    Protection of mRNA vaccines against hospitalized COVID-19 in adults over the first year following authorization in the United States.
    Clin Infect Dis. 2022 May 17. pii: 6587132. doi: 10.1093.
    >> Share

  139. MARTINUZZI E, Benzaquen J, Guerin O, Leroy S, et al
    A Single Dose of BNT162b2 mRNA Vaccine Induces Airway Immunity in SARS-CoV-2 Naive and recovered COVID-19 subjects.
    Clin Infect Dis. 2022 May 17. pii: 6586846. doi: 10.1093.
    >> Share

  140. SHOHAM S, Bloch EM, Casadevall A, Hanley D, et al
    Transfusing convalescent plasma as post-exposure prophylaxis against SARS-CoV-2 infection: a double-blinded, phase 2 randomized, controlled trial.
    Clin Infect Dis. 2022 May 17. pii: 6586841. doi: 10.1093.
    >> Share

  141. WEITZMAN ER, Kossowsky J, Blakemore LM, Cox R, et al
    Acceptability of a Fentanyl Vaccine to Prevent Opioid Overdose and Need for Personalized Decision-Making.
    Clin Infect Dis. 2022 May 17. pii: 6586840. doi: 10.1093.
    >> Share

  142. ODUMADE OA, van Haren SD, Angelidou A
    Implications of the SARS-CoV-2 pandemic on the epidemiology of pediatric Respiratory Syncytial Virus (RSV) infection.
    Clin Infect Dis. 2022 May 17. pii: 6586842. doi: 10.1093.
    >> Share

  143. WEITZMAN ER, Sherman AC, Levy O
    Pediatric SARS-CoV-2 Vaccines: Perceptions and Attitudes from the FDA Public Commentary.
    Clin Infect Dis. 2022 May 17. pii: 6586838. doi: 10.1093.
    >> Share

  144. COLE KA, Zhou AY, Jones T, Moore WJ, et al
    How to Harness the Power of Social Media for Quality Drug Information in Infectious Diseases: Perspectives on Behalf of the Society of Infectious Diseases Pharmacists.
    Clin Infect Dis. 2022;74.
    >> Share

  145. NEMATOLLAHI S, Minter DJ, Barlow B, Nolan NS, et al
    The Digital Classroom: How to Leverage Social Media for Infectious Diseases Education.
    Clin Infect Dis. 2022;74.
    >> Share

  146. SCHWARTZ IS, McCarty T, Woc-Colburn LE, Titanji BK, et al
    Educational Impact of #IDJClub, a Twitter-Based Infectious Diseases Journal Club.
    Clin Infect Dis. 2022;74.
    >> Share

  147. BARI A, Heymann M, Cohen RJ, Zhao R, et al
    Exploring Coronavirus Disease 2019 Vaccine Hesitancy on Twitter Using Sentiment Analysis and Natural Language Processing Algorithms.
    Clin Infect Dis. 2022;74.
    >> Share

  148. ZENG C, Zhang J, Li Z, Sun X, et al
    Population Mobility and Aging Accelerate the Transmission of Coronavirus Disease 2019 in the Deep South: A County-Level Longitudinal Analysis.
    Clin Infect Dis. 2022;74.
    >> Share

  149. DESAI AN, Ruidera D, Steinbrink JM, Granwehr B, et al
    Misinformation and Disinformation: The Potential Disadvantages of Social Media in Infectious Disease and How to Combat Them.
    Clin Infect Dis. 2022;74.
    >> Share

  150. POH XY, Tan CW, Lee IR, Chavatte JM, et al
    Antibody response of heterologous vs homologous mRNA vaccine boosters against the SARS-CoV-2 Omicron variant: interim results from the PRIBIVAC study, A Randomized Clinical Trial.
    Clin Infect Dis. 2022 May 11. pii: 6583615. doi: 10.1093.
    >> Share

  151. DE CASTILHOS J, Zamir E, Hippchen T, Rohrbach R, et al
    Correction to: Severe Dysbiosis and Specific Haemophilus and Neisseria Signatures as Hallmarks of the Oropharyngeal Microbiome in Critically Ill Coronavirus Disease 2019 (COVID-19) Patients.
    Clin Infect Dis. 2022 May 10. pii: 6583345. doi: 10.1093.
    >> Share

  152. CONTI MG, Terreri S, Terrin G, Natale F, et al
    SARS-CoV-2 infection versus vaccination in pregnancy: Implications for maternal and infant immunity.
    Clin Infect Dis. 2022 May 10. pii: 6583148. doi: 10.1093.
    >> Share

  153. MOISAN A, Mastrovito B, De Oliveira F, Martel M, et al
    Evidence of transmission and circulation of Deltacron XD recombinant SARS-CoV-2 in Northwest France.
    Clin Infect Dis. 2022 May 10. pii: 6583149. doi: 10.1093.
    >> Share

  154. SPARKE M, Levy O
    Competing responses to global inequalities in access to COVID vaccines: Vaccine Diplomacy and Vaccine Charity Versus Vaccine Liberty.
    Clin Infect Dis. 2022 May 10. pii: 6583150. doi: 10.1093.
    >> Share

  155. ZURCHER K, Abela IA, Stange M, Dupont C, et al
    Alpha variant coronavirus outbreak in a nursing home despite high vaccination coverage: molecular, epidemiological and immunological studies.
    Clin Infect Dis. 2022 May 6. pii: 6582009. doi: 10.1093/cid/ciab1005.
    >> Share

  156. DALAI SC, Dines JN, Snyder TM, Gittelman RM, et al
    Clinical Validation of a Novel T-cell Receptor Sequencing Assay for Identification of Recent or Prior SARS-CoV-2 Infection.
    Clin Infect Dis. 2022 May 6. pii: 6581622. doi: 10.1093.
    >> Share

  157. DOWLING DJ, Levy O
    A Precision Adjuvant Approach to Enhance SARS-CoV-2 Vaccines Optimized for Immunologically Distinct Vulnerable Populations.
    Clin Infect Dis. 2022 May 4. pii: 6580093. doi: 10.1093.
    >> Share

  158. LASSER J, Hell T, Garcia D
    Assessment of the effectiveness of Omicron transmission mitigation strategies for European universities using an agent-based network model.
    Clin Infect Dis. 2022 May 3. pii: 6577094. doi: 10.1093.
    >> Share

  159. BUTT AA, Talisa VB, Shaikh OS, Omer SB, et al
    Relative Vaccine Effectiveness of a SARS-CoV-2 mRNA Vaccine Booster Dose Against the Omicron Variant.
    Clin Infect Dis. 2022 May 3. pii: 6577096. doi: 10.1093.
    >> Share

  160. VERDERESE JP, Henry L, Younossi ZM
    Reply to Bailly et al.
    Clin Infect Dis. 2022;74:1707-1708.
    >> Share

    April 2022
  161. MILLER AD, Zambrano LD, Yousaf AR, Abrams JY, et al
    Correction to: Multisystem Inflammatory Syndrome in Children-United States, February 2020-July 2021.
    Clin Infect Dis. 2022 Apr 27. pii: 6574996. doi: 10.1093.
    >> Share

  162. ROSS JA, Malone PK, Levy S
    The Impact of the SARS-CoV-2 Pandemic on Substance Use in the US.
    Clin Infect Dis. 2022 Apr 27. pii: 6574792. doi: 10.1093.
    >> Share

  163. CADNUM JL, Jencson AL, Alhmidi H, Zabarsky TF, et al
    Airflow patterns in double occupancy patient rooms may contribute to roommate-to-roommate transmission of severe acute respiratory syndrome coronavirus 2.
    Clin Infect Dis. 2022 Apr 27. pii: 6574835. doi: 10.1093.
    >> Share

  164. SHRESTHA NK, Shrestha P, Burke PC, Nowacki AS, et al
    Coronavirus Disease 2019 (COVID-19) Vaccine Boosting in Previously Infected or Vaccinated Individuals.
    Clin Infect Dis. 2022 Apr 27. pii: 6574819. doi: 10.1093.
    >> Share

  165. CORVOL H, de Miranda S, Dehillotte C, Lemonnier L, et al
    Cumulative Incidence and Risk Factors for Severe COVID-19 in French People with Cystic Fibrosis.
    Clin Infect Dis. 2022 Apr 27. pii: 6574734. doi: 10.1093.
    >> Share

  166. SHARMA A, Oda G, Holodniy M
    Effectiveness of mRNA-based vaccines during the emergence of SARS-CoV-2 Omicron variant.
    Clin Infect Dis. 2022 Apr 27. pii: 6574744. doi: 10.1093.
    >> Share

  167. BENFIELD T, Bodilsen J, Brieghel C, Harboe ZB, et al
    Correction to: Improved Survival Among Hospitalized Patients With Coronavirus Disease 2019 (COVID-19) Treated With Remdesivir and Dexamethasone. A Nationwide Population-Based Cohort Study.
    Clin Infect Dis. 2022 Apr 23. pii: 6572821. doi: 10.1093.
    >> Share

  168. GAYLIS NB, Ritter A, Kelly SA, Pourhassan NZ, et al
    Reduced Cell Surface Levels of C-C Chemokine Receptor 5 and Immunosuppression in Long Coronavirus Disease 2019 Syndrome.
    Clin Infect Dis. 2022 Apr 22. pii: 6572226. doi: 10.1093.
    >> Share

  169. HOLUBAR M, Subramanian A, Purington N, Hedlin H, et al
    Favipiravir for treatment of outpatients with asymptomatic or uncomplicated COVID-19: a double-blind randomized, placebo-controlled, phase 2 trial.
    Clin Infect Dis. 2022 Apr 21. pii: 6572081. doi: 10.1093.
    >> Share

  170. SOLERA JT, Arbol BG, Alshahrani A, Bahinskaya I, et al
    Impact of Vaccination and Early Monoclonal Antibody Therapy on COVID-19 Outcomes in Organ Transplant Recipients During the Omicron Wave.
    Clin Infect Dis. 2022 Apr 21. pii: 6571785. doi: 10.1093.
    >> Share

  171. LIANG EN W, Ko KK, Conceicao EP, Aung MK, et al
    Enhanced infection-prevention measures including universal N95 usage and daily testing: the impact on SARS-CoV-2 transmission in cohorted hospital cubicles through successive Delta and Omicron waves.
    Clin Infect Dis. 2022 Apr 21. pii: 6571575. doi: 10.1093.
    >> Share

  172. ZAHRA FT, Grubbs G, Dummer K, Tremoulet AH, et al
    Neutralization of SARS-CoV-2 Omicron and other variants in serum from children with vaccination-induced myocarditis.
    Clin Infect Dis. 2022 Apr 21. pii: 6571576. doi: 10.1093.
    >> Share

  173. LONG SM, Chern A, Cooley V, Chung S, et al
    Temporal Dynamics of Nasopharyngeal and Tracheal SARS-CoV-2 Cycle Thresholds in COVID-19 Patients with Tracheostomy.
    Clin Infect Dis. 2022 Apr 20. pii: 6571468. doi: 10.1093.
    >> Share

  174. LOPEZ MONTESINOS I, Arrieta-Aldea I, Dicastillo A, Zuccarino F, et al
    Comparison of hospitalized COVID-19 and influenza patients requiring supplemental oxygen in a cohort study: clinical impact and resource consumption.
    Clin Infect Dis. 2022 Apr 20. pii: 6571459. doi: 10.1093.
    >> Share

  175. BONENFANT G, Deyoe J, Wong T, Grijalva CG, et al
    Surveillance and correlation of SARS-CoV-2 viral RNA, antigen, virus isolation, and self-reported symptoms in a longitudinal study with daily sampling.
    Clin Infect Dis. 2022 Apr 20. pii: 6571330. doi: 10.1093.
    >> Share

  176. MELGAR M, Haston J, DeCuir J, Cheng Q, et al
    Multisystem inflammatory syndrome in adults (MIS-A): case finding through systematic review of electronic medical records.
    Clin Infect Dis. 2022 Apr 20. pii: 6571412. doi: 10.1093.
    >> Share

  177. DAN J, da Silva Antunes R, Grifoni A, Weiskopf D, et al
    Observations and perspectives on adaptive immunity to SARS-CoV-2.
    Clin Infect Dis. 2022 Apr 20. pii: 6571103. doi: 10.1093.
    >> Share

  178. KIM J, Choe YJ, Jang EJ, Lim DS, et al
    Effectiveness of Booster mRNA Vaccines against SARS-CoV-2 Infection in Elderly Population, South Korea, October 2021 - January 2022.
    Clin Infect Dis. 2022 Apr 19. pii: 6570782. doi: 10.1093.
    >> Share

  179. NANISHI E, Angelidou A, Rotman C, Dowling DJ, et al
    Precision Vaccine Adjuvants for Older Adults: A Scoping Review.
    Clin Infect Dis. 2022 Apr 19. pii: 6570880. doi: 10.1093.
    >> Share

  180. LEVY O, Angelidou A, Idoko O, Lewis NP, et al
    Precision Vaccines: Lessons Learned from the Coronavirus Pandemic.
    Clin Infect Dis. 2022 Apr 19. pii: 6570826. doi: 10.1093.
    >> Share

  181. PLUMMER JT, Contreras D, Zhang W, Binek A, et al
    USA SARS-CoV-2 Epsilon Variant: Though Highly Transmissible has an Adjusted Muted Host T-Cell Response.
    Clin Infect Dis. 2022 Apr 19. pii: 6570676. doi: 10.1093.
    >> Share

  182. WOLDEMESKEL BA, Garliss CC, Aytenfisu TY, Johnston TS, et al
    Discordant antibody and T cell responses to the SARS-CoV-2 Omicron variant in COVID-19 mRNA vaccine recipient.
    Clin Infect Dis. 2022 Apr 19. pii: 6570698. doi: 10.1093.
    >> Share

  183. SKOWRONSKI DM, Febriani Y, Ouakki M, Setayeshgar S, et al
    Two-dose SARS-CoV-2 vaccine effectiveness with mixed schedules and extended dosing intervals: test-negative design studies from British Columbia and Quebec, Canada.
    Clin Infect Dis. 2022 Apr 19. pii: 6570607. doi: 10.1093.
    >> Share

  184. MAEDA H, Saito N, Igarashi A, Ishida M, et al
    Effectiveness of mRNA COVID-19 vaccines against symptomatic SARS-CoV-2 infections during the Delta variant epidemic in Japan: Vaccine Effectiveness Real-time Surveillance for SARS-CoV-2 (VERSUS).
    Clin Infect Dis. 2022 Apr 19. pii: 6570603. doi: 10.1093.
    >> Share

  185. SHERMAN AC, Rouphael N, Baden LR
    COVID-19 Vaccine Trials (and Tribulations): How to improve the process of clinical trials in a pandemic.
    Clin Infect Dis. 2022 Apr 18. pii: 6569988. doi: 10.1093.
    >> Share

  186. MASSO-SILVA JA, Moshensky A, Lam MTY, Odish M, et al
    Correction to: Increased Peripheral Blood Neutrophil Activation Phenotypes and Neutrophil Extracellular Trap Formation in Critically Ill Coronavirus Disease 2019 Patients: A Case Series and Review of the Literature.
    Clin Infect Dis. 2022 Apr 13. pii: 6568031. doi: 10.1093.
    >> Share

  187. DALE AP, Almendares O, Howard B, Burnett E, et al
    Investigation of A SARS-CoV-2 Delta (B.1.617.2) Variant Outbreak Among Residents of a Skilled Nursing Facility and Vaccine Effectiveness Analysis - Maricopa County, Arizona, June-July 2021.
    Clin Infect Dis. 2022 Apr 12. pii: 6567536. doi: 10.1093.
    >> Share

  188. PREMIKHA M, Chiew CJ, Wei WE, Leo YS, et al
    Comparative Effectiveness of mRNA and Inactivated Whole Virus Vaccines against COVID-19 Infection and Severe Disease in Singapore.
    Clin Infect Dis. 2022 Apr 12. pii: 6567428. doi: 10.1093.
    >> Share

  189. PAREDES MI, Lunn SM, Famulare M, Frisbie LA, et al
    Associations between SARS-CoV-2 variants and risk of COVID-19 hospitalization among confirmed cases in Washington State: a retrospective cohort study.
    Clin Infect Dis. 2022 Apr 12. pii: 6567408. doi: 10.1093.
    >> Share

  190. MOLODTSOV IA, Kegeles E, Mitin AN, Mityaeva O, et al
    SARS-CoV-2-specific T cells and antibodies in COVID-19 protection: a prospective study.
    Clin Infect Dis. 2022 Apr 12. pii: 6567222. doi: 10.1093.
    >> Share

  191. BUTT AA, Dargham SR, Loka S, Shaik RM, et al
    COVID-19 Disease Severity in Children Infected with the Omicron Variant.
    Clin Infect Dis. 2022 Apr 11. pii: 6566327. doi: 10.1093.
    >> Share

  192. SKEGGS J, MacPhail A, Korman T, Woolley I, et al
    Reductions in Antibiotic Prescribing in Australia During the SARS-CoV-2 Pandemic: National Prescribing Data.
    Clin Infect Dis. 2022 Apr 11. pii: 6566296. doi: 10.1093.
    >> Share

  193. MARGALIT I, Yelin D, Sagi M, Rahat MM, et al
    Risk factors and multidimensional assessment of long COVID fatigue: a nested case-control study.
    Clin Infect Dis. 2022 Apr 11. pii: 6566295. doi: 10.1093.
    >> Share

  194. RZYMSKI P, Falfushynska H, Fal A
    Vaccination of Ukrainian Refugees: Need for Urgent Action.
    Clin Infect Dis. 2022 Apr 11. pii: 6569707. doi: 10.1093.
    >> Share

  195. CAI J, Lin Y, Wu MJ
    Letter to editor regarding "Clinical Presentation and Outcomes of Pregnant Women With Coronavirus Disease 2019: A Systematic Review and Meta-analysis".
    Clin Infect Dis. 2022;74:1319.
    >> Share

  196. KOLODZIEJ LM, van Lelyveld SFL, Haverkort ME, Mariman R, et al
    High SARS-CoV-2 household transmission rates detected by dense saliva sampling.
    Clin Infect Dis. 2022 Apr 6. pii: 6564312. doi: 10.1093.
    >> Share

  197. GAZIT S, Shlezinger R, Perez G, Lotan R, et al
    SARS-CoV-2 Naturally Acquired Immunity vs. Vaccine-induced Immunity, Reinfections versus Breakthrough Infections: a Retrospective Cohort Study.
    Clin Infect Dis. 2022 Apr 5. pii: 6563799. doi: 10.1093.
    >> Share

  198. ANTINORI A, Cicalini S, Meschi S, Bordoni V, et al
    Humoral and cellular immune response elicited by mRNA vaccination against SARS-CoV-2 in people living with HIV (PLWH) receiving antiretroviral therapy (ART) according with current CD4 T-lymphocyte count.
    Clin Infect Dis. 2022 Apr 2. pii: 6562777. doi: 10.1093.
    >> Share

  199. PARK S, Lim SY, Kim JY, Park H, et al
    Clinical and virological characteristics of SARS-CoV-2 B.1.617.2 (Delta) variant: a prospective cohort study.
    Clin Infect Dis. 2022 Apr 1. pii: 6562005. doi: 10.1093.
    >> Share

    March 2022
  200. GARRETT N, Tapley A, Andriesen J, Seocharan I, et al
    High Asymptomatic Carriage with the Omicron Variant in South Africa.
    Clin Infect Dis. 2022 Mar 30. pii: 6556153. doi: 10.1093.
    >> Share

  201. TANDE AJ, Swift MD, Challener DW, Berbari EF, et al
    Utility of Follow-up COVID-19 Antigen Tests After Acute SARS-CoV-2 Infection Among Healthcare Personnel.
    Clin Infect Dis. 2022 Mar 30. pii: 6555774. doi: 10.1093.
    >> Share

  202. NATHAVITHARANA RR, Mishra H, Sullivan A, Hurwitz S, et al
    Predicting airborne infection risk: Association between personal ambient carbon dioxide level monitoring and incidence of tuberculosis infection in South African health workers.
    Clin Infect Dis. 2022 Mar 26. pii: 6554598. doi: 10.1093.
    >> Share

  203. DOLL MK, Pettigrew SM, Ma J, Verma A, et al
    Effects of Confounding Bias in COVID-19 and Influenza Vaccine Effectiveness Test-Negative Designs Due to Correlated Influenza and COVID-19 Vaccination Behaviors.
    Clin Infect Dis. 2022 Mar 24. pii: 6553950. doi: 10.1093.
    >> Share

  204. HERNANDEZ AV, Roman YM, Burela PA, Pasupuleti V, et al
    Reply to Banno et al and Padhi et al.
    Clin Infect Dis. 2022;74:1122-1123.
    >> Share

  205. NG OT, Koh V, Chiew CJ, Marimuthu K, et al
    Impact of SARS-CoV-2 Vaccination and Paediatric Age on Delta Variant Household Transmission.
    Clin Infect Dis. 2022 Mar 22. pii: 6551710. doi: 10.1093.
    >> Share

  206. CHANDNA A, Mahajan R, Gautam P, Mwandigha L, et al
    Facilitating safe discharge through predicting disease progression in moderate COVID-19: a prospective cohort study to develop and validate a clinical prediction model in resource-limited settings.
    Clin Infect Dis. 2022 Mar 21. pii: 6551704. doi: 10.1093.
    >> Share

  207. GIMENEZ E, Albert E, Zulaica J, Torres I, et al
    SARS-CoV-2 adaptive immunity in nursing home residents following a third dose of the Comirnaty(R) COVID-19 vaccine.
    Clin Infect Dis. 2022 Mar 21. pii: 6551700. doi: 10.1093.
    >> Share


  208. Erratum to: Risk Factors for Coronavirus Disease 2019 (COVID-19) Death in a Population Cohort Study from the Western Cape Province, South Africa.
    Clin Infect Dis. 2022 Mar 17. pii: 6549865. doi: 10.1093.
    >> Share

  209. EDELSTEIN M, Beiruti KW, Ben-Amram H, Bar-Zeev N, et al
    Antibody-mediated Immunogenicity against SARS-CoV-2 following priming, boosting and hybrid immunity: insights from 11 months of follow-up of a healthcare worker cohort in Israel, December 2020-October 2021.
    Clin Infect Dis. 2022 Mar 12. pii: 6547893. doi: 10.1093.
    >> Share

  210. DOERNBERG SB, Holubar M, Jain V, Weng Y, et al
    Incidence and prevalence of COVID-19 within a healthcare worker cohort during the first year of the SARS-CoV-2 pandemic.
    Clin Infect Dis. 2022 Mar 12. pii: 6547892. doi: 10.1093.
    >> Share

  211. GALLAGHER KME, Leick MB, Larson RC, Berger TR, et al
    Differential T cell immunity to SARS-CoV-2 in mRNA-1273 and BNT162b2 vaccinated individuals.
    Clin Infect Dis. 2022 Mar 12. pii: 6547848. doi: 10.1093.
    >> Share

  212. ALSVED M, Nygren D, Thuresson S, Medstrand P, et al
    SARS-CoV-2 in exhaled aerosol particles from covid-19 cases and its association to household transmission.
    Clin Infect Dis. 2022 Mar 10. pii: 6546685. doi: 10.1093.
    >> Share

  213. FITZGERALD R, Dickinson L, Else L, Fletcher T, et al
    Pharmacokinetics of ss-d-N4-hydroxycytidine, the parent nucleoside of prodrug molnupiravir, in non-plasma compartments of patients with SARS-CoV-2 infection.
    Clin Infect Dis. 2022 Mar 10. pii: 6546684. doi: 10.1093.
    >> Share

  214. CHENG VC, Ip JD, Chu AW, Tam AR, et al
    Rapid spread of SARS-CoV-2 Omicron subvariant BA.2 in a single-source community outbreak.
    Clin Infect Dis. 2022 Mar 10. pii: 6546687. doi: 10.1093.
    >> Share

  215. RIFE MAGALIS B, Rich S, Tagliamonte MS, Mavian C, et al
    SARS-CoV-2 Delta vaccine breakthrough transmissibility in Alachua County, Florida.
    Clin Infect Dis. 2022 Mar 10. pii: 6546683. doi: 10.1093.
    >> Share

  216. WESTBROOK AL, Benedit LC, Frediani JK, Griffiths MA, et al
    Predictive value of isolated symptoms for diagnosis of SARS-CoV-2 infection in children tested during peak circulation of the delta variant.
    Clin Infect Dis. 2022 Mar 10. pii: 6546602. doi: 10.1093.
    >> Share

  217. WOLTER N, Tempia S, von Gottberg A, Bhiman JN, et al
    Seroprevalence of SARS-CoV-2 after the second wave in South Africa in HIV-infected and uninfected persons: a cross-sectional household survey.
    Clin Infect Dis. 2022 Mar 10. pii: 6546682. doi: 10.1093.
    >> Share

  218. LUSTIG Y, Mendelson E, Mandelboim M, Biber A, et al
    Existence of immunological memory response in true sero-negative individuals post COVID-19 molecular diagnosis.
    Clin Infect Dis. 2022 Mar 10. pii: 6546613. doi: 10.1093.
    >> Share

  219. YAU CH, Masuda Y, Ng QX, Teoh SE, et al
    Addressing the Elephant in the Room: Intravenous Injection of COVID-19 mRNA.
    Clin Infect Dis. 2022 Mar 9. pii: 6545850. doi: 10.1093.
    >> Share

  220. BALCELLS ME, Le Corre N, Duran J, Ceballos ME, et al
    Reduced immune response to inactivated SARS-CoV-2 vaccine in a cohort of immunocompromised patients in Chile.
    Clin Infect Dis. 2022 Mar 7. pii: 6543937. doi: 10.1093.
    >> Share

  221. SANDMANN FG, Tessier E, Lacy J, Kall M, et al
    Long-term health-related quality of life in non-hospitalised COVID-19 cases with confirmed SARS-CoV-2 infection in England: Longitudinal analysis and cross-sectional comparison with controls.
    Clin Infect Dis. 2022 Mar 5. pii: 6542727. doi: 10.1093.
    >> Share

  222. MOORLAG SJCFM, Taks E, Ten Doesschate T, van der Vaart TW, et al
    Efficacy of Bacillus Calmette-Guerin vaccination against respiratory tract infections in the elderly during the Covid-19 pandemic.
    Clin Infect Dis. 2022 Mar 5. pii: 6543010. doi: 10.1093.
    >> Share

  223. POLLOCK BD, Storlie CB, Tande AJ, Sampathkumar P, et al
    Real-world incidence of breakthrough COVID-19 hospitalization after vaccination versus natural infection in a large, local, empaneled primary care population using time-to-event analysis.
    Clin Infect Dis. 2022 Mar 5. pii: 6542971. doi: 10.1093.
    >> Share

  224. HURST JH, McCumber AW, Aquino JN, Rodriguez J, et al
    Age-related changes in the nasopharyngeal microbiome are associated with SARS-CoV-2 infection and symptoms among children, adolescents, and young adults.
    Clin Infect Dis. 2022 Mar 5. pii: 6542968. doi: 10.1093.
    >> Share

  225. SARAVOLATZ LD, Depcinski S, Sharma M
    Molnupiravir and Nirmatrelvir-Ritonavir: Oral COVID Antiviral Drugs.
    Clin Infect Dis. 2022 Mar 4. pii: 6542722. doi: 10.1093.
    >> Share

  226. BUTT AA, Talisa VB, Yan P, Shaikh OS, et al
    Vaccine Effectiveness of Three vs. Two Doses of SARS-CoV-2 mRNA Vaccines in a High Risk National Population.
    Clin Infect Dis. 2022 Mar 4. pii: 6542712. doi: 10.1093.
    >> Share

  227. SPINELLI MA, Le Tourneau N, Glidden DV, Hsu L, et al
    Impact of Multi-Component Support Strategies on HIV Virologic Suppression Rates during COVID-19: An Interrupted Time Series Analysis.
    Clin Infect Dis. 2022 Mar 4. pii: 6542721. doi: 10.1093.
    >> Share

  228. CHAN JF, Siu GK, Yuan S, Ip JD, et al
    Probable Animal-to-Human Transmission of SARS-CoV-2 Delta Variant AY.127 Causing a Pet Shop-Related COVID-19 Outbreak in Hong Kong.
    Clin Infect Dis. 2022 Mar 2. pii: 6541148. doi: 10.1093.
    >> Share

  229. SPEICH B, Chammartin F, Abela IA, Amico P, et al
    Antibody response in immunocompromised patients after the administration of SARS-CoV-2 vaccine BNT162b2 or mRNA-1273: A randomised controlled trial.
    Clin Infect Dis. 2022 Mar 2. pii: 6540899. doi: 10.1093.
    >> Share

  230. HOENIGL M, Abramovitz D, Flores Ortega RE, Martin NK, et al
    Sustained impact of the COVID-2019 pandemic on HCV treatment initiations in the United States.
    Clin Infect Dis. 2022 Mar 2. pii: 6540915. doi: 10.1093.
    >> Share

  231. FISMAN DN, Tuite AR
    Age-Specific Changes in Virulence Associated with SARS-CoV-2 Variants of Concern.
    Clin Infect Dis. 2022 Mar 2. pii: 6541156. doi: 10.1093.
    >> Share

  232. KOTILOGLU-KARAA E, Kele B, Kulasegaran-Shylini R, Broad CE, et al
    SARS-CoV-2 placental infection is associated with massive perivillous fibrin deposition at the maternal-fetal interface: a preliminary study".
    Clin Infect Dis. 2022 Mar 2. pii: 6540910. doi: 10.1093.
    >> Share

  233. GANDHI M
    Immunity Against the Omicron Variant from Vaccination, Recovery or Both.
    Clin Infect Dis. 2022 Mar 2. pii: 6540839. doi: 10.1093.
    >> Share

  234. SAUD Z, Ponsford M, Bentley K, Cole JM, et al
    Mechanically ventilated patients shed high titre live SARS-CoV2 for extended periods from both the upper and lower respiratory tract.
    Clin Infect Dis. 2022 Mar 1. pii: 6540532. doi: 10.1093.
    >> Share

    February 2022
  235. THURESSON S, Fraenkel CJ, Sasinovich S, Soldemyr J, et al
    Airborne SARS-CoV-2 in hospitals - effects of aerosol-generating procedures, HEPA-filtration units, patient viral load and physical distance.
    Clin Infect Dis. 2022 Feb 28. pii: 6539846. doi: 10.1093.
    >> Share

  236. SIVAPALASINGAM S, Lederer DJ, Bhore R, Hajizadeh N, et al
    Efficacy and Safety of Sarilumab in Hospitalized Patients With COVID-19: A Randomized Clinical Trial.
    Clin Infect Dis. 2022 Feb 26. pii: 6537638. doi: 10.1093.
    >> Share

  237. KATONA P, Kullar R, Zhang K
    Bringing Transmission of SARS-CoV-2 to the Surface: Is there a Role for Fomites?
    Clin Infect Dis. 2022 Feb 26. pii: 6537376. doi: 10.1093.
    >> Share

  238. MA KC, Hale JE, Grad YH, Alter G, et al
    Trends in SARS-CoV-2 seroprevalence in Massachusetts estimated from newborn screening specimens.
    Clin Infect Dis. 2022 Feb 25. pii: 6537111. doi: 10.1093.
    >> Share

  239. SIGAL GB, Novak T, Mathew A, Chou J, et al
    Measurement of SARS-CoV-2 antigens in plasma of pediatric patients with acute COVID-19 or MIS-C using an ultrasensitive and quantitative immunoassay.
    Clin Infect Dis. 2022 Feb 25. pii: 6537114. doi: 10.1093.
    >> Share

  240. HELDMAN MR, Kates OS, Safa K, Kotton CN, et al
    Delayed mortality among solid organ transplant recipients hospitalized for COVID-19.
    Clin Infect Dis. 2022 Feb 25. pii: 6536752. doi: 10.1093.
    >> Share

  241. WANG Y, He Y, Tong J, Qin Y, et al
    Erratum to: Characterization of an Asymptomatic Cohort of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infected Individuals Outside of Wuhan, China.
    Clin Infect Dis. 2022 Feb 24. pii: 6535534. doi: 10.1093.
    >> Share

  242. HAIDAR G, Agha M, Bilderback A, Lukanski A, et al
    Prospective evaluation of COVID-19 vaccine responses across a broad spectrum of immunocompromising conditions: the COVICS study.
    Clin Infect Dis. 2022 Feb 18. pii: 6530582. doi: 10.1093.
    >> Share

  243. LI C, Ye Z, Zhang AJ, Chan JF, et al
    Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections by intranasal or testicular inoculation induces testicular damage preventable by vaccination in golden Syrian hamsters.
    Clin Infect Dis. 2022 Feb 18. pii: 6530400. doi: 10.1093.
    >> Share

  244. BRIZZI A, O'Driscoll M, Dorigatti I
    Refining reproduction number estimates to account for unobserved generations of infection in emerging epidemics.
    Clin Infect Dis. 2022 Feb 17. pii: 6530349. doi: 10.1093.
    >> Share

  245. ROTTENSTREICH A, Zarbiv G, Oiknine-Djian E, Vorontsov O, et al
    The effect of gestational age at BNT162b2 mRNA vaccination on maternal and neonatal SARS-CoV-2 antibody levels.
    Clin Infect Dis. 2022 Feb 16. pii: 6529520. doi: 10.1093.
    >> Share

  246. DU Z, Liu C, Wang C, Xu L, et al
    Reproduction Numbers of SARS-CoV-2 Variants: A Systematic Review and Meta-analysis.
    Clin Infect Dis. 2022 Feb 16. pii: 6529536. doi: 10.1093.
    >> Share

  247. VAN DEN BERG P, Schechter-Perkins EM, Jack RS, Epshtein I, et al
    Corrigendum to: Effectiveness of 3 Versus 6 ft of Physical Distancing for Controlling Spread of Coronavirus Disease 2019 Among Primary and Secondary Students and Staff: A Retrospective, Statewide Cohort Study.
    Clin Infect Dis. 2022 Feb 16. pii: 6529266. doi: 10.1093/cid/ciab1049.
    >> Share

  248. SCHUMACHER CM, Thornton N, Wagner J, Tilchin C, et al
    Sexually Transmitted Infection Transmission Dynamics During the Coronavirus Disease 2019 (COVID-19) Pandemic Among Urban Gay, Bisexual, and Other Men Who Have Sex With Men.
    Clin Infect Dis. 2022 Feb 16. pii: 6520505. doi: 10.1093/cid/ciab1053.
    >> Share

  249. BERSHTEYN A, Dahl AM, Dong TQ, Deming ME, et al
    Self-Assessed Severity as a Determinant of COVID-19 Symptom Specificity: A Longitudinal Cohort Study.
    Clin Infect Dis. 2022 Feb 13. pii: 6527943. doi: 10.1093.
    >> Share

  250. GAO DX, Fisher LD, Miller DR, Geller AC, et al
    Inequities in COVID-19 vaccination rates among adolescents in Massachusetts: a cross-sectional study.
    Clin Infect Dis. 2022 Feb 13. pii: 6527834. doi: 10.1093.
    >> Share

  251. HSU AL, Ohler AM, Goldstein A, Truong S, et al
    Coronavirus Disease 2019 (COVID-19) Disease Severity: Pregnant vs Nonpregnant Women at 82 Facilities.
    Clin Infect Dis. 2022;74:467-471.
    >> Share

  252. DONNELLY MAP, Chuey MR, Soto R, Schwartz NG, et al
    Household transmission of SARS-CoV-2 Alpha variant - United States, 2021.
    Clin Infect Dis. 2022 Feb 11. pii: 6526950. doi: 10.1093.
    >> Share

  253. ZAIA JA
    In the Fog of Coronavirus Disease (COVID).
    Clin Infect Dis. 2022;74:511-512.
    >> Share

  254. NIV Y, Eliakim-Raz N, Bar-Lavi Y, Green M, et al
    Comparing Covid-19 pandemic waves in hospitalized patients - a retrospective, multicenter, cohort study.
    Clin Infect Dis. 2022 Feb 10. pii: 6526377. doi: 10.1093.
    >> Share

  255. BUTT AA, Talisa VB, Yan P, Shaikh OS, et al
    Real-world Effectiveness of the SARS-CoV-2 mRNA Vaccines in Preventing Confirmed Infection in Patients on Chronic Hemodialysis.
    Clin Infect Dis. 2022 Feb 9. pii: 6525466. doi: 10.1093.
    >> Share

  256. TANG W, Chen HL
    Predictors of SARS-CoV-2 infection: is there a comprehensive analysis?
    Clin Infect Dis. 2022 Feb 8. pii: 6524191. doi: 10.1093.
    >> Share

  257. BAKER MA, Rhee C, Tucker R, Badwaik A, et al
    Rapid control of hospital-based SARS-CoV-2 Omicron clusters through daily testing and universal use of N95 respirators.
    Clin Infect Dis. 2022 Feb 7. pii: 6523822. doi: 10.1093.
    >> Share

  258. DRAWZ PE, DeSilva M, Bodurtha P, Benitez GV, et al
    Effectiveness of BNT162b2 and mRNA-1273 Second Doses and Boosters for SARS-CoV-2 infection and SARS-CoV-2 Related Hospitalizations: A Statewide Report from the Minnesota Electronic Health Record Consortium.
    Clin Infect Dis. 2022 Feb 7. pii: 6523820. doi: 10.1093.
    >> Share

  259. LI Z, Lewis B, Berney K, Hallisey E, et al
    Social vulnerability and rurality associated with higher SARS-CoV-2 infection-induced seroprevalence: a nationwide blood donor study, United States, July 2020 - June 2021.
    Clin Infect Dis. 2022 Feb 7. pii: 6523818. doi: 10.1093.
    >> Share

  260. RISK M, Shen C, Hayek SS, Holevinski L, et al
    Comparative Effectiveness of COVID-19 Vaccines against the Delta Variant.
    Clin Infect Dis. 2022 Feb 7. pii: 6523819. doi: 10.1093.
    >> Share

  261. PERNICIARO S, van der Linden M, Weinberger DM
    Re-emergence of Invasive Pneumococcal Disease in Germany during the Spring and Summer of 2021.
    Clin Infect Dis. 2022 Feb 7. pii: 6523816. doi: 10.1093.
    >> Share

  262. ERAUSQUIN JT, Tan RKJ, Uhlich M, Francis JM, et al
    The International Sexual Health And Reproductive Health Survey (I-SHARE-1): A Multi-Country Analysis of Adults from 30 Countries Prior to and During the Initial COVID-19 Wave.
    Clin Infect Dis. 2022 Feb 7. pii: 6523817. doi: 10.1093.
    >> Share

  263. HELMSDAL G, Hansen OK, Moller LF, Christiansen DH, et al
    Omicron outbreak at a private gathering in the Faroe Islands, infecting 21 of 33 triple-vaccinated healthcare workers.
    Clin Infect Dis. 2022 Feb 3. pii: 6520882. doi: 10.1093.
    >> Share

  264. NEUZIL KM
    Prevention and Control of COVID-19: Where do we go from here?
    Clin Infect Dis. 2022 Feb 3. pii: 6520891. doi: 10.1093.
    >> Share

  265. ONG SWX, Sutjipto S, Lee PH, Dugan C, et al
    Validation of ISARIC 4C mortality and deterioration scores in a mixed vaccination status cohort of hospitalized COVID-19 patients in Singapore.
    Clin Infect Dis. 2022 Feb 3. pii: 6520952. doi: 10.1093.
    >> Share

  266. PISCHEL L, Patel KM, Goshua G, Omer SB, et al
    Adenovirus-based vaccines and thrombosis in pregnancy: A systematic review and meta-analysis.
    Clin Infect Dis. 2022 Feb 2. pii: 6520532. doi: 10.1093.
    >> Share

  267. NOUSHAD M, Al-Awar MS, Al-Saqqaf IS, Nassani MZ, et al
    Lack of access to COVID-19 vaccines could be a greater threat than vaccine hesitancy in low-income and conflict nations: the case of Yemen.
    Clin Infect Dis. 2022 Feb 2. pii: 6520556. doi: 10.1093.
    >> Share

  268. MEIRING S, Tempia S, Bhiman JN, Buys A, et al
    Prolonged shedding of SARS-CoV-2 at high viral loads amongst hospitalised immunocompromised persons living with HIV, South Africa.
    Clin Infect Dis. 2022 Feb 2. pii: 6520530. doi: 10.1093.
    >> Share

  269. CROMER D, Reynaldi A, Steain M, Triccas JA, et al
    Relating in vitro neutralisation level and protection in the CVnCoV (CUREVAC) trial.
    Clin Infect Dis. 2022 Feb 1. pii: 6518223. doi: 10.1093.
    >> Share

    January 2022
  270. FRIEDMAN N, Levy N, Kaplan O, Padeh G, et al
    Pediatric Hospitalizations after School Reopening during the SARS-CoV-2 Alpha (B.1.1.7) Variant Spread: A Multicenter Cross-sectional Study in Israel.
    Clin Infect Dis. 2022 Jan 29. pii: 6517373. doi: 10.1093.
    >> Share

  271. HOLMDAHL I, Kahn R, Slifka KJ, Dooling K, et al
    Modeling the impact of vaccination strategies for nursing homes in the context of increased SARS-CoV-2 community transmission and variants.
    Clin Infect Dis. 2022 Jan 29. pii: 6517371. doi: 10.1093.
    >> Share

  272. WATKINS LKF, Mitruka K, Dorough L, Bressler SS, et al
    Characteristics of Reported Deaths Among Fully Vaccinated Persons with COVID-19 -United States, January-April 2021.
    Clin Infect Dis. 2022 Jan 29. pii: 6517385. doi: 10.1093.
    >> Share

  273. STRAHM C, Seneghini M, Gusewell S, Egger T, et al
    Symptoms compatible with long-COVID in healthcare workers with and without SARS-CoV-2 infection - results of a prospective multicenter cohort.
    Clin Infect Dis. 2022 Jan 28. pii: 6516835. doi: 10.1093.
    >> Share

  274. PEROFSKY AC, Tempia S, Bingham J, Maslo C, et al
    The direct and indirect effects of the COVID-19 pandemic on private healthcare utilization in South Africa, March 2020 - September 2021.
    Clin Infect Dis. 2022 Jan 27. pii: 6515907. doi: 10.1093.
    >> Share

  275. MARRONE A, Nevola R, Sellitto A, Cozzolino D, et al
    Remdesivir plus dexamethasone versus dexamethasone alone for the treatment of COVID-19 patients requiring supplemental O2 therapy: a prospective controlled non-randomized study.
    Clin Infect Dis. 2022 Jan 27. pii: 6515763. doi: 10.1093.
    >> Share

  276. CHIN ET, Leidner D, Zhang Y, Long E, et al
    Effectiveness of COVID-19 vaccines among incarcerated people in California state prisons: retrospective cohort study.
    Clin Infect Dis. 2022 Jan 27. pii: 6515675. doi: 10.1093/cid/ciab1032.
    >> Share

  277. SPAULDING AC, Zawitz C
    Vaccination in Prisons and Jails: Corrections Needed in Future Plans.
    Clin Infect Dis. 2022 Jan 27. pii: 6515673. doi: 10.1093/cid/ciab1031.
    >> Share

  278. LAWRENZ J, Xie Q, Zech F, Weil T, et al
    SARS-CoV-2 Vaccination boosts Neutralizing Activity against Seasonal Human Coronaviruses.
    Clin Infect Dis. 2022 Jan 25. pii: 6515378. doi: 10.1093.
    >> Share

  279. MURUGESAN K, Jagannathan P, Altamirano J, Maldonado YA, et al
    Long Term Accuracy of SARS-CoV-2 Interferon-gamma Release Assay and its Application in Household Investigation.
    Clin Infect Dis. 2022 Jan 25. pii: 6515439. doi: 10.1093.
    >> Share

  280. MICHELI V, Bracchitta F, Rizzo A, Mancon A, et al
    First identification of the new SARS-CoV-2 Omicron variant (B.1.1.529) in Italy.
    Clin Infect Dis. 2022 Jan 21. pii: 6513588. doi: 10.1093/cid/ciab1044.
    >> Share

  281. ROWAN SE, McCormick DW, Wendel KA, Scott T, et al
    Lower Prevalence of SARS-CoV-2 Infection Among People Experiencing Homelessness Tested in Outdoor Encampments Compared with Overnight Shelters - Denver, Colorado, June - July 2020.
    Clin Infect Dis. 2022 Jan 18. pii: 6510919. doi: 10.1093.
    >> Share

  282. HUANG YA, Zhu W, Wiener J, Kourtis AP, et al
    Impact of COVID-19 on HIV Preexposure Prophylaxis Prescriptions in the United States - A Time Series Analysis.
    Clin Infect Dis. 2022 Jan 18. pii: 6510912. doi: 10.1093.
    >> Share

  283. PILZ S
    Contributions to the mitigation of the COVID-19 pandemic.
    Clin Infect Dis. 2022 Jan 17. pii: 6509528. doi: 10.1093.
    >> Share

  284. KRONFLI N, Dussault C, Maheu-Giroux M, Halavrezos A, et al
    Seroprevalence and risk factors for SARS-CoV-2 among incarcerated adult men in Quebec, Canada (2021).
    Clin Infect Dis. 2022 Jan 17. pii: 6509066. doi: 10.1093.
    >> Share

  285. SHOJI K, Tsuzuki S, Akiyama T, Matsunaga N, et al
    Clinical characteristics and outcomes of COVID-19 in pregnant women: a propensity score matched analysis of the data from the COVID-19 Registry Japan.
    Clin Infect Dis. 2022 Jan 17. pii: 6509063. doi: 10.1093.
    >> Share

  286. LIU J, Laurie MT, Rubio L, Vazquez SE, et al
    SARS-CoV-2 transmission dynamics and immune responses in a household of vaccinated persons.
    Clin Infect Dis. 2022 Jan 17. pii: 6509064. doi: 10.1093.
    >> Share

  287. SEXTON ME, Waggoner JJ, Carmola LR, Nguyen PV, et al
    Rapid detection and characterization of SARS-CoV-2 omicron variant in a returning traveler.
    Clin Infect Dis. 2022 Jan 17. pii: 6509065. doi: 10.1093.
    >> Share

  288. SHRESTHA NK, Burke PC, Nowacki AS, Terpeluk P, et al
    Necessity of COVID-19 Vaccination in Persons Who Have Already Had COVID-19.
    Clin Infect Dis. 2022 Jan 13. pii: 6507165. doi: 10.1093.
    >> Share

  289. BAILIE CR, Tseng YY, Carolan L, Kirk MD, et al
    Trend in sensitivity of SARS-CoV-2 serology one year after mild and asymptomatic COVID-19: unpacking potential bias in seroprevalence studies.
    Clin Infect Dis. 2022 Jan 13. pii: 6506584. doi: 10.1093.
    >> Share

  290. WARREN BG, Nelson A, Barrett A, Addison B, et al
    SARS-CoV-2 Environmental contamination in hospital rooms is uncommon using viral culture techniques.
    Clin Infect Dis. 2022 Jan 12. pii: 6505265. doi: 10.1093.
    >> Share

  291. TODD FOJO A, Wallengren E, Schnure M, Dowdy DW, et al
    Potential Effects of the COVID-19 Pandemic on HIV Transmission: A Modeling Study in 32 US Cities.
    Clin Infect Dis. 2022 Jan 7. pii: 6500774. doi: 10.1093/cid/ciab1029.
    >> Share

  292. HEFTDAL LD, Schultz M, Lange T, Knudsen AD, et al
    Incidence of positive SARS-CoV-2 PCR after COVID-19 vaccination with up to eight months of follow-up: Real life data from the Capital Region of Denmark.
    Clin Infect Dis. 2022 Jan 7. pii: 6500168. doi: 10.1093.
    >> Share

  293. JANI IV, Peter TF
    Nucleic Acid Point-of-Care Testing to Improve Diagnostic Preparedness.
    Clin Infect Dis. 2022 Jan 7. pii: 6500010. doi: 10.1093.
    >> Share

  294. PARHIZKAR H, Dietz L, Olsen-Martinez A, Horve PF, et al
    Quantifying environmental mitigation of aerosol viral load in a controlled chamber with participants diagnosed with COVID-19.
    Clin Infect Dis. 2022 Jan 6. pii: 6498295. doi: 10.1093.
    >> Share

  295. LI X, Chan JM, Lam B, Lung DC, et al
    COVID-19 mRNA vaccines delay the onset of breakthrough infections with less radiographic abnormalities.
    Clin Infect Dis. 2022 Jan 4. pii: 6497432. doi: 10.1093/cid/ciab1062.
    >> Share

  296. MARUKI T, Iwamoto N, Kanda K, Okumura N, et al
    Two cases of breakthrough SARS-CoV-2 infections caused by the Omicron variant (B.1.1.529 lineage) in international travelers to Japan.
    Clin Infect Dis. 2022 Jan 3. pii: 6494531. doi: 10.1093/cid/ciab1072.
    >> Share

  297. REDDY KP, Kruse GR, Lee S, Shuter J, et al
    Tobacco Use and Treatment of Tobacco Dependence Among People with HIV: A Practical Guide for Clinicians.
    Clin Infect Dis. 2022 Jan 3. pii: 6494528. doi: 10.1093/cid/ciab1069.
    >> Share

  298. JAKOBSEN A, Skov MT, Larsen L, Petersen PT, et al
    Herpes simplex virus 2 meningitis in adults: A prospective, nationwide, population-based cohort study.
    Clin Infect Dis. 2022 Jan 3. pii: 6494530. doi: 10.1093/cid/ciab1071.
    >> Share

    December 2021
  299. STEIN D, Oviedo-Orta E, Kampman WA, McGinniss J, et al
    Compassionate Use of REGEN-COV (R) in Patients with COVID-19 and Immunodeficiency-Associated Antibody Disorders.
    Clin Infect Dis. 2021 Dec 31. pii: 6491226. doi: 10.1093/cid/ciab1059.
    >> Share

  300. YAMAMOTO S, Maeda K, Matsuda K, Tanaka A, et al
    COVID-19 breakthrough infection and post-vaccination neutralizing antibody among healthcare workers in a referral hospital in Tokyo: a case-control matching study.
    Clin Infect Dis. 2021 Dec 24. pii: 6482345. doi: 10.1093/cid/ciab1048.
    >> Share

  301. ANDREJKO KL, Pry J, Myers JF, Openshaw J, et al
    Predictors of SARS-CoV-2 infection following high-risk exposure.
    Clin Infect Dis. 2021 Dec 21. pii: 6473597. doi: 10.1093/cid/ciab1040.
    >> Share

  302. SACHDEV DD, Chew Ng R, Sankaran M, Ernst A, et al
    Contact tracing outcomes among household contacts of fully vaccinated COVID-19 patients - San Francisco, California, January 29-July 2, 2021.
    Clin Infect Dis. 2021 Dec 20. pii: 6470866. doi: 10.1093/cid/ciab1042.
    >> Share

  303. TYNER HL, Burgess JL, Grant L, Gaglani M, et al
    Neutralizing Antibody Response to Pseudotype SARS-CoV-2 Differs between mRNA-1273 and BNT162b2 COVID-19 Vaccines and by History of SARS-CoV-2 Infection.
    Clin Infect Dis. 2021 Dec 20. pii: 6470720. doi: 10.1093/cid/ciab1038.
    >> Share

  304. PERSAD G, Peek ME, Shah SK
    Fair Allocation of Scarce Therapies for COVID-19.
    Clin Infect Dis. 2021 Dec 18. pii: 6469906. doi: 10.1093/cid/ciab1039.
    >> Share

  305. LUO CH, Morris CP, Sachithanandham J, Amadi A, et al
    Infection with the SARS-CoV-2 Delta Variant is Associated with Higher Recovery of Infectious Virus Compared to the Alpha Variant in both Unvaccinated and Vaccinated Individuals.
    Clin Infect Dis. 2021 Dec 18. pii: 6469786. doi: 10.1093.
    >> Share

  306. LU L, Mok BW, Chen LL, Chan JM, et al
    Neutralization of SARS-CoV-2 Omicron variant by sera from BNT162b2 or Coronavac vaccine recipients.
    Clin Infect Dis. 2021 Dec 16. pii: 6463504. doi: 10.1093/cid/ciab1041.
    >> Share

  307. MUDENDA V, Mumba C, Pieciak RC, Mwananyanda L, et al
    Histopathological Evaluation of Deceased Persons in Lusaka, Zambia With or Without Coronavirus Disease 2019 (COVID-19) Infection: Results Obtained From Minimally Invasive Tissue Sampling.
    Clin Infect Dis. 2021;73.
    >> Share

  308. BASSAT Q, Varo R, Hurtado JC, Marimon L, et al
    Minimally Invasive Tissue Sampling as an Alternative to Complete Diagnostic Autopsies in the Context of Epidemic Outbreaks and Pandemics: The Example of Coronavirus Disease 2019 (COVID-19).
    Clin Infect Dis. 2021;73.
    >> Share

  309. DUARTE-NETO AN, Ferraz da Silva LF, Monteiro RAA, Theodoro Filho J, et al
    Ultrasound-Guided Minimally Invasive Tissue Sampling: A Minimally Invasive Autopsy Strategy During the COVID-19 Pandemic in Brazil, 2020.
    Clin Infect Dis. 2021;73.
    >> Share

  310. GOCO NJ, McClure EM, Rakislova N, Bassat Q, et al
    Minimally Invasive Tissue Sampling Surveillance Alliance-Facilitating the Expansion of Pathology-Based Mortality Surveillance.
    Clin Infect Dis. 2021;73.
    >> Share

  311. RAKISLOVA N, Rodrigo-Calvo MT, Marimon L, Ribera-Cortada I, et al
    Minimally Invasive Tissue Sampling Findings in 12 Patients With Coronavirus Disease 2019.
    Clin Infect Dis. 2021;73.
    >> Share

  312. GARIBALDI BT, Wang K, Robinson ML, Betz J, et al
    Real-World Effectiveness Of Remdesivir In Adults Hospitalized With Covid-19: A Retrospective, Multicenter Comparative Effectiveness Study.
    Clin Infect Dis. 2021 Dec 15. pii: 6463010. doi: 10.1093/cid/ciab1035.
    >> Share

  313. DANINO D, Ben-Shimol S, Van Der Beek BA, Givon-Lavi N, et al
    Decline in Pneumococcal Disease in Young Children during the COVID-19 Pandemic in Israel Associated with Suppression of seasonal Respiratory Viruses, despite Persistent Pneumococcal Carriage: A Prospective Cohort Study.
    Clin Infect Dis. 2021 Dec 14. pii: 6460745. doi: 10.1093/cid/ciab1014.
    >> Share

  314. BRUNEAU T, Wack M, Poulet G, Robillard N, et al
    Circulating ubiquitous RNA, a highly predictive and prognostic biomarker in hospitalized COVID-19 patients.
    Clin Infect Dis. 2021 Dec 11. pii: 6459561. doi: 10.1093.
    >> Share

  315. BART SM, Harizaj A, Pearson CL, Conteh T, et al
    SARS-CoV-2 Delta outbreak among fully vaccinated nursing home residents likely initiated by a fully vaccinated staff member - Connecticut, July-August 2021.
    Clin Infect Dis. 2021 Dec 10. pii: 6459157. doi: 10.1093/cid/ciab1025.
    >> Share

  316. KHAN K, Lustig G, Bernstein M, Archary D, et al
    Immunogenicity of SARS-CoV-2 infection and Ad26.CoV2.S vaccination in people living with HIV.
    Clin Infect Dis. 2021 Dec 10. pii: 6459255. doi: 10.1093/cid/ciab1008.
    >> Share

  317. ROCCO JM, Mallarino-Haeger C, Randolph AH, Ray SM, et al
    Hyperinflammatory syndromes after SARS-CoV-2 mRNA vaccination in individuals with underlying immune dysregulation.
    Clin Infect Dis. 2021 Dec 10. pii: 6459155. doi: 10.1093/cid/ciab1024.
    >> Share

  318. FERNANDEZ-GONZALEZ M, Agullo V, Padilla S, Garcia JA, et al
    Clinical performance of a standardized SARS-CoV-2 interferon-gamma release assay for simple detection of T-cell responses after infection or vaccination.
    Clin Infect Dis. 2021 Dec 10. pii: 6459152. doi: 10.1093/cid/ciab1021.
    >> Share

  319. BUTT AA, Yan P, Shaikh OS, Mayr FB, et al
    Rate and Risk Factors for Severe/Critical Disease Among Fully Vaccinated Persons with Breakthrough SARS-CoV-2 Infection in a High-risk National Population.
    Clin Infect Dis. 2021 Dec 10. pii: 6459161. doi: 10.1093/cid/ciab1023.
    >> Share

  320. SHIN HS, Kim Y, Kang J, Um J, et al
    Longitudinal Analysis of Memory T cell Responses in Survivors of Middle East respiratory syndrome.
    Clin Infect Dis. 2021 Dec 10. pii: 6459149. doi: 10.1093/cid/ciab1019.
    >> Share

  321. TANG L, Cherry S, Tuomanen EI, Roubidoux EK, et al
    Host predictors of broadly cross-reactive antibodies against SARS-CoV-2 variants of concern differ between infection and vaccination.
    Clin Infect Dis. 2021 Dec 10. pii: 6458694. doi: 10.1093.
    >> Share

  322. SHAW ER, Rosen LB, Cheng A, Dobbs K, et al
    Temporal Dynamics of Anti-Type 1 Interferon Autoantibodies in COVID-19 Patients.
    Clin Infect Dis. 2021 Dec 7. pii: 6455230. doi: 10.1093/cid/ciab1002.
    >> Share

  323. ENDO A
    Estimated Sensitivity Values of Severe Acute Respiratory Syndrome Coronavirus 2 Tests from Cross-sectional Data Warrant Caution Due to Unvalidated Model Assumptions.
    Clin Infect Dis. 2021;73:e3984-e3985.
    >> Share

  324. THOMAS BR
    Does Expert Opinion Trump Evidence?
    Clin Infect Dis. 2021;73:e3982-e3983.
    >> Share

  325. LOHR B, Niemann D, Verheyen J
    Bamlanivimab Treatment Leads to Rapid Selection of Immune Escape Variant Carrying the E484K Mutation in a B.1.1.7-Infected and Immunosuppressed Patient.
    Clin Infect Dis. 2021;73:2144-2145.
    >> Share

  326. SPINELLI MA, Peluso MJ, Lynch KL, Yun C, et al
    Differences in Post-mRNA Vaccination SARS-CoV-2 IgG Concentrations and Surrogate Virus Neutralization Test Response by HIV Status and Type of Vaccine: a Matched Case-Control Observational Study.
    Clin Infect Dis. 2021 Dec 5. pii: 6453392. doi: 10.1093/cid/ciab1009.
    >> Share

  327. MILLER AD, Zambrano LD, Yousaf AR, Abrams JY, et al
    Multisystem Inflammatory Syndrome in Children-United States, February 2020-July 2021.
    Clin Infect Dis. 2021 Dec 5. pii: 6453395. doi: 10.1093/cid/ciab1007.
    >> Share

  328. PANNUS P, Neven KY, De Craeye S, Heyndrickx L, et al
    Poor antibody response to BioNTech/Pfizer COVID-19 vaccination in SARS-CoV-2 naive residents of nursing homes.
    Clin Infect Dis. 2021 Dec 3. pii: 6448839. doi: 10.1093.
    >> Share

  329. KIM P, Gordon SM, Sheehan MM, Rothberg MB, et al
    Duration of SARS-CoV-2 Natural Immunity and Protection against the Delta Variant: A Retrospective Cohort Study.
    Clin Infect Dis. 2021 Dec 3. pii: 6448857. doi: 10.1093.
    >> Share

  330. JOSEPH NT, Satten GA, Williams RE, Haddad LB, et al
    The Effect of Antiretroviral Therapy for the Treatment of HIV-1 in Pregnancy on Gestational Weight Gain.
    Clin Infect Dis. 2021 Dec 3. pii: 6448917. doi: 10.1093.
    >> Share

    November 2021
  331. GRUNAU B, Asamoah-Boaheng M, Lavoie PM, Karim ME, et al
    A Higher Antibody Response Is Generated With a 6- to 7-Week (vs Standard) Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccine Dosing Interval.
    Clin Infect Dis. 2021 Nov 30. pii: 6446287. doi: 10.1093.
    >> Share

  332. ZAVALA M, Ireland G, Amin-Chowdhury Z, Ramsay ME, et al
    Acute and persistent symptoms in children with PCR-confirmed SARS-CoV-2 infection compared to test-negative children in England: active, prospective, national surveillance.
    Clin Infect Dis. 2021 Nov 29. pii: 6446232. doi: 10.1093.
    >> Share

  333. BELAY ED, Godfred Cato S, Rao AK, Abrams J, et al
    Multisystem Inflammatory Syndrome in Adults after SARS-CoV-2 infection and COVID-19 vaccination.
    Clin Infect Dis. 2021 Nov 28. pii: 6445178. doi: 10.1093.
    >> Share

  334. CHUA GT, Kwan MYW, Chui CSL, Smith RD, et al
    Epidemiology of Acute Myocarditis/Pericarditis in Hong Kong Adolescents Following Comirnaty Vaccination.
    Clin Infect Dis. 2021 Nov 28. pii: 6445179. doi: 10.1093.
    >> Share

  335. DIMEGLIO C, Herin F, Da-Silva I, Porcheron M, et al
    Post-vaccination SARS-CoV-2 antibody kinetics and protection duration.
    Clin Infect Dis. 2021 Nov 27. pii: 6444809. doi: 10.1093.
    >> Share

  336. SAHANIC S, Tymoszuk P, Ausserhofer D, Rass V, et al
    Phenotyping of acute and persistent COVID-19 features in the outpatient setting: exploratory analysis of an international cross-sectional online survey.
    Clin Infect Dis. 2021 Nov 26. pii: 6440836. doi: 10.1093.
    >> Share

  337. CORREA H, Soslow JH, Dendy JM, Creech CB, et al
    Acute myopericarditis post intravenous injection of COVID-19 mRNA vaccine differs from viral myocarditis.
    Clin Infect Dis. 2021 Nov 26. pii: 6443709. doi: 10.1093.
    >> Share

  338. LI C, Chen Y, Zhao Y, Christopher Lung D, et al
    Corrigendum to: Intravenous Injection of Coronavirus Disease 2019 (COVID-19) mRNA Vaccine Can Induce Acute Myopericarditis in Mouse Model.
    Clin Infect Dis. 2021 Nov 25. pii: 6438764. doi: 10.1093.
    >> Share

  339. GAZIT S, Mizrahi B, Kalkstein N, Neuberger A, et al
    BNT162b2 mRNA Vaccine Effectiveness Given Confirmed Exposure: Analysis of Household Members of COVID-19 Patients.
    Clin Infect Dis. 2021 Nov 24. pii: 6437962. doi: 10.1093.
    >> Share

  340. MOLLAN KR, Eron JJ, Krajewski TJ, Painter W, et al
    Infectious Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Virus in Symptomatic Coronavirus Disease 2019 (COVID-19) Outpatients: Host, Disease, and Viral Correlates.
    Clin Infect Dis. 2021 Nov 23. pii: 6433715. doi: 10.1093.
    >> Share

  341. STRATHDEE SA, Abramovitz D, Harvey-Vera A, Vera CF, et al
    Correlates of Coronavirus Disease 2019 (COVID-19) Vaccine Hesitancy Among People Who Inject Drugs in the San Diego-Tijuana Border Region.
    Clin Infect Dis. 2021 Nov 22. pii: 6433374. doi: 10.1093.
    >> Share

  342. CHUAH CH, Chow TS, Hor CP, Cheng JT, et al
    Efficacy of Early Treatment with Favipiravir on Disease Progression among High Risk COVID-19 Patients: A Randomized, Open-Label Clinical Trial.
    Clin Infect Dis. 2021 Nov 19. pii: 6432025. doi: 10.1093.
    >> Share

  343. CANADAY DH, Oyebanji OA, Keresztesy D, Payne M, et al
    Significant Reduction in Vaccine-Induced Antibody Levels and Neutralization Activity Among Healthcare Workers and Nursing Home Residents 6 Months Following Coronavirus Disease 2019 BNT162b2 mRNA Vaccination.
    Clin Infect Dis. 2021 Nov 19. pii: 6432026. doi: 10.1093.
    >> Share

  344. GILNER J, Kansal N, Biggio JR, Delaney S, et al
    Universal SARS-CoV-2 testing for obstetric inpatient units across the United States.
    Clin Infect Dis. 2021 Nov 17. pii: 6430425. doi: 10.1093.
    >> Share

  345. MADELON N, Lauper K, Breville G, Sabater Royo I, et al
    Robust T cell responses in anti-CD20 treated patients following COVID-19 vaccination: a prospective cohort study.
    Clin Infect Dis. 2021 Nov 17. pii: 6430423. doi: 10.1093.
    >> Share

  346. TEN DOESSCHATE T, Kuiper S, van Nieuwkoop C, Hassing RJ, et al
    Fosfomycin versus ciprofloxacin as oral stepdown treatment for Escherichia coli febrile urinary tract infection in women: a randomised, placebo-controlled, double blind, multicenter trial.
    Clin Infect Dis. 2021 Nov 16. pii: 6429720. doi: 10.1093.
    >> Share

  347. AKINBAMI LJ, Biggerstaff BJ, Chan PA, McGibbon E, et al
    Reinfection with SARS-CoV-2 among previously infected healthcare personnel and first responders.
    Clin Infect Dis. 2021 Nov 15. pii: 6428613. doi: 10.1093.
    >> Share

  348. LYNCH JB, Davitkov P, Anderson DJ, Bhimraj A, et al
    Infectious Diseases Society of America Guidelines on Infection Prevention for Healthcare Personnel Caring for Patients with Suspected or Known COVID-19.
    Clin Infect Dis. 2021 Nov 15. pii: 6428563. doi: 10.1093.
    >> Share

  349. HARRIS TG, Jaszi E, Lamb MR, Laudari CA, et al
    Effects of the COVID-19 Pandemic on HIV Services: Findings from 11 Sub-Saharan African Countries.
    Clin Infect Dis. 2021 Nov 15. pii: 6428385. doi: 10.1093.
    >> Share

  350. SHEN Z, Xiao Y, Kang L, Ma W, et al
    Corrigendum to: Genomic Diversity of Severe Acute Respiratory Syndrome-Coronavirus 2 in Patients With Coronavirus Disease 2019.
    Clin Infect Dis. 2021 Nov 13. pii: 6427503. doi: 10.1093.
    >> Share

  351. LI ZJ, Yu LJ, Zhang HY, Shan CX, et al
    Broad impacts of COVID-19 pandemic on acute respiratory infections in China: an observational study.
    Clin Infect Dis. 2021 Nov 12. pii: 6426178. doi: 10.1093.
    >> Share

  352. BEAN DJ, Monroe J, Turcinovic J, Moreau Y, et al
    SARS-CoV-2 reinfection associates with unstable housing and occurs in the presence of antibodies.
    Clin Infect Dis. 2021 Nov 10. pii: 6424810. doi: 10.1093.
    >> Share

  353. VIHTA KD, Pouwels KB, Peto T, Pritchard E, et al
    Symptoms and SARS-CoV-2 positivity in the general population in the UK.
    Clin Infect Dis. 2021 Nov 8. pii: 6423489. doi: 10.1093.
    >> Share

  354. LIEN CE, Kuo TY, Lin YJ, Lian WC, et al
    Evaluating the Neutralizing Ability of a CpG-Adjuvanted S-2P Subunit Vaccine Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants of Concern.
    Clin Infect Dis. 2021 Nov 5. pii: 6421519. doi: 10.1093.
    >> Share

  355. PEREZ Y, Levy ER, Joshi AY, Virk A, et al
    Myocarditis Following COVID-19 mRNA Vaccine: A Case Series and Incidence Rate Determination.
    Clin Infect Dis. 2021 Nov 3. pii: 6420408. doi: 10.1093.
    >> Share

  356. GRENINGER AL, Dien Bard J, Colgrove RC, Graf EH, et al
    Clinical and Infection Prevention Applications of SARS-CoV-2 Genotyping: An IDSA/ASM Consensus Review Document.
    Clin Infect Dis. 2021 Nov 3. pii: 6420112. doi: 10.1093.
    >> Share

  357. SHERMAN AC, Desjardins M, Cheng CA, Bausk B, et al
    SARS-CoV-2 mRNA Vaccines in Allogeneic Hematopoietic Stem Cell Transplant Recipients: Immunogenicity and Reactogenicity.
    Clin Infect Dis. 2021 Nov 2. pii: 6415965. doi: 10.1093.
    >> Share

  358. BOSCH W, Cowart JB, Bhakta S, Carter RE, et al
    COVID-19 Vaccine-Breakthrough Infections Requiring Hospitalization in Mayo Clinic Florida through August 2021.
    Clin Infect Dis. 2021 Nov 2. pii: 6415962. doi: 10.1093.
    >> Share

  359. LIU K, Ai S, Song S, Zhu G, et al
    Corrigendum to: Population Movement, City Closure in Wuhan, and Geographical Expansion of the COVID-19 Infection in China in January 2020.
    Clin Infect Dis. 2021 Nov 1. pii: 6414998. doi: 10.1093.
    >> Share

    October 2021
  360. CONWAY MORRIS A, Sharrocks K, Bousfield R, Kermack L, et al
    The removal of airborne SARS-CoV-2 and other microbial bioaerosols by air filtration on COVID-19 surge units.
    Clin Infect Dis. 2021 Oct 30. pii: 6414657. doi: 10.1093.
    >> Share

  361. DOUGAN M, Azizad M, Mocherla B, Gottlieb RL, et al
    A randomized, placebo-controlled clinical trial of bamlanivimab and etesevimab together in high-risk ambulatory patients with COVID-19 and validation of the prognostic value of persistently high viral load.
    Clin Infect Dis. 2021 Oct 28. pii: 6413724. doi: 10.1093.
    >> Share

  362. LEDNICKY JA, Tagliamonte MS, White SK, Blohm GM, et al
    Isolation of a Novel Recombinant Canine Coronavirus from a Visitor to Haiti: Further Evidence of Transmission of Coronaviruses of Zoonotic Origin to Humans.
    Clin Infect Dis. 2021 Oct 28. pii: 6413759. doi: 10.1093.
    >> Share

  363. YANG B, Tsang TK, Gao H, Lau EHY, et al
    Universal community nucleic acid testing for COVID-19 in Hong Kong reveals insights into transmission dynamics: a cross-sectional and modelling study.
    Clin Infect Dis. 2021 Oct 28. pii: 6413763. doi: 10.1093.
    >> Share

  364. HORITA N, Kato H, Watanabe K, Hara Y, et al
    Declined mortality due to seasonal influenza in Japan during the coronavirus disease 2019 pandemic.
    Clin Infect Dis. 2021 Oct 28. pii: 6413653. doi: 10.1093.
    >> Share

  365. WILLIAMS LR, Ferguson NM, Donnelly CA, Grassly NC, et al
    Measuring vaccine efficacy against infection and disease in clinical trials: sources and magnitude of bias in COVID-19 vaccine efficacy estimates.
    Clin Infect Dis. 2021 Oct 26. pii: 6410688. doi: 10.1093.
    >> Share

  366. MUHSEN K, Maimon N, Mizrahi A, Bodenneimer O, et al
    Effectiveness of BNT162b2 mRNA COVID-19 vaccine against acquisitions of SARS-CoV-2 among health care workers in long-term care facilities: a prospective cohort study.
    Clin Infect Dis. 2021 Oct 26. pii: 6410737. doi: 10.1093.
    >> Share

  367. DE CASTILHOS J, Zamir E, Hippchen T, Rohrbach R, et al
    Severe dysbiosis and specific Haemophilus and Neisseria signatures as hallmarks of the oropharyngeal microbiome in critically ill COVID-19 patients.
    Clin Infect Dis. 2021 Oct 25. pii: 6409876. doi: 10.1093.
    >> Share

  368. WOLDEMESKEL BA, Garliss CC, Blankson JN
    mRNA Vaccine-Elicited SARS-CoV-2-Specific T cells Persist at 6 Months and Recognize the Delta Variant.
    Clin Infect Dis. 2021 Oct 25. pii: 6409907. doi: 10.1093.
    >> Share

  369. WALDMAN SE, Buehring T, Escobar DJ, Gohil SK, et al
    Secondary Cases of Delta-Variant COVID-19 Among Vaccinated Healthcare Workers with Breakthrough Infections is Rare.
    Clin Infect Dis. 2021 Oct 25. pii: 6409806. doi: 10.1093.
    >> Share

  370. BHIMRAJ A, Morgan RL, Shumaker AH, Lavergne V, et al
    Therapeutic Emergency Use Authorizations (EUAs) During Pandemics: Double-Edged Swords.
    Clin Infect Dis. 2021 Oct 20. pii: 6398590. doi: 10.1093.
    >> Share

  371. BHIMRAJ A, Morgan RL, Shumaker AH, Baden L, et al
    Lessons learned from COVID-19 therapies: Critical perspectives from the IDSA COVID-19 treatment guideline panel.
    Clin Infect Dis. 2021 Oct 20. pii: 6398589. doi: 10.1093.
    >> Share

  372. ABU-RADDAD LJ, Chemaitelly H, Ayoub HH, Yassine HM, et al
    Severity, criticality, and fatality of the SARS-CoV-2 Beta variant.
    Clin Infect Dis. 2021 Oct 17. pii: 6398699. doi: 10.1093.
    >> Share

  373. BROSSEAU LM, Escandon K, Ulrich AK, Rasmussen AL, et al
    SARS-CoV-2 Dose, Infection, and Disease Outcomes for COVID-19 - A Review.
    Clin Infect Dis. 2021 Oct 15. pii: 6397523. doi: 10.1093.
    >> Share

  374. ROBILOTTI EV, Whiting K, Lucca A, Poon C, et al
    Clinical and Genomic Characterization of SARS CoV-2 infections in mRNA Vaccinated Health Care Personnel in New York City.
    Clin Infect Dis. 2021 Oct 13. pii: 6396142. doi: 10.1093.
    >> Share

  375. PELUSO MJ, Thomas IJ, Munter SE, Deeks SG, et al
    Lack of Antinuclear Antibodies in Convalescent COVID-19 Patients with Persistent Symptoms.
    Clin Infect Dis. 2021 Oct 7. pii: 6383256. doi: 10.1093.
    >> Share

  376. ZHANG J, Lin H, Ye B, Zhao M, et al
    One-year sustained cellular and humoral immunities of COVID-19 convalescents.
    Clin Infect Dis. 2021 Oct 5. pii: 6381561. doi: 10.1093.
    >> Share

  377. KLOMPAS M, Ye S, Vaidya V, Ochoa A, et al
    Association between Airborne Infection Isolation Room Utilization Rates and Healthcare Worker COVID-19 Infections in Two Academic Hospitals.
    Clin Infect Dis. 2021 Oct 2. pii: 6380290. doi: 10.1093.
    >> Share

  378. BAILLY B, Pere H, Veyer D, Berceanu A, et al
    Persistent COVID-19 in an immunocompromised host treated by SARS-CoV-2-specific monoclonal antibodies.
    Clin Infect Dis. 2021 Oct 1. pii: 6379055. doi: 10.1093.
    >> Share

  379. MOZAFFARI E, Chandak A, Zhang Z, Liang S, et al
    Remdesivir treatment in hospitalized patients with COVID-19: a comparative analysis of in-hospital all-cause mortality in a large multi-center observational cohort.
    Clin Infect Dis. 2021 Oct 1. pii: 6378778. doi: 10.1093.
    >> Share

  380. ZHU N, Rawson TM, Mookerjee S, Price JR, et al
    Changing patterns of bloodstream infections in the community and acute care across two COVID-19 epidemic waves: a retrospective analysis using data linkage.
    Clin Infect Dis. 2021 Oct 1. pii: 6378783. doi: 10.1093.
    >> Share

    September 2021
  381. JAAFAR R, Aherfi S, Wurtz N, Grimaldier C, et al
    Corrigendum to: Correlation Between 3790 Quantitative Polymerase Chain Reaction-Positives Samples and Positive Cell Cultures, Including 1941 Severe Acute Respiratory Syndrome Coronavirus 2 Isolates.
    Clin Infect Dis. 2021 Sep 29. pii: 6377803. doi: 10.1093.
    >> Share

  382. FORD N, Vitoria M, Doherty M
    WHO guidance to support HIV care models during the Covid-19 era.
    Clin Infect Dis. 2021 Sep 24. pii: 6374892. doi: 10.1093.
    >> Share

  383. STAUFT CB, Tegenge M, Khurana S, Lee Y, et al
    Pharmacokinetics and Efficacy of Human Hyperimmune Intravenous Immunoglobulin Treatment of SARS-CoV-2 Infection in Adult Syrian Hamsters.
    Clin Infect Dis. 2021 Sep 23. pii: 6374486. doi: 10.1093.
    >> Share

  384. LESIEUR E, Torrents J, Fina F, Zandotti C, et al
    Congenital infection of SARS-CoV-2 with intrauterine foetal death: a clinicopathological study with molecular analysis.
    Clin Infect Dis. 2021 Sep 23. pii: 6374309. doi: 10.1093.
    >> Share

  385. ZHU F, Jin P, Zhu T, Wang W, et al
    Safety and immunogenicity of a recombinant adenovirus type-5-vectored COVID-19 vaccine with a homologous prime-boost regimen in healthy participants aged 6 years and above: a randomised, double-blind, placebo-controlled, phase 2b trial.
    Clin Infect Dis. 2021 Sep 22. pii: 6374123. doi: 10.1093.
    >> Share

  386. FRALEY E, LeMaster C, Khanal S, Banerjee D, et al
    Prior infection and age impacts antibody persistence after SARS-CoV-2 mRNA vaccine.
    Clin Infect Dis. 2021 Sep 22. pii: 6373987. doi: 10.1093.
    >> Share

  387. HASAN ALI O, Bomze D, Risch L, Brugger SD, et al
    Erratum to: Severe Coronavirus Disease 2019 (COVID-19) is Associated With Elevated Serum Immunoglobulin (Ig) A and Antiphospholipid IgA Antibodies.
    Clin Infect Dis. 2021 Sep 22. pii: 6373914. doi: 10.1093.
    >> Share

  388. HU M, Wang J, Lin H, Ruktanonchai CW, et al
    Risk of SARS-CoV-2 Transmission among Air Passengers in China.
    Clin Infect Dis. 2021 Sep 21. pii: 6373518. doi: 10.1093.
    >> Share

  389. CHAUHAN L, Pattee J, Ford J, Thomas C, et al
    A Multi-center, Prospective, Observational-cohort controlled study of Clinical Outcomes following COVID-19 Convalescent plasma therapy in hospitalized COVID-19 patients.
    Clin Infect Dis. 2021 Sep 21. pii: 6373512. doi: 10.1093.
    >> Share

  390. WHITTAKER C, Watson OJ, Alvarez-Moreno C, Angkasekwinai N, et al
    Understanding the Potential Impact of Different Drug Properties On SARS-CoV-2 Transmission and Disease Burden: A Modelling Analysis.
    Clin Infect Dis. 2021 Sep 21. pii: 6373521. doi: 10.1093.
    >> Share

  391. BUENO SM, Abarca K, Gonzalez PA, Galvez NMS, et al
    Safety and Immunogenicity of an Inactivated SARS-CoV-2 Vaccine in a Subgroup of Healthy Adults in Chile.
    Clin Infect Dis. 2021 Sep 19. pii: 6372423. doi: 10.1093.
    >> Share

  392. CHAN JF, Poon VK, Chan CC, Chik KK, et al
    Low Environmental Temperature Exacerbates Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Golden Syrian Hamsters.
    Clin Infect Dis. 2021 Sep 18. pii: 6372264. doi: 10.1093.
    >> Share

  393. MAN NIU M, Cao Y, Li RX, Fan GZ, et al
    Outcome heterogeneity in COVID-19 patients receiving tocilizumab.
    Clin Infect Dis. 2021 Sep 17. pii: 6371851. doi: 10.1093.
    >> Share

  394. MOON RC, Mackey RH, Cao Z, Emont S, et al
    Is COVID-19 Less Deadly Now? -- Trends of In-Hospital Mortality Among Hospitalized COVID-19 Patients in the United States.
    Clin Infect Dis. 2021 Sep 17. pii: 6371824. doi: 10.1093.
    >> Share

  395. ANANWORANICH J, Mogg R, Dunne MW, Bassyouni M, et al
    Randomized study of rivaroxaban vs. placebo on disease progression and symptoms resolution in high-risk adults with mild COVID-19.
    Clin Infect Dis. 2021 Sep 15. pii: 6370549. doi: 10.1093.
    >> Share

  396. STRUTNER J, Ramchandar N, Dubey S, Gamboa M, et al
    Comparison of RT-PCR Cycle Threshold Values from Respiratory Specimens in Symptomatic and Asymptomatic Children with SARS-CoV-2 Infection.
    Clin Infect Dis. 2021 Sep 15. pii: 6370557. doi: 10.1093.
    >> Share

  397. PECHTER E, Lessin N, Brosseau L
    Schools and Coronavirus Disease 2019 Prevention.
    Clin Infect Dis. 2021;73:e1403-e1404.
    >> Share

  398. ADENAIYE OO, Lai J, de Mesquita PJB, Hong F, et al
    Infectious SARS-CoV-2 in Exhaled Aerosols and Efficacy of Masks During Early Mild Infection.
    Clin Infect Dis. 2021 Sep 14. pii: 6370149. doi: 10.1093.
    >> Share

  399. PAMPA-ESPINOZA L, Silva-Valencia J, Fernandez M, Padilla-Rojas C, et al
    Reinfections are more frequent than currently considered in countries with high incidence of COVID-19 cases due to stringent definitions.
    Clin Infect Dis. 2021 Sep 11. pii: 6368494. doi: 10.1093.
    >> Share

  400. BAROCAS JA, Savinkina A, Lodi S, Epstein RL, et al
    Projected long-term impact of the COVID-19 pandemic on hepatitis C outcomes in the United States: a modelling study.
    Clin Infect Dis. 2021 Sep 9. pii: 6367757. doi: 10.1093.
    >> Share

  401. TO KK, Li X, Lung DC, Ip JD, et al
    False COVID-19 cases due to contamination by inactivated virus vaccine.
    Clin Infect Dis. 2021 Sep 9. pii: 6367446. doi: 10.1093.
    >> Share

  402. LEE M
    Lack of Severe Acute Respiratory Syndrome Coronavirus 2 Neutralization by Antibodies to Seasonal Coronaviruses: Making Sense of the Coronavirus Disease 2019 Pandemic.
    Clin Infect Dis. 2021;73:e1212-e1213.
    >> Share

  403. KULKARNI O, Narreddy S, Zaveri L, Kalal IG, et al
    Evidence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Reinfection Without Mutations in the Spike Protein.
    Clin Infect Dis. 2021;73:e1239-e1241.
    >> Share

  404. GUARALDI G, Milic J, Martinez E, Kamarulzaman A, et al
    Human Immunodeficiency Virus (HIV) Care Models During the Coronavirus Disease 2019 (COVID-19) Era.
    Clin Infect Dis. 2021;73:e1222-e1227.
    >> Share

  405. GRINT DJ, Wing K, Houlihan C, Gibbs HP, et al
    Severity of SARS-CoV-2 alpha variant (B.1.1.7) in England.
    Clin Infect Dis. 2021 Sep 6. pii: 6365124. doi: 10.1093.
    >> Share

  406. WYNBERG E, van Willigen HDG, Dijkstra M, Boyd A, et al
    Evolution of COVID-19 symptoms during the first 12 months after illness onset.
    Clin Infect Dis. 2021 Sep 2. pii: 6362727. doi: 10.1093.
    >> Share

  407. FEDER KA, Patel A, Vepachedu VR, Dominguez C, et al
    Association of E484K spike protein mutation with SARS-CoV-2 infection in vaccinated persons---Maryland, January - May 2021.
    Clin Infect Dis. 2021 Sep 2. pii: 6362726. doi: 10.1093.
    >> Share

  408. SNYMAN J, Hwa SH, Krause R, Muema D, et al
    Similar antibody responses against SARS-CoV-2 in HIV uninfected and infected individuals on antiretroviral therapy during the first South African infection wave.
    Clin Infect Dis. 2021 Sep 2. pii: 6362722. doi: 10.1093.
    >> Share

  409. TAGLIAMONTE MS, Mavian C, Zainabadi K, Cash MN, et al
    Rapid emergence and spread of SARS-CoV-2 gamma (P.1) variant in Haiti.
    Clin Infect Dis. 2021 Sep 2. pii: 6359631. doi: 10.1093.
    >> Share

  410. STRICH JR, Tian X, Samour M, King CS, et al
    Fostamatinib for the treatment of hospitalized adults with COVD-19 A randomized trial.
    Clin Infect Dis. 2021 Sep 1. pii: 6358811. doi: 10.1093.
    >> Share

  411. SHAW J, Hanley S, Stewart T, Salmon DA, et al
    Health Care Personnel (HCP) attitudes about COVID-19 vaccination after emergency use authorization.
    Clin Infect Dis. 2021 Sep 1. pii: 6357694. doi: 10.1093.
    >> Share

    August 2021
  412. MARTINEZ DA, Klein EY, Parent C, Prieto D, et al
    Latino Household Transmission of SARS-CoV-2.
    Clin Infect Dis. 2021 Aug 31. pii: 6360016. doi: 10.1093.
    >> Share

  413. CARAZO S, Talbot D, Boulianne N, Brisson M, et al
    Single-dose mRNA vaccine effectiveness against SARS-CoV-2 in healthcare workers extending 16 weeks post-vaccination: a test-negative design from Quebec, Canada.
    Clin Infect Dis. 2021 Aug 30. pii: 6359881. doi: 10.1093.
    >> Share

  414. XIN H, Li Y, Wu P, Li Z, et al
    Estimating the latent period of coronavirus disease 2019 (COVID-19).
    Clin Infect Dis. 2021 Aug 28. pii: 6359063. doi: 10.1093.
    >> Share

  415. KNOWLTON KU
    Insights from a murine model of COVID-19 mRNA vaccination-induced myopericarditis: Could accidental intravenous vaccine injection induce myopericarditis?
    Clin Infect Dis. 2021 Aug 28. pii: 6359059. doi: 10.1093.
    >> Share

  416. GOTTLIEB L, Fridkin SK
    It's hard to measure success while caring for surges in COVID-19 hospitalizations.
    Clin Infect Dis. 2021 Aug 28. pii: 6359066. doi: 10.1093.
    >> Share

  417. MACK CD, Tai C, Sikka R, Grad YH, et al
    SARS-CoV-2 Reinfection: A Case Series from a 12-Month Longitudinal Occupational Cohort.
    Clin Infect Dis. 2021 Aug 28. pii: 6359055. doi: 10.1093.
    >> Share

  418. ONG SWX, Chiew CJ, Ang LW, Mak TM, et al
    Clinical and virological features of SARS-CoV-2 variants of concern: a retrospective cohort study comparing B.1.1.7 (Alpha), B.1.315 (Beta), and B.1.617.2 (Delta).
    Clin Infect Dis. 2021 Aug 23. pii: 6356459. doi: 10.1093.
    >> Share

  419. NARAYANAN S, Chua JV, Baddley JW
    COVID-19 associated Mucormycosis (CAM): risk factors and mechanisms of disease.
    Clin Infect Dis. 2021 Aug 22. pii: 6356215. doi: 10.1093.
    >> Share

  420. WONG CKH, Lau KTK, Au ICH, Xiong X, et al
    Optimal timing of remdesivir initiation in hospitalized COVID-19 patients administered with dexamethasone.
    Clin Infect Dis. 2021 Aug 22. pii: 6356217. doi: 10.1093.
    >> Share

  421. PETTI S
    Undetected and relatively sustained SARS-CoV-2 circulation worldwide during the year 2019.
    Clin Infect Dis. 2021 Aug 22. pii: 6356216. doi: 10.1093.
    >> Share

  422. MARR LC, Tang JW
    A Paradigm Shift to Align Transmission Routes with Mechanisms.
    Clin Infect Dis. 2021 Aug 20. pii: 6355601. doi: 10.1093.
    >> Share

  423. MAIER HE, Kuan G, Saborio S, Bustos Carrillo FA, et al
    Clinical spectrum of SARS-CoV-2 infection and protection from symptomatic re-infection.
    Clin Infect Dis. 2021 Aug 19. pii: 6354980. doi: 10.1093.
    >> Share

  424. BALTAS I, Boshier FAT, Williams CA, Bayzid N, et al
    Post-vaccination COVID-19: A case-control study and genomic analysis of 119 breakthrough infections in partially vaccinated individuals.
    Clin Infect Dis. 2021 Aug 19. pii: 6354928. doi: 10.1093.
    >> Share

  425. DUNAY MA, McClain SL, Holloway RL, Norris SLW, et al
    Pre-Hospital Administration of Remdesivir during a SARS-CoV-2 Outbreak in a Skilled Nursing Facility.
    Clin Infect Dis. 2021 Aug 19. pii: 6354937. doi: 10.1093.
    >> Share

  426. DAWOOD FS, Varner M, Tita A, Newes-Adeyi G, et al
    Incidence, Clinical Characteristics, and Risk Factors of SARS-CoV-2 Infection among Pregnant Individuals in the United States.
    Clin Infect Dis. 2021 Aug 19. pii: 6354856. doi: 10.1093.
    >> Share

  427. FINTZI J, Bonnett T, Sweeney DA, Huprikar NA, et al
    Deconstructing the Treatment Effect of Remdesivir in the Adaptive COVID-19 Treatment Trial-1: Implications for Critical Care Resource Utilization.
    Clin Infect Dis. 2021 Aug 19. pii: 6354746. doi: 10.1093.
    >> Share

  428. DIAZ GA, Christensen AB, Pusch T, Goulet D, et al
    Remdesivir and Mortality in Patients with COVID-19.
    Clin Infect Dis. 2021 Aug 19. pii: 6352176. doi: 10.1093.
    >> Share

  429. LI C, Chen Y, Zhao Y, Lung DC, et al
    Intravenous injection of COVID-19 mRNA vaccine can induce acute myopericarditis in mouse model.
    Clin Infect Dis. 2021 Aug 18. pii: 6353927. doi: 10.1093.
    >> Share

  430. LIU T, Wu D, Yan W, Wang X, et al
    Twelve-month systemic consequences of COVID-19 in patients discharged from hospital: a prospective cohort study in Wuhan, China.
    Clin Infect Dis. 2021 Aug 14. pii: 6352408. doi: 10.1093.
    >> Share

  431. DIMEGLIO C, Herin F, Da-Silva I, Jougla I, et al
    Heterologous ChAdOx1-S/BNT162b2 vaccination: neutralizing antibody response to SARS-CoV-2.
    Clin Infect Dis. 2021 Aug 12. pii: 6349304. doi: 10.1093.
    >> Share

  432. CERAMI C, Popkin-Hall ZR, Rapp T, Tompkins K, et al
    Household transmission of SARS-CoV-2 in the United States: living density, viral load, and disproportionate impact on communities of color.
    Clin Infect Dis. 2021 Aug 12. pii: 6349288. doi: 10.1093.
    >> Share

  433. CALDERON-PARRA J, Munez-Rubio E, Fernandez-Cruz A, Garcia Sanchez MC, et al
    Incidence, clinical presentation, relapses and outcome of SARS-CoV-2 infection in patients treated with anti-CD20 monoclonal antibodies.
    Clin Infect Dis. 2021 Aug 12. pii: 6348942. doi: 10.1093.
    >> Share

  434. PAULES CI, Gallagher SK, Rapaka RR, Davey RT, et al
    Remdesivir for the prevention of invasive mechanical ventilation or death in COVID-19 - A post-hoc analysis of the Adaptive COVID-19 Treatment Trial-1 Cohort Data.
    Clin Infect Dis. 2021 Aug 11. pii: 6348134. doi: 10.1093.
    >> Share

  435. JACOBS JL, Bain W, Naqvi A, Staines B, et al
    SARS-CoV-2 Viremia is Associated with COVID-19 Severity and Predicts Clinical Outcomes.
    Clin Infect Dis. 2021 Aug 10. pii: 6347519. doi: 10.1093.
    >> Share

  436. CLIPMAN SJ, Wesolowski A, Mehta SH, Cobey S, et al
    Improvements in SARS-CoV-2 Testing Cascade in the US: Data from Serial Cross-sectional Assessments.
    Clin Infect Dis. 2021 Aug 10. pii: 6347429. doi: 10.1093.
    >> Share

  437. BAKER MA, Sands KE, Huang SS, Kleinman K, et al
    The Impact of COVID-19 on Healthcare-Associated Infections.
    Clin Infect Dis. 2021 Aug 9. pii: 6346721. doi: 10.1093.
    >> Share

  438. NORTH CM, Barczak A, Goldstein RH, Healy BC, et al
    Determining the Incidence of Asymptomatic SARS-CoV-2 among Early Recipients of COVID-19 Vaccines: A Prospective Cohort Study of Healthcare Workers before, during and after Vaccination [DISCOVER-COVID-19].
    Clin Infect Dis. 2021 Aug 7. pii: 6345339. doi: 10.1093.
    >> Share

  439. TENFORDE MW, Patel MM, Ginde AA, Douin DJ, et al
    Effectiveness of SARS-CoV-2 mRNA Vaccines for Preventing Covid-19 Hospitalizations in the United States.
    Clin Infect Dis. 2021 Aug 6. pii: 6343399. doi: 10.1093.
    >> Share

  440. BANNO M, Tsujimoto Y, Ishikane M
    Need for more randomized controlled trials with rigorous methodology to confirm that ivermectin is not a viable option for the treatment of coronavirus disease.
    Clin Infect Dis. 2021 Aug 6. pii: 6343415. doi: 10.1093.
    >> Share

  441. COLEMAN KK, Tay DJW, Sen Tan K, Ong SWX, et al
    Viral Load of SARS-CoV-2 in Respiratory Aerosols Emitted by COVID-19 Patients while Breathing, Talking, and Singing.
    Clin Infect Dis. 2021 Aug 6. pii: 6343417. doi: 10.1093.
    >> Share

  442. PADHI S, Pati A, Panda AK
    Effect of ivermectin in the treatment of COVID-19: A trial sequential analysis highlighted the requirement of additional randomized controlled trials.
    Clin Infect Dis. 2021 Aug 6. pii: 6343157. doi: 10.1093.
    >> Share

  443. LAWANDI A, Warner S, Sun J, Demirkale CY, et al
    Suspected SARS-CoV-2 Reinfections: Incidence, Predictors, and Healthcare Use among Patients at 238 U.S. Healthcare Facilities, June 1, 2020- February 28, 2021.
    Clin Infect Dis. 2021 Aug 5. pii: 6342166. doi: 10.1093.
    >> Share

  444. BIGGERSTAFF M, Slayton RB, Johansson MA, Butler JC, et al
    Improving Pandemic Response: Employing Mathematical Modeling to Confront COVID-19.
    Clin Infect Dis. 2021 Aug 3. pii: 6338173. doi: 10.1093.
    >> Share

  445. FOURATI S, Bailly B, Le Bouter A, Guilpain L, et al
    Differential anti-S antibody titers in vaccinated residents during an outbreak of SARS-CoV-2 variant B.1.351 (beta) in an elderly nursing home.
    Clin Infect Dis. 2021 Aug 3. pii: 6338175. doi: 10.1093.
    >> Share

  446. XIANG F, Sun J, Chen PH, Han P, et al
    Early Elevation of Fibrosis-4 Liver Fibrosis Score Is Associated With Adverse Outcomes Among Patients With Coronavirus Disease 2019.
    Clin Infect Dis. 2021;73:e594-e601.
    >> Share

  447. LI P, Ikram A, Peppelenbosch MP, Ma Z, et al
    Systematically Mapping Clinical Features of Infections With Classical Endemic Human Coronaviruses.
    Clin Infect Dis. 2021;73:554-555.
    >> Share

  448. CASADEVALL A, Joyner MJ, Pirofski LA
    Implications of Coronavirus Disease 2019 (COVID-19) Antibody Dynamics for Immunity and Convalescent Plasma Therapy.
    Clin Infect Dis. 2021;73:e540-e542.
    >> Share

  449. GIL E, Martyn E, Rokadiya S, Jain S, et al
    Bacterial Coinfection in COVID-19.
    Clin Infect Dis. 2021;73:e843-e845.
    >> Share

    July 2021
  450. CHOW K, Aslam A, McClure T, Singh J, et al
    Risk of Healthcare-Associated Transmission of SARS-CoV-2 in Hospitalized Cancer Patients.
    Clin Infect Dis. 2021 Jul 30. pii: 6331919. doi: 10.1093.
    >> Share

  451. MACCANNELL T, Batson J, Bonin B, Kc A, et al
    Genomic epidemiology and transmission dynamics of SARS-CoV-2 in congregate healthcare facilities in Santa Clara County, California.
    Clin Infect Dis. 2021 Jul 30. pii: 6330915. doi: 10.1093.
    >> Share

  452. SCHOOLEY RT
    Introduction to the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS CoV-2) Supplement.
    Clin Infect Dis. 2021;73.
    >> Share

  453. TSUBOI M, Hachiya M, Ohtsu H, Akashi H, et al
    Epidemiology and risk of COVID-19 among travelers at airport and port quarantine stations across Japan: a nationwide descriptive analysis and an individually matched case-control study.
    Clin Infect Dis. 2021 Jul 28. pii: 6329456. doi: 10.1093.
    >> Share

  454. HERSTEIN JJ, Lowe JJ, Wolf T, Vasoo S, et al
    Leveraging a preexisting global infectious disease network for local decision-making during a pandemic.
    Clin Infect Dis. 2021 Jul 28. pii: 6329401. doi: 10.1093.
    >> Share

  455. CHEN LL, Lu L, Choi CY, Cai JP, et al
    Impact of SARS-CoV-2 variant-associated RBD mutations on the susceptibility to serum antibodies elicited by COVID-19 infection or vaccination.
    Clin Infect Dis. 2021 Jul 26. pii: 6328361. doi: 10.1093.
    >> Share

  456. CORVOL H, Alimi A, Prevost B, Schnuriger A, et al
    Atypical severe organizing pneumonia following COVID-19 in an immunocompromised teenager.
    Clin Infect Dis. 2021 Jul 26. pii: 6328309. doi: 10.1093.
    >> Share

  457. CHEN X, Chen Z, Azman AS, Sun R, et al
    Neutralizing antibodies against SARS-CoV-2 variants induced by natural infection or vaccination: a systematic review and pooled meta-analysis.
    Clin Infect Dis. 2021 Jul 24. pii: 6327511. doi: 10.1093.
    >> Share

  458. SUHS T, Gerlach D, Garfin J, Lorentz A, et al
    COVID-19 Outbreak Associated with a Fitness Center - Minnesota, September-November 2020.
    Clin Infect Dis. 2021 Jul 23. pii: 6326825. doi: 10.1093.
    >> Share

  459. GHARBHARAN A, GeurtsvanKessel CH, Jordans CCE, Blaauw M, et al
    Effects of treatment of COVID-19 with convalescent plasma in 25 B-cell depleted patients.
    Clin Infect Dis. 2021 Jul 22. pii: 6325623. doi: 10.1093.
    >> Share

  460. WOLDEMESKEL BA, Karaba AH, Garliss CC, Beck EJ, et al
    The BNT162b2 mRNA Vaccine Elicits Robust Humoral and Cellular Immune Responses in People Living with HIV.
    Clin Infect Dis. 2021 Jul 22. pii: 6325617. doi: 10.1093.
    >> Share

  461. HALBROOK M, Gadoth A, Martin-Blais R, Gray AN, et al
    Longitudinal assessment of COVID-19 vaccine acceptance and uptake among frontline medical workers in Los Angeles, California.
    Clin Infect Dis. 2021 Jul 22. pii: 6325325. doi: 10.1093.
    >> Share

  462. ANDREJKO KL, Pry J, Myers JF, Jewell NP, et al
    Prevention of COVID-19 by mRNA-based vaccines within the general population of California.
    Clin Infect Dis. 2021 Jul 20. pii: 6324500. doi: 10.1093.
    >> Share

  463. MORRIS CP, Luo CH, Amadi A, Schwartz M, et al
    An Update on SARS-CoV-2 Diversity in the United States National Capital Region: Evolution of Novel and Variants of Concern.
    Clin Infect Dis. 2021 Jul 17. pii: 6323262. doi: 10.1093.
    >> Share

  464. ALBHAISI S, Wenzel RP
    The Value of Medical Registries and Observational Studies Early in Pandemics: The COVID-19 Experience.
    Clin Infect Dis. 2021 Jul 16. pii: 6322561. doi: 10.1093.
    >> Share

  465. TRAM KH, Saeed S, Bradley C, Fox B, et al
    Deliberation, Dissent, and Distrust: Understanding distinct drivers of COVID-19 vaccine hesitancy in the United States.
    Clin Infect Dis. 2021 Jul 16. pii: 6323151. doi: 10.1093.
    >> Share

  466. GOSWAMI ND, Fiore AE, Walke HT
    Evidence, Experience, Expertise, and the US Coronavirus Disease 2019 Public Health Response.
    Clin Infect Dis. 2021;73.
    >> Share

  467. MCCARTY T
    Candidemia and Severe COVID-19 - Which Risk Factors are Modifiable?
    Clin Infect Dis. 2021 Jul 15. pii: 6322064. doi: 10.1093.
    >> Share

  468. WONG CKH, Lau KTK, Au ICH, Xiong X, et al
    Clinical improvement, outcomes, antiviral activity, and costs associated with early treatment with remdesivir for patients with COVID-19.
    Clin Infect Dis. 2021 Jul 15. pii: 6321803. doi: 10.1093.
    >> Share

  469. LIN DY, Gu Y, Zeng D, Janes HE, et al
    Evaluating Vaccine Efficacy Against SARS-CoV-2 Infection.
    Clin Infect Dis. 2021 Jul 14. pii: 6321290. doi: 10.1093.
    >> Share

  470. DAS ADHIKARI U, Eng G, Farcasanu M, Avena LE, et al
    Fecal SARS-CoV-2 RNA is associated with decreased COVID-19 survival.
    Clin Infect Dis. 2021 Jul 10. pii: 6318824. doi: 10.1093.
    >> Share

  471. TORRES JR
    Sequential Dengue and Covid-19. A case of viral Dr. Jekyll or Mr. Hyde?
    Clin Infect Dis. 2021 Jul 10. pii: 6318742. doi: 10.1093.
    >> Share

  472. SULLIVAN PS, Siegler AJ, Shioda K, Hall EW, et al
    SARS-CoV-2 cumulative incidence, United States, August-December 2020.
    Clin Infect Dis. 2021 Jul 10. pii: 6318822. doi: 10.1093.
    >> Share

  473. DAWOOD FS, Naleway AL, Flannery B, Levine MZ, et al
    Comparison of the Immunogenicity of Cell Culture-Based and Recombinant Quadrivalent Influenza Vaccines to Conventional Egg-Based Quadrivalent Influenza Vaccines among Healthcare Personnel Aged 18-64 Years: A Randomized Open-Label Trial.
    Clin Infect Dis. 2021 Jul 10. pii: 6318730. doi: 10.1093.
    >> Share

  474. SKOWRONSKI DM, Setayeshgar S, Zou M, Prystajecky N, et al
    Single-dose mRNA vaccine effectiveness against SARS-CoV-2, including Alpha and Gamma variants: a test-negative design in adults 70 years and older in British Columbia, Canada.
    Clin Infect Dis. 2021 Jul 9. pii: 6318435. doi: 10.1093.
    >> Share

  475. WILLIAMS C, Al-Bargash D, Macalintal C, Stuart R, et al
    COVID-19 Outbreak Associated with a SARS-CoV-2 P.1 Lineage in a Long-Term Care Home after Implementation of a Vaccination Program - Ontario, April-May 2021.
    Clin Infect Dis. 2021 Jul 8. pii: 6317716. doi: 10.1093.
    >> Share

  476. SEESSLE J, Waterboer T, Hippchen T, Simon J, et al
    Persistent symptoms in adult patients one year after COVID-19: a prospective cohort study.
    Clin Infect Dis. 2021 Jul 5. pii: 6315216. doi: 10.1093.
    >> Share

  477. GRANDJEAN L, Saso A, Ortiz AT, Lam T, et al
    Long-Term Persistence of Spike Antibody and Predictive Modeling of Antibody Dynamics Following Infection with SARS-CoV-2.
    Clin Infect Dis. 2021 Jul 4. pii: 6314536. doi: 10.1093.
    >> Share

  478. LUMLEY SF, Rodger G, Constantinides B, Sanderson N, et al
    An observational cohort study on the incidence of SARS-CoV-2 infection and B.1.1.7 variant infection in healthcare workers by antibody and vaccination status.
    Clin Infect Dis. 2021 Jul 3. pii: 6314286. doi: 10.1093.
    >> Share

  479. BERBENYUK A, Bobkova P, Bordyugov S, Borisenko A, et al
    Erratum to: Stop COVID Cohort: An Observational Study of 3480 Patients Admitted to the Sechenov University Hospital Network in Moscow City for Suspected Coronavirus Disease 2019 (COVID-19) Infection.
    Clin Infect Dis. 2021;73:174.
    >> Share

  480. ROTHENBERG R
    Death and the Virus.
    Clin Infect Dis. 2021;73:e86-e87.
    >> Share

    June 2021
  481. DARCIS G, Meuris C, Kremer C, Faes C, et al
    The risk of underestimating the contribution of children to SARS-CoV-2 pandemic.
    Clin Infect Dis. 2021 Jun 30. pii: 6311795. doi: 10.1093.
    >> Share

  482. SAGARA I, Woodford J, Kone M, Assadou MH, et al
    Rapidly increasing SARS-CoV-2 seroprevalence and limited clinical disease in three Malian communities: a prospective cohort study.
    Clin Infect Dis. 2021 Jun 29. pii: 6311302. doi: 10.1093.
    >> Share

  483. ROMAN YM, Burela PA, Pasupuleti V, Piscoya A, et al
    Ivermectin for the treatment of COVID-19: A systematic review and meta-analysis of randomized controlled trials.
    Clin Infect Dis. 2021 Jun 28. pii: 6310839. doi: 10.1093.
    >> Share

  484. WALKER A, Houwaart T, Finzer P, Ehlkes L, et al
    Characterization of SARS-CoV-2 infection clusters based on integrated genomic surveillance, outbreak analysis and contact tracing in an urban setting.
    Clin Infect Dis. 2021 Jun 28. pii: 6310838. doi: 10.1093.
    >> Share

  485. COLEBUNDERS R, Kenyon C
    Extensive SARS-CoV-2 transmission associated with low mortality in Kinshasa, Democratic Republic of Congo. For how long?
    Clin Infect Dis. 2021 Jun 28. pii: 6310791. doi: 10.1093.
    >> Share

  486. VERDERESE JP, Stepanova M, Lam B, Racila A, et al
    Neutralizing Monoclonal Antibody Treatment Reduces Hospitalization for Mild and Moderate COVID-19: A Real-World Experience.
    Clin Infect Dis. 2021 Jun 24. pii: 6309036. doi: 10.1093.
    >> Share

  487. MAZZOLA A, Todesco E, Drouin S, Hazan F, et al
    Poor Antibody Response after Two Doses of SARS-CoV-2 vaccine in Transplant Recipients.
    Clin Infect Dis. 2021 Jun 24. pii: 6309017. doi: 10.1093.
    >> Share

  488. MCEWEN AE, Cohen S, Bryson-Cahn C, Liu C, et al
    Variants of concern are overrepresented among post-vaccination breakthrough infections of SARS-CoV-2 in Washington State.
    Clin Infect Dis. 2021 Jun 24. pii: 6309019. doi: 10.1093.
    >> Share

  489. HANSON KE, Altayar O, Caliendo AM, Arias CA, et al
    The Infectious Diseases Society of America Guidelines on the Diagnosis of COVID-19: Antigen Testing.
    Clin Infect Dis. 2021 Jun 23. pii: 6308396. doi: 10.1093.
    >> Share

  490. ANTONIO-VILLA NE, Fernandez-Chirino L, Pisanty-Alatorre J, Mancilla-Galindo J, et al
    Comprehensive evaluation of the impact of sociodemographic inequalities on adverse outcomes and excess mortality during the COVID-19 pandemic in Mexico City.
    Clin Infect Dis. 2021 Jun 22. pii: 6308070. doi: 10.1093.
    >> Share

  491. DIMEGLIO C, Herin F, Da-Silva I, Porcheron M, et al
    Strong SARS-CoV-2-neutralizing antibody response of previously-infected healthcare workers given one dose of mRNA vaccine.
    Clin Infect Dis. 2021 Jun 22. pii: 6307902. doi: 10.1093.
    >> Share

  492. LODI L, Moriondo M, Pucci A, Pisano L, et al
    Chronic asymptomatic SARS-CoV-2 infection in the immunocompromised patient: new challenges and urgent needs.
    Clin Infect Dis. 2021 Jun 22. pii: 6307947. doi: 10.1093.
    >> Share

  493. BUONSENSO D, Valentini P
    Children and SARS-CoV-2 transmission: a step closer to better understanding and evidence-based interventions?
    Clin Infect Dis. 2021 Jun 18. pii: 6305136. doi: 10.1093.
    >> Share

  494. SEAGLE EE, Jackson BR, Lockhart SR, Georgacopoulos O, et al
    The landscape of candidemia during the COVID-19 pandemic.
    Clin Infect Dis. 2021 Jun 18. pii: 6305138. doi: 10.1093.
    >> Share

  495. KARAN A, Klompas M, Tucker R, Baker M, et al
    The Risk of SARS-CoV-2 Transmission from Patients with Undiagnosed Covid-19 to Roommates in a Large Academic Medical Center.
    Clin Infect Dis. 2021 Jun 18. pii: 6305137. doi: 10.1093.
    >> Share

  496. JACOBSON KB, Pinsky BA, Montez Rath ME, Wang H, et al
    Post-vaccination SARS-CoV-2 infections and incidence of presumptive B.1.427/B.1.429 variant among healthcare personnel at a northern California academic medical center.
    Clin Infect Dis. 2021 Jun 17. pii: 6303032. doi: 10.1093.
    >> Share

  497. MANICA M, Pancheri S, Poletti P, Giovanazzi G, et al
    The risk of symptomatic infection during a second COVID-19 wave, in SARS-CoV-2 seropositive individuals.
    Clin Infect Dis. 2021 Jun 16. pii: 6301134. doi: 10.1093.
    >> Share

  498. STANKOV MV, Cossmann A, Bonifacius A, Dopfer-Jablonka A, et al
    Humoral and cellular immune responses against SARS-CoV-2 variants and human coronaviruses after single BNT162b2 vaccination.
    Clin Infect Dis. 2021 Jun 16. pii: 6301133. doi: 10.1093.
    >> Share

  499. ALTHOFF KN, Schlueter DJ, Anton-Culver H, Cherry J, et al
    Antibodies to SARS-CoV-2 in All of Us Research Program Participants, January 2-March 18, 2020.
    Clin Infect Dis. 2021 Jun 15. pii: 6294073. doi: 10.1093.
    >> Share

  500. MALGIE J, Schoones JW, Pijls BG
    Reply to Tleyjeh.
    Clin Infect Dis. 2021;72:e1155-e1156.
    >> Share

  501. WANG M, Hu K
    Reply to DeVito.
    Clin Infect Dis. 2021;72:e1165-e1166.
    >> Share

  502. DEVITO NJ
    Concerning Trials Registration.
    Clin Infect Dis. 2021;72:e1164-e1165.
    >> Share

  503. MUNBLIT D, Nekliudov NA, Bugaeva P, Blyuss O, et al
    Reply to Russo et al.
    Clin Infect Dis. 2021;72:e1159-e1160.
    >> Share

  504. MALGIE J, Schoones JW, Pijls BG
    Reply to Huang et al.
    Clin Infect Dis. 2021;72:e1157-e1158.
    >> Share

  505. GU S, Lv L, Wu Z, Li L, et al
    Reply to Klann et al.
    Clin Infect Dis. 2021;72:2248-2249.
    >> Share

  506. GU S, Chen Y, Lv L, Li L, et al
    Reply to Marcialis et al.
    Clin Infect Dis. 2021;72:2246-2247.
    >> Share

  507. POLLETT SD, Richard SA, Fries AC, Simons MP, et al
    The SARS-CoV-2 mRNA vaccine breakthrough infection phenotype includes significant symptoms, live virus shedding, and viral genetic diversity.
    Clin Infect Dis. 2021 Jun 12. pii: 6297424. doi: 10.1093.
    >> Share

  508. XIN H, Wong JY, Murphy C, Yeung A, et al
    The incubation period distribution of coronavirus disease 2019 (COVID-19): a systematic review and meta-analysis.
    Clin Infect Dis. 2021 Jun 12. pii: 6297425. doi: 10.1093.
    >> Share

  509. KLOMPAS M, Rhee C, Baker M
    Universal Use of N95s in Healthcare Settings when Community Covid-19 Rates are High.
    Clin Infect Dis. 2021 Jun 11. pii: 6296401. doi: 10.1093.
    >> Share

  510. BENFIELD T, Bodilsen J, Brieghel C, Harboe ZB, et al
    Improved survival among hospitalized patients with COVID-19 treated with remdesivir and dexamethasone. A nationwide population-based cohort study.
    Clin Infect Dis. 2021 Jun 10. pii: 6296026. doi: 10.1093.
    >> Share

  511. STONE M, Di Germanio C, Wright DJ, Sulaeman H, et al
    Use of U.S. Blood Donors for National Serosurveillance of SARS-CoV-2 Antibodies: Basis for an Expanded National Donor Serosurveillance Program.
    Clin Infect Dis. 2021 Jun 10. pii: 6296028. doi: 10.1093.
    >> Share

  512. ZHANG AW, Morjaria S, Kaltsas A, Hohl TM, et al
    The Effect of Neutropenia and Filgrastim (G-CSF) in Cancer Patients With COVID-19 Infection.
    Clin Infect Dis. 2021 Jun 10. pii: 6296025. doi: 10.1093.
    >> Share

  513. BUCHAN SA, Tibebu S, Daneman N, Whelan M, et al
    Increased household secondary attacks rates with Variant of Concern SARS-CoV-2 index cases.
    Clin Infect Dis. 2021 Jun 9. pii: 6295404. doi: 10.1093.
    >> Share

  514. CRANE MA, Popovic A, Panaparambil R, Stolbach AI, et al
    Reporting of Infectious Diseases in the United States During the COVID-19 Pandemic.
    Clin Infect Dis. 2021 Jun 7. pii: 6294158. doi: 10.1093.
    >> Share

  515. VANKER A, McGeer A, O'Byrne G, Snyder ECR, et al
    Adverse Outcomes Associated with SARS-CoV-2 variant B.1.351 Infection in Vaccinated Residents of a Long Term Care Home, Ontario, Canada.
    Clin Infect Dis. 2021 Jun 6. pii: 6294072. doi: 10.1093.
    >> Share

  516. JENKS JD, Aslam S, Horton LE, Law N, et al
    Early Monoclonal Antibody Administration Can Reduce Both Hospitalizations and Mortality in High-Risk Outpatients with COVID-19.
    Clin Infect Dis. 2021 Jun 6. pii: 6294071. doi: 10.1093.
    >> Share

  517. NKUBA AN, Makiala SM, Guichet E, Tshiminyi PM, et al
    High prevalence of anti-SARS-CoV-2 antibodies after the first wave of COVID-19 in Kinshasa, Democratic Republic of the Congo: results of a cross-sectional household-based survey.
    Clin Infect Dis. 2021 Jun 5. pii: 6293985. doi: 10.1093.
    >> Share

  518. JACOBSON MA, Zakaria A, Maung Z, Hart C, et al
    Incidence and Characteristics of Delayed Injection Site Reaction to the mRNA-1273 SARS-CoV2 Vaccine (Moderna) in a Cohort of Hospital Employees.
    Clin Infect Dis. 2021 Jun 4. pii: 6291929. doi: 10.1093.
    >> Share

  519. LESHO E, Corey B, Lebreton F, Ong AC, et al
    Emergence of the E484K Mutation in SARS-CoV-2 Lineage B.1.1.345 in Upstate New York.
    Clin Infect Dis. 2021 Jun 4. pii: 6292251. doi: 10.1093.
    >> Share

  520. KAHN R, Holmdahl I, Reddy S, Jernigan J, et al
    Mathematical modeling to inform vaccination strategies and testing approaches for COVID-19 in nursing homes.
    Clin Infect Dis. 2021 Jun 4. pii: 6292250. doi: 10.1093.
    >> Share

  521. YEH HF
    The potential declining efficacy of the ChAdOx1 nCoV-19 vaccine(AZD1222) on inoculators with NSAIDs intake.
    Clin Infect Dis. 2021 Jun 3. pii: 6291428. doi: 10.1093.
    >> Share

  522. ROUSSEL Y, Million M, Chabriere E, Lagier JC, et al
    Be Careful With Big Data: Reanalysis of Patient Characteristics and Outcomes of 11 721 Patients With Coronavirus Disease 2019 Hospitalized Across the United States.
    Clin Infect Dis. 2021;72:e928.
    >> Share

  523. VAUGHN VM, Flanders SA
    Reply to Stevenson et al.
    Clin Infect Dis. 2021;72:e927.
    >> Share

    May 2021
  524. MAROT S, Malet I, Leducq V, Abdi B, et al
    Neutralization heterogeneity of United Kingdom and South-African SARS-CoV-2 variants in BNT162b2-vaccinated or convalescent COVID-19 healthcare workers.
    Clin Infect Dis. 2021 May 29. pii: 6288468. doi: 10.1093.
    >> Share

  525. TALBOT HK, Martin ET, Gaglani M, Middleton DB, et al
    Coronavirus disease 2019 (COVID-19) Versus Influenza in Hospitalized Adult Patients in the United States: Differences in Demographic and Severity Indicators.
    Clin Infect Dis. 2021 May 29. pii: 6288408. doi: 10.1093.
    >> Share

  526. COHEN MS, Wohl DA, Fischer WA, Smith DJ, et al
    Outpatient Treatment of SARS-CoV-2 Infection to Prevent COVID-19 Progression.
    Clin Infect Dis. 2021 May 28. pii: 6287650. doi: 10.1093.
    >> Share

  527. CANTERINO JE, Wang K, Golden M
    Provider Satisfaction with Infectious Diseases Telemedicine Consults for Hospitalized Patients During the COVID-19 Pandemic.
    Clin Infect Dis. 2021 May 28. pii: 6287628. doi: 10.1093.
    >> Share

  528. ZHANG Y, Luo W, Li Q, Wang X, et al
    Risk Factors for Death Among the First 80 543 COVID-19 Cases in China: Relationships Between Age, Underlying Disease, Case Severity, and Region.
    Clin Infect Dis. 2021 May 27. pii: 6287117. doi: 10.1093.
    >> Share

  529. LEIDI A, Koegler F, Dumont R, Dubos R, et al
    Risk of reinfection after seroconversion to SARS-CoV-2: A population-based propensity-score matched cohort study.
    Clin Infect Dis. 2021 May 27. pii: 6287116. doi: 10.1093.
    >> Share

  530. MEHRAVARAN S, Ahmed H, Chen YC
    Disparities in COVID-19 outcomes for African Americans: more studies are warranted.
    Clin Infect Dis. 2021 May 26. pii: 6285195. doi: 10.1093.
    >> Share

  531. ALI ST, Yeung A, Shan S, Wang L, et al
    Serial intervals and case isolation delays for COVID-19: a systematic review and meta-analysis.
    Clin Infect Dis. 2021 May 26. pii: 6284329. doi: 10.1093.
    >> Share

  532. KLOPFENSTEIN T, Gerazime A, Puyraveau M, Kadiane-Oussou NJ, et al
    It is time to determine Tocilizumab place in COVID-19.
    Clin Infect Dis. 2021 May 24. pii: 6283696. doi: 10.1093.
    >> Share

  533. YADAV PD, Sapkal GN, Abraham P, Deshpande G, et al
    Neutralization potential of Covishield vaccinated individuals sera against B.1.617.1.
    Clin Infect Dis. 2021 May 24. pii: 6283706. doi: 10.1093.
    >> Share

  534. GALANG RR, Newton SM, Woodworth KR, Griffin I, et al
    Risk factors for illness severity among pregnant women with confirmed SARS-CoV-2 infection - Surveillance for Emerging Threats to Mothers and Babies Network, 22 state, local, and territorial health departments, March 29, 2020 -March 5, 2021.
    Clin Infect Dis. 2021 May 22. pii: 6280195. doi: 10.1093.
    >> Share

  535. VERNA EC, Landis C, Brown RS Jr, Mospan AR, et al
    Factors Associated with Readmission in the US Following Hospitalization with COVID-19.
    Clin Infect Dis. 2021 May 20. pii: 6279074. doi: 10.1093.
    >> Share

  536. OGATA AF, Cheng CA, Desjardins M, Senussi Y, et al
    Circulating SARS-CoV-2 Vaccine Antigen Detected in the Plasma of mRNA-1273 Vaccine Recipients.
    Clin Infect Dis. 2021 May 20. pii: 6279075. doi: 10.1093.
    >> Share

  537. KARABA AH, Zhou W, Hsieh LL, Figueroa A, et al
    Differential Cytokine Signatures of SARS-CoV-2 and Influenza Infection Highlight Key Differences in Pathobiology.
    Clin Infect Dis. 2021 May 20. pii: 6278486. doi: 10.1093.
    >> Share

  538. VLASOVA AN, Diaz A, Damtie D, Xiu L, et al
    Novel Canine Coronavirus Isolated from a Hospitalized Pneumonia Patient, East Malaysia.
    Clin Infect Dis. 2021 May 20. pii: 6278597. doi: 10.1093.
    >> Share

  539. HIRSCHTICK JL, Titus AR, Slocum E, Power LE, et al
    Population-based estimates of post-acute sequelae of SARS-CoV-2 infection (PASC) prevalence and characteristics.
    Clin Infect Dis. 2021 May 19. pii: 6276644. doi: 10.1093.
    >> Share

  540. FURUKAWA D, Graber CJ
    Antimicrobial Stewardship in a Pandemic: Picking Up the Pieces.
    Clin Infect Dis. 2021;72:e542-e544.
    >> Share

  541. PISCHEL L, Goshua G
    Cost-effectiveness of tocilizumab in severe COVID-19: to see or not to see.
    Clin Infect Dis. 2021 May 17. pii: 6277058. doi: 10.1093.
    >> Share

  542. CHODICK G, Tene L, Rotem RS, Patalon T, et al
    The effectiveness of the TWO-DOSE BNT162b2 vaccine: analysis of real-world data.
    Clin Infect Dis. 2021 May 17. pii: 6276888. doi: 10.1093.
    >> Share

  543. HENSLEY KS, Jordans CCE, van Kampen JJA, Mollema FPN, et al
    Significant impact of COVID-19 on HIV care in hospitals affecting the first pillar of the HIV care continuum.
    Clin Infect Dis. 2021 May 16. pii: 6276393. doi: 10.1093.
    >> Share

  544. BAILLY B, Guilpain L, Bouiller K, Chirouze C, et al
    BNT162b2 mRNA vaccination did not prevent an outbreak of SARS COV-2 variant 501Y.V2 in an elderly nursing home but reduced transmission and disease severity.
    Clin Infect Dis. 2021 May 16. pii: 6276392. doi: 10.1093.
    >> Share

  545. CANADAY DH, Carias L, Oyebanji OA, Keresztesy D, et al
    Reduced BNT162b2 mRNA vaccine response in SARS-CoV-2-naive nursing home residents.
    Clin Infect Dis. 2021 May 16. pii: 6276391. doi: 10.1093.
    >> Share

  546. RENNERT L, McMahan C
    Risk of SARS-CoV-2 reinfection in a university student population.
    Clin Infect Dis. 2021 May 16. pii: 6276528. doi: 10.1093.
    >> Share

  547. HARRIS DA, Sobers M, Greenwald ZR, Simmons AE, et al
    Is 3 feet of physical distancing enough?
    Clin Infect Dis. 2021 May 14. pii: 6275593. doi: 10.1093.
    >> Share

  548. MASSO-SILVA JA, Moshensky A, Lam MTY, Odish M, et al
    Increased peripheral blood neutrophil activation phenotypes and NETosis in critically ill COVID-19 patients: a case series and review of the literature.
    Clin Infect Dis. 2021 May 14. pii: 6275596. doi: 10.1093.
    >> Share

  549. BRANCH-ELLIMAN W, Jack RS, Schechter-Perkins EM, van den Berg P, et al
    Reply to Author.
    Clin Infect Dis. 2021 May 14. pii: 6275594. doi: 10.1093.
    >> Share

  550. LUTGRING JD, Tobolowsky FA, Hatfield KM, Lehnertz NB, et al
    Evaluating the Presence of Replication-Competent SARS-CoV-2 from Nursing Home Residents with Persistently Positive RT-PCR Results.
    Clin Infect Dis. 2021 May 14. pii: 6275595. doi: 10.1093.
    >> Share

  551. VANIJCHAROENKARN K, Lee FE, Martin L, Shih J, et al
    Immediate reactions following the first dose of the SARS-CoV2 mRNA vaccines do not preclude second dose administration.
    Clin Infect Dis. 2021 May 14. pii: 6275836. doi: 10.1093.
    >> Share

  552. GUAGLIARDO SAJ, Prasad PV, Rodriguez A, Fukunaga R, et al
    Cruise ship travel in the era of COVID-19: A summary of outbreaks and a model of public health interventions.
    Clin Infect Dis. 2021 May 12. pii: 6274545. doi: 10.1093.
    >> Share

  553. SAMI S, Tenforde MW, Talbot HK, Lindsell CJ, et al
    Adults Hospitalized with COVID-19 -United States, March-June and October-December 2020: Implications for the Potential Effects of COVID-19 Tier-1 Vaccination on Future Hospitalizations and Outcomes.
    Clin Infect Dis. 2021 May 12. pii: 6270754. doi: 10.1093.
    >> Share

  554. FOX MD, Leiszler MS, Seamon MD, Garmin BL, et al
    Results of a Shortened Quarantine Protocol on a Midwestern College Campus.
    Clin Infect Dis. 2021 May 12. pii: 6274299. doi: 10.1093.
    >> Share

  555. KO JY, DeSisto CL, Simeone RM, Ellington S, et al
    Adverse pregnancy outcomes, maternal complications, and severe illness among U.S. delivery hospitalizations with and without a COVID-19 diagnosis.
    Clin Infect Dis. 2021 May 12. pii: 6274300. doi: 10.1093.
    >> Share

  556. MARKS SM, Clara A, Fiebelkorn AP, Le X, et al
    Influenza Vaccination in Health Centers during the COVID-19 Pandemic-United States, November 7-27, 2020.
    Clin Infect Dis. 2021 May 12. pii: 6274304. doi: 10.1093.
    >> Share

  557. MORENO GK, Braun KM, Pray IW, Segaloff HE, et al
    SARS-CoV-2 transmission in intercollegiate athletics not fully mitigated with daily antigen testing.
    Clin Infect Dis. 2021 May 12. pii: 6274297. doi: 10.1093.
    >> Share

  558. IOANNOU GN, O'Hare AM, Berry K, Fan VS, et al
    Trends over time in the risk of adverse outcomes among patients with SARS-CoV-2 infection.
    Clin Infect Dis. 2021 May 11. pii: 6273415. doi: 10.1093.
    >> Share

  559. LEE LYW, Rozmanowski S, Pang M, Charlett A, et al
    SARS-CoV-2 infectivity by viral load, S gene variants and demographic factors and the utility of lateral flow devices to prevent transmission.
    Clin Infect Dis. 2021 May 11. pii: 6273394. doi: 10.1093.
    >> Share

  560. FITZGERALD KC, Mecoli CA, Douglas M, Harris S, et al
    Risk Factors For Infection And Health Impacts Of The Covid-19 Pandemic In People With Autoimmune Diseases.
    Clin Infect Dis. 2021 May 6. pii: 6270948. doi: 10.1093.
    >> Share

  561. NICOLETE VC, Rodrigues PT, Johansen IC, Corder RM, et al
    Interacting Epidemics in Amazonian Brazil: Prior Dengue Infection Associated with Increased COVID-19 Risk in a Population-Based Cohort Study.
    Clin Infect Dis. 2021 May 6. pii: 6270997. doi: 10.1093.
    >> Share

  562. SINHA P, Linas BP
    Combination therapy with tocilizumab and dexamethasone cost-effectively reduces Coronavirus disease 2019 mortality.
    Clin Infect Dis. 2021 May 6. pii: 6270961. doi: 10.1093.
    >> Share

  563. HUI KP, Cheung MC, Lai KL, Ng KC, et al
    Role of epithelial-endothelial cell interaction in the pathogenesis of SARS-CoV-2 infection.
    Clin Infect Dis. 2021 May 6. pii: 6270945. doi: 10.1093.
    >> Share

  564. NARITA M, Hatt G, Toren KG, Vuong K, et al
    Delayed Tuberculosis Diagnoses During the COVID-19 Pandemic in 2020 - King County, Washington.
    Clin Infect Dis. 2021 May 6. pii: 6270740. doi: 10.1093.
    >> Share

  565. SCHRODT CA, Malenfant JH, Hunter JC, Slifka KJ, et al
    Investigation of a Suspect SARS-CoV-2 and Influenza A Mixed Outbreak: Lessons Learned for Long-Term Care Facilities Nationwide.
    Clin Infect Dis. 2021 May 6. pii: 6270741. doi: 10.1093.
    >> Share

  566. WILSON K, Dennison C, Struminger B, Armistad A, et al
    Building a Virtual Global Knowledge Network during COVID-19: The Infection Prevention and Control Global Webinar Series.
    Clin Infect Dis. 2021 May 6. pii: 6270763. doi: 10.1093.
    >> Share

  567. HANDBERRY M, Bull-Otterson L, Dai M, Mann CN, et al
    Changes in Emergency Medical Services before and during COVID-19 in the United States, January 2018-December 2020.
    Clin Infect Dis. 2021 May 6. pii: 6270742. doi: 10.1093.
    >> Share

  568. NUNES MC, Baillie VL, Kwatra G, Bhikha S, et al
    SARS-CoV-2 infection among healthcare workers in South Africa: a longitudinal cohort study.
    Clin Infect Dis. 2021 May 5. pii: 6265294. doi: 10.1093.
    >> Share

  569. RAM-MOHAN N, Kim D, Zudock EJ, Hashemi MM, et al
    SARS-CoV-2 RNAemia predicts clinical deterioration and extrapulmonary complications from COVID-19.
    Clin Infect Dis. 2021 May 5. pii: 6265285. doi: 10.1093.
    >> Share

  570. ROSE K, Grant-Kels JM, Striano P, Neubauer D, et al
    Warp speed for COVID-19 drugs and vaccines - time to re-consider how we use the term 'children'.
    Clin Infect Dis. 2021 May 5. pii: 6265295. doi: 10.1093.
    >> Share

  571. BELLON M, Baggio S, Bausch FJ, Spechbach H, et al
    SARS-CoV-2 viral load kinetics in symptomatic children, adolescents and adults.
    Clin Infect Dis. 2021 May 5. pii: 6265276. doi: 10.1093.
    >> Share

  572. ANDERSON EJ, Kamidani S, Orenstein W, Campbell JD, et al
    COVID-19 Vaccines Have Moved Out of Neutral, but Still Gearing Up in Children.
    Clin Infect Dis. 2021 May 5. pii: 6265296. doi: 10.1093.
    >> Share

  573. HAIDAR G, Mellors JW
    Improving the Outcomes of Immunocompromised Patients with COVID-19.
    Clin Infect Dis. 2021 May 5. pii: 6265293. doi: 10.1093.
    >> Share

  574. STRUTNER J, Ramchandar N, Dubey S, Gamboa M, et al
    Comparison of Reverse-Transcription Polymerase Chain Reaction Cycle Threshold Values From Respiratory Specimens in Symptomatic and Asymptomatic Children With Severe Acute Respiratory Syndrome Coronavirus 2 Infection.
    Clin Infect Dis. 2021 May 5. pii: 6266745. doi: 10.1093.
    >> Share

  575. MARTINEZ-URBISTONDO D, Costa Segovia R, Suarez Del Villar Carrero R, Risco Risco C, et al
    Early Combination of Tocilizumab and Corticosteroids: An Upgrade in Anti-inflammatory Therapy for Severe Coronavirus Disease (COVID).
    Clin Infect Dis. 2021;72:1682-1683.
    >> Share

  576. RAN L, Tan X
    Reply to Belingheri et al.
    Clin Infect Dis. 2021;72:1676-1677.
    >> Share

  577. MILLION M, Chaudet H, Raoult D
    Hydroxychloroquine Failure: The End Does Not Justify the Means.
    Clin Infect Dis. 2021;72:e439.
    >> Share

  578. HAJAGE D, Pourcher V, Paccoud O, Bleibtreu A, et al
    Reply to Million et al.
    Clin Infect Dis. 2021;72:e440-e441.
    >> Share

  579. ROSENBERG ES, Hall EW, Rosenthal EM, Maxted AM, et al
    Reply to Flannery et al.
    Clin Infect Dis. 2021;72:e429.
    >> Share

  580. ZHANG M, Yao X, Cui C, Liu X, et al
    Reply to Wolowich and Kwon.
    Clin Infect Dis. 2021;72:1678-1680.
    >> Share

  581. WOLOWICH WR, Kwon YM
    Simulation of Drug in the Lung Can Be Misleading.
    Clin Infect Dis. 2021;72:1677-1678.
    >> Share

  582. HILT EE, Boocock J, Trejo M, Le CQ, et al
    Retrospective Detection of SARS-CoV-2 in Symptomatic Patients prior to Widespread Diagnostic Testing in Southern California.
    Clin Infect Dis. 2021 May 3. pii: 6262672. doi: 10.1093.
    >> Share

    April 2021
  583. BEALL RF, Kesselheim AS, Hollis A
    Pre-market development times for innovative vaccines - to what extent are the COVID-19 vaccines outliers?
    Clin Infect Dis. 2021 Apr 29. pii: 6259217. doi: 10.1093.
    >> Share

  584. MARX GE, Biggerstaff BJ, Nawrocki CC, Totten SE, et al
    SARS-CoV-2 detection on self-collected saliva or anterior nasal specimens compared with healthcare personnel-collected nasopharyngeal specimens.
    Clin Infect Dis. 2021 Apr 29. pii: 6257585. doi: 10.1093.
    >> Share

  585. LAWS RL, Biraro S, Kirungi W, Gianetti B, et al
    COVID-19 Mitigation Efforts and Testing During an In-Person Training Event - Uganda, October 12-29, 2020.
    Clin Infect Dis. 2021 Apr 29. pii: 6257593. doi: 10.1093.
    >> Share

  586. CARTER RJ, Rose D, Sabo R, Clayton J, et al
    Widespread SARS-CoV-2 Transmission Among Attendees at a Large Motorcycle Rally and their Contacts, 30 US Jurisdictions, August-September, 2020.
    Clin Infect Dis. 2021 Apr 29. pii: 6257584. doi: 10.1093.
    >> Share

  587. TRAN VT, Riveros C, Clepier B, Desvarieux M, et al
    Development and validation of the long covid symptom and impact tools, a set of patient-reported instruments constructed from patients' lived experience.
    Clin Infect Dis. 2021 Apr 29. pii: 6252414. doi: 10.1093.
    >> Share

  588. RODGERS L, Sheppard M, Smith A, Dietz S, et al
    Changes in Seasonal Respiratory Illnesses in the United States During the COVID-19 Pandemic.
    Clin Infect Dis. 2021 Apr 29. pii: 6257582. doi: 10.1093.
    >> Share

  589. BUSHMAN D, Sekaran J, Jeffery N, Rath C, et al
    COVID-19 Outbreaks at Two Construction Sites - New York City, October-November 2020.
    Clin Infect Dis. 2021 Apr 29. pii: 6257583. doi: 10.1093.
    >> Share

  590. CHEVINSKY JR, Tao G, Lavery AM, Kukielka EA, et al
    Late conditions diagnosed 1-4 months following an initial COVID-19 encounter: a matched cohort study using inpatient and outpatient administrative data - United States, March 1-June 30, 2020.
    Clin Infect Dis. 2021 Apr 28. pii: 6257082. doi: 10.1093.
    >> Share

  591. SHAH MM, Salvatore PP, Ford L, Kamitani E, et al
    Performance of Repeat BinaxNOW SARS-CoV-2 Antigen Testing in a Community Setting, Wisconsin, November-December 2020.
    Clin Infect Dis. 2021 Apr 28. pii: 6257223. doi: 10.1093.
    >> Share

  592. GABLE P, Huang JY, Gilbert SE, Bollinger S, et al
    A Comparison of Less Invasive SARS-CoV-2 Diagnostic Specimens in Nursing Home Residents - Arkansas, June-August 2020.
    Clin Infect Dis. 2021 Apr 28. pii: 6257222. doi: 10.1093.
    >> Share

  593. TENG JLL, Fok KMN, Lin KPK, Chan E, et al
    Substantial decline in invasive pneumococcal disease (IPD) during COVID-19 pandemic in Hong Kong.
    Clin Infect Dis. 2021 Apr 27. pii: 6255967. doi: 10.1093.
    >> Share

  594. MULLER L, Andree M, Moskorz W, Drexler I, et al
    Age-dependent immune response to the Biontech/Pfizer BNT162b2 COVID-19 vaccination.
    Clin Infect Dis. 2021 Apr 27. pii: 6255965. doi: 10.1093.
    >> Share

  595. DEAR N, Duff E, Esber A, Parikh A, et al
    Transient reductions in HIV clinic attendance and food security during the COVID-19 pandemic for people living with HIV in four African countries.
    Clin Infect Dis. 2021 Apr 27. pii: 6255964. doi: 10.1093.
    >> Share

  596. CHOUDHARY MC, Crain CR, Qiu X, Hanage W, et al
    SARS-CoV-2 Sequence Characteristics of COVID-19 Persistence and Reinfection.
    Clin Infect Dis. 2021 Apr 27. pii: 6255966. doi: 10.1093.
    >> Share

  597. PAPAYANNI PG, Chasiotis D, Koukoulias K, Georgakopoulou A, et al
    Vaccinated and convalescent donor-derived SARS-CoV-2-specific T cells as adoptive immunotherapy for high-risk COVID-19 patients.
    Clin Infect Dis. 2021 Apr 27. pii: 6255711. doi: 10.1093.
    >> Share

  598. PIROFSKI LA
    Disease severity and durability of the SARS-CoV-2 antibody response: A view through the lens of the second year of the pandemic.
    Clin Infect Dis. 2021 Apr 27. pii: 6255716. doi: 10.1093.
    >> Share

  599. BASTOS RH, Blos PK, Rodrigues VD, da S Miranda B, et al
    One in every three COVID-19 reinfections result in hospitalization in the US.
    Clin Infect Dis. 2021 Apr 26. pii: 6253740. doi: 10.1093.
    >> Share

  600. SWIFT MD, Breeher LE, Tande AJ, Tommaso CP, et al
    Effectiveness of mRNA COVID-19 vaccines against SARS-CoV-2 infection in a cohort of healthcare personnel.
    Clin Infect Dis. 2021 Apr 26. pii: 6253721. doi: 10.1093.
    >> Share

  601. ALANGADEN G, Ramesh MS
    Reply to Fernandez Cruz, et al.
    Clin Infect Dis. 2021;72:1487.
    >> Share

  602. YU F, Yan L, Wang N, Guo Y, et al
    Reply to Aquino-Jarquin.
    Clin Infect Dis. 2021;72:1490-1491.
    >> Share

  603. AQUINO-JARQUIN G
    The Raw Cycle Threshold Values From Reverse-transcription Polymerase Chain Reaction Detection Are Not Viral Load Quantitation Units.
    Clin Infect Dis. 2021;72:1489-1490.
    >> Share

  604. LYNCH RM, Favata E, Gochfeld M
    Assess Ventilation When Determining Safe Distancing in Schools to Control COVID-19 Transmission.
    Clin Infect Dis. 2021 Apr 25. pii: 6250101. doi: 10.1093.
    >> Share

  605. QURESHI AI, Baskett WI, Huang W, Lobanova I, et al
    Re-infection with SARS-CoV-2 in Patients Undergoing Serial Laboratory Testing.
    Clin Infect Dis. 2021 Apr 25. pii: 6251701. doi: 10.1093.
    >> Share

  606. BRANCH-ELLIMAN W, Schechter-Perkins EM, Jack RS, van den Berg P, et al
    Reply to authors.
    Clin Infect Dis. 2021 Apr 25. pii: 6250099. doi: 10.1093.
    >> Share

  607. GOSWAMI ND, Fiore AE, Walke HT
    Evidence, Experience, Expertise, and the U.S. COVID-19 Public Health Response.
    Clin Infect Dis. 2021 Apr 24. pii: 6248544. doi: 10.1093.
    >> Share

  608. ETYANG AO, Lucinde R, Karanja H, Kalu C, et al
    Seroprevalence of Antibodies to SARS-CoV-2 among Health Care Workers in Kenya.
    Clin Infect Dis. 2021 Apr 24. pii: 6248493. doi: 10.1093.
    >> Share

  609. BROCCIA MM, de Knegt VEVE, Mills EHAEHA, Moller ALAL, et al
    Household exposure to SARS-CoV-2 and association with COVID-19 severity: a Danish nationwide cohort study.
    Clin Infect Dis. 2021 Apr 24. pii: 6248492. doi: 10.1093.
    >> Share

  610. FINSTERER J, Scorza FA
    COVID-19 can be complicated by immune-encephalopathy rather than encephalitis.
    Clin Infect Dis. 2021 Apr 24. pii: 6248513. doi: 10.1093.
    >> Share

  611. GAUTAM N, Madathil S, Tahani N, Bolton S, et al
    Medium-term outcome of severe to critically ill patients with SARS-CoV-2 infection.
    Clin Infect Dis. 2021 Apr 24. pii: 6248543. doi: 10.1093.
    >> Share

  612. LILLIE PJ, O'Brien P, Lawtie M, Jessop S, et al
    First dose of BNT162b2 mRNA vaccine in a Health Care Worker cohort is associated with reduced symptomatic and asymptomatic SARS-CoV-2 infection.
    Clin Infect Dis. 2021 Apr 24. pii: 6248435. doi: 10.1093.
    >> Share

  613. JONES LD, Chan ER, Zabarsky TF, Cadnum JL, et al
    Transmission of SARS-CoV-2 on a Patient Transport Van.
    Clin Infect Dis. 2021 Apr 24. pii: 6248519. doi: 10.1093.
    >> Share

  614. TOVAR M, Peinado J, Palomino S, Llanos F, et al
    Prevalence of SARS-CoV-2 antibodies among market and city bus depot workers in Lima, Peru.
    Clin Infect Dis. 2021 Apr 21. pii: 6243873. doi: 10.1093.
    >> Share

  615. GETTINGS JR, Gold JAW, Kimball A, Forsberg K, et al
    SARS-CoV-2 transmission in a Georgia school district - United States, December 2020-January 2021.
    Clin Infect Dis. 2021 Apr 17. pii: 6232104. doi: 10.1093.
    >> Share

  616. TANG J, Grubbs G, Lee Y, Golding H, et al
    Impact of convalescent plasma therapy on SARS CoV-2 antibody profile in COVID-19 patients.
    Clin Infect Dis. 2021 Apr 16. pii: 6228549. doi: 10.1093.
    >> Share

  617. BRAUN KM, Moreno GK, Buys A, Somsen ED, et al
    Viral sequencing reveals US healthcare personnel rarely become infected with SARS-CoV-2 through patient contact.
    Clin Infect Dis. 2021 Apr 15. pii: 6226897. doi: 10.1093.
    >> Share

  618. BETTON M, Livrozet M, Planas D, Fayol A, et al
    Sera neutralizing activities against SARS-CoV-2 and multiple variants six month after hospitalization for COVID-19.
    Clin Infect Dis. 2021 Apr 14. pii: 6225251. doi: 10.1093.
    >> Share

  619. CHENG VC, Fung KS, Siu GK, Wong SC, et al
    Nosocomial outbreak of COVID-19 by possible airborne transmission leading to a superspreading event.
    Clin Infect Dis. 2021 Apr 14. pii: 6225253. doi: 10.1093.
    >> Share

  620. KUMAR RN, Wu EL, Stosor V, Moore WJ, et al
    Real-World Experience of Bamlanivimab for COVID-19: A Case-Control Study.
    Clin Infect Dis. 2021 Apr 13. pii: 6224410. doi: 10.1093.
    >> Share

  621. FORD L, Lee C, Pray IW, Cole D, et al
    Epidemiologic characteristics associated with SARS-CoV-2 antigen-based test results, rRT-PCR cycle threshold values, subgenomic RNA, and viral culture results from university testing.
    Clin Infect Dis. 2021 Apr 13. pii: 6224406. doi: 10.1093.
    >> Share

  622. BOSSLET GT, Pollak M, Jang JH, Roll R, et al
    The effect of in-person primary and secondary school instruction on county-level SARS-CoV-2 spread in Indiana.
    Clin Infect Dis. 2021 Apr 13. pii: 6224418. doi: 10.1093.
    >> Share

  623. WANG H, Hogan CA, Verghese M, Solis D, et al
    Ultra-sensitive Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antigen Detection for the Diagnosis of Coronavirus Disease 2019 (COVID-19) in Upper Respiratory Samples.
    Clin Infect Dis. 2021 Apr 8. pii: 6217390. doi: 10.1093.
    >> Share

  624. CHEN Y, Li L
    Influence of Corticosteroid Dose on Viral Shedding Duration in Patients With COVID-19.
    Clin Infect Dis. 2021;72:1298-1300.
    >> Share

  625. GUO L, Ren L, Sharma L, Wang J, et al
    Reply to Yamaoka, et al.
    Clin Infect Dis. 2021;72:1293.
    >> Share

  626. VAN PRAET JT, Vandecasteele S, De Roo A, De Vriese AS, et al
    Humoral and cellular immunogenicity of the BNT162b2 mRNA Covid-19 Vaccine in nursing home residents.
    Clin Infect Dis. 2021 Apr 7. pii: 6213866. doi: 10.1093.
    >> Share

  627. WESTHOLTER D, Taube C
    SARS-CoV-2 outbreak in a long-term care facility after vaccination with BNT162b2.
    Clin Infect Dis. 2021 Apr 7. pii: 6213878. doi: 10.1093.
    >> Share

  628. ROTTENSTREICH A, Zarbiv G, Oiknine-Djian E, Zigron R, et al
    Efficient maternofetal transplacental transfer of anti- SARS-CoV-2 spike antibodies after antenatal SARS-CoV-2 BNT162b2 mRNA vaccination.
    Clin Infect Dis. 2021 Apr 3. pii: 6209876. doi: 10.1093.
    >> Share

  629. WILEY Z, Ross-Driscoll K, Wang Z, Smothers L, et al
    Racial and Ethnic Differences and Clinical Outcomes of COVID-19 Patients Presenting to the Emergency Department.
    Clin Infect Dis. 2021 Apr 2. pii: 6209403. doi: 10.1093.
    >> Share

  630. REUKERS DFM, van Boven M, Meijer A, Rots N, et al
    High infection secondary attack rates of SARS-CoV-2 in Dutch households revealed by dense sampling.
    Clin Infect Dis. 2021 Apr 2. pii: 6209401. doi: 10.1093.
    >> Share

    March 2021
  631. PENG J, Liu J, Mann SA, Mitchell AM, et al
    Estimation of secondary household attack rates for emergent spike L452R SARS-CoV-2 variants detected by genomic surveillance at a community-based testing site in San Francisco.
    Clin Infect Dis. 2021 Mar 31. pii: 6206738. doi: 10.1093.
    >> Share

  632. DEGRAZIA D, Miller FG
    SARS-CoV-2 Infection Challenge Experiments in Nonhuman Primates: An Ethical Perspective.
    Clin Infect Dis. 2021 Mar 31. pii: 6205379. doi: 10.1093.
    >> Share

  633. FWOLOSHI S, Hines JZ, Barradas DT, Yingst S, et al
    Prevalence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) among Health Care Workers-Zambia, July 2020.
    Clin Infect Dis. 2021 Mar 30. pii: 6204763. doi: 10.1093.
    >> Share

  634. WU P, Liu F, Chang Z, Lin Y, et al
    Assessing asymptomatic, pre-symptomatic and symptomatic transmission risk of SARS-CoV-2.
    Clin Infect Dis. 2021 Mar 27. pii: 6193430. doi: 10.1093.
    >> Share

  635. VOS ERA, van Boven M, den Hartog G, Backer JA, et al
    Associations between measures of social distancing and SARS-CoV-2 seropositivity: a nationwide population-based study in the Netherlands.
    Clin Infect Dis. 2021 Mar 27. pii: 6189768. doi: 10.1093.
    >> Share

  636. CHAILLON A, Smith DM
    Phylogenetic analyses of SARS-CoV-2 B.1.1.7 lineage suggest a single origin followed by multiple exportation events versus convergent evolution.
    Clin Infect Dis. 2021 Mar 27. pii: 6189784. doi: 10.1093.
    >> Share

  637. MCELLISTREM MC, Clancy CJ, Buehrle DJ, Lucas A, et al
    Single dose of a mRNA SARS-CoV-2 vaccine is associated with lower nasopharyngeal viral load among nursing home residents with asymptomatic COVID-19.
    Clin Infect Dis. 2021 Mar 26. pii: 6188727. doi: 10.1093.
    >> Share

  638. ECKSTEIN L, Rid A, Kamuya D, Shah SK, et al
    The essential role of DSMBs in ensuring the ethics of global vaccine trials to address COVID-19.
    Clin Infect Dis. 2021 Mar 24. pii: 6184613. doi: 10.1093.
    >> Share

  639. ESCANDON K, Ulrich AK, Chou R
    Concerns with and recommendations for COVID-19 research related to asymptomatic infection and mask wearing.
    Clin Infect Dis. 2021 Mar 23. pii: 6180410. doi: 10.1093.
    >> Share

  640. BADDLEY JW
    COVID-19 Associated Pulmonary Aspergillosis: Do We Have the CAPAcity to Improve Outcomes?
    Clin Infect Dis. 2021 Mar 23. pii: 6180413. doi: 10.1093.
    >> Share

  641. CUMMINS NW
    Remdesivir: An antiviral still seeking a raison d'etre.
    Clin Infect Dis. 2021 Mar 22. pii: 6179767. doi: 10.1093.
    >> Share


  642. Corrigendum to: A Case of 2019 Novel Coronavirus in a Pregnant Woman With Preterm Delivery.
    Clin Infect Dis. 2021 Mar 19. pii: 6178940. doi: 10.1093.
    >> Share

  643. MCNAB S, Ha Do LA, Clifford V, Crawford NW, et al
    Changing Epidemiology of Respiratory Syncytial Virus in Australia - delayed re-emergence in Victoria compared to WA/NSW after prolonged lock-down for COVID-19.
    Clin Infect Dis. 2021 Mar 18. pii: 6178344. doi: 10.1093.
    >> Share

  644. POLAND GA
    Antibody Dynamics, Seroreversion, and Persistence After SARS-CoV-2: Another Answer.
    Clin Infect Dis. 2021 Mar 17. pii: 6175316. doi: 10.1093.
    >> Share

  645. SLUGGETT JK, Dinh YH, Wesselingh SL, Inacio MC, et al
    National Changes in Outpatient Systemic Antibiotic Use During the Coronavirus Disease 2019 Pandemic in Australia.
    Clin Infect Dis. 2021 Mar 17. pii: 6175263. doi: 10.1093.
    >> Share


  646. Corrigendum to: Changing Disease Epidemiology to Inform Expanded Coronavirus Disease 2019 Testing.
    Clin Infect Dis. 2021;72:1108.
    >> Share

  647. SHEEHAN MM, Reddy AJ, Rothberg MB
    Reinfection Rates among Patients who Previously Tested Positive for COVID-19: a Retrospective Cohort Study.
    Clin Infect Dis. 2021 Mar 15. pii: 6170939. doi: 10.1093.
    >> Share

  648. JORDAN I, de Sevilla MF, Fumado V, Bassat Q, et al
    Transmission of SARS-CoV-2 infection among children in summer schools applying stringent control measures in Barcelona, Spain.
    Clin Infect Dis. 2021 Mar 12. pii: 6168543. doi: 10.1093.
    >> Share

  649. SORIANO-ARANDES A, Gatell A, Serrano P, Biosca M, et al
    Household SARS-CoV-2 transmission and children: a network prospective study.
    Clin Infect Dis. 2021 Mar 12. pii: 6168547. doi: 10.1093.
    >> Share

  650. KLOMPAS M, Baker MA, Griesbach D, Tucker R, et al
    Transmission of SARS-CoV-2 from asymptomatic and presymptomatic individuals in healthcare settings despite medical masks and eye protection.
    Clin Infect Dis. 2021 Mar 11. pii: 6168040. doi: 10.1093.
    >> Share

  651. TANDE AJ, Pollock BD, Shah ND, Farrugia G, et al
    Impact of the COVID-19 Vaccine on Asymptomatic Infection Among Patients Undergoing Pre-Procedural COVID-19 Molecular Screening.
    Clin Infect Dis. 2021 Mar 10. pii: 6167855. doi: 10.1093.
    >> Share

  652. VAN DEN BERG P, Schechter-Perkins EM, Jack RS, Epshtein I, et al
    Effectiveness of three versus six feet of physical distancing for controlling spread of COVID-19 among primary and secondary students and staff: A retrospective, state-wide cohort study.
    Clin Infect Dis. 2021 Mar 10. pii: 6167856. doi: 10.1093.
    >> Share

  653. GOUIN KA, Creasy S, Beckerson M, Wdowicki M, et al
    Trends in Prescribing of Antibiotics and Drugs Investigated for COVID-19 Treatment in U.S. Nursing Home Residents During the COVID-19 Pandemic.
    Clin Infect Dis. 2021 Mar 10. pii: 6167836. doi: 10.1093.
    >> Share

  654. LIN DY, Zeng D, Gilbert PB
    Evaluating the Long-Term Efficacy of COVID-19 Vaccines.
    Clin Infect Dis. 2021 Mar 10. pii: 6167839. doi: 10.1093.
    >> Share

  655. PERMPALUNG N, Chiang TP, Massie AB, Zhang SX, et al
    COVID-19 Associated Pulmonary Aspergillosis in Mechanically Ventilated Patients.
    Clin Infect Dis. 2021 Mar 9. pii: 6164950. doi: 10.1093.
    >> Share

  656. PIANTADOSI A
    SARS-CoV-2 Episode 2? A sequel nobody wants to see.
    Clin Infect Dis. 2021 Mar 9. pii: 6164969. doi: 10.1093.
    >> Share

  657. VAN ELSLANDE J, Gruwier L, Godderis L, Vermeersch P, et al
    Estimated half-life of SARS-CoV-2 anti-spike antibodies more than double the half-life of anti-nucleocapsid antibodies in healthcare workers.
    Clin Infect Dis. 2021 Mar 8. pii: 6162856. doi: 10.1093.
    >> Share

  658. CAPETTI AF, Stangalini CA, Borgonovo F, Mileto D, et al
    Impressive boosting of anti-S1/S2 IgG production in COVID-19-experienced patients after the first shot of the BNT162b2 mRNA COVID-19 Vaccine.
    Clin Infect Dis. 2021 Mar 6. pii: 6159798. doi: 10.1093.
    >> Share

  659. RAPAKA RR, Hammershaimb EA, Neuzil KM
    Are some COVID vaccines better than others? Interpreting and comparing estimates of efficacy in trials of COVID-19 vaccines.
    Clin Infect Dis. 2021 Mar 6. pii: 6159795. doi: 10.1093.
    >> Share

  660. PAUL LA, Daneman N, Brown KA, Johnson J, et al
    Characteristics associated with household transmission of SARS-CoV-2 in Ontario, Canada: A cohort study.
    Clin Infect Dis. 2021 Mar 5. pii: 6159706. doi: 10.1093.
    >> Share

  661. TSE H, Lung DC, Wong SC, Ip KF, et al
    Emergence of a Severe Acute Respiratory Syndrome Coronavirus 2 virus variant with novel genomic architecture in Hong Kong.
    Clin Infect Dis. 2021 Mar 2. pii: 6155931. doi: 10.1093.
    >> Share

  662. VAN LOON W, Hommes F, Theuring S, von der Haar A, et al
    Renewed absence of SARS-CoV-2 infections in the day care context in Berlin, January 2021.
    Clin Infect Dis. 2021 Mar 2. pii: 6155930. doi: 10.1093.
    >> Share

  663. RAWSON TM, Moore LSP, Zhu N, Ranganathan N, et al
    Reply to Dudoignon et al.
    Clin Infect Dis. 2021;72:906-908.
    >> Share

    February 2021
  664. EYAL N, Lipsitch M
    How to test SARS-CoV-2 vaccines ethically even after one is available.
    Clin Infect Dis. 2021 Feb 26. pii: 6152007. doi: 10.1093.
    >> Share

  665. LIM T, Delorey M, Bestul N, Johannsen M, et al
    Changes in SARS CoV-2 Seroprevalence Over Time in Ten Sites in the United States, March - August, 2020.
    Clin Infect Dis. 2021 Feb 26. pii: 6152134. doi: 10.1093.
    >> Share

  666. HYDE Z
    Difference in SARS-CoV-2 attack rate between children and adults may reflect bias.
    Clin Infect Dis. 2021 Feb 26. pii: 6150026. doi: 10.1093.
    >> Share

  667. GROOTHOF D, Post A, Gans ROB, Bakker SJL, et al
    Reduced Vitamin K Status and Coronavirus Disease 2019: An Epiphenomenon of Impaired Kidney Function?
    Clin Infect Dis. 2021 Feb 25. pii: 6149918. doi: 10.1093.
    >> Share

  668. SAFE IP, Lacerda MVG, Almeida Val FF, Sampaio VS, et al
    Severe Hypoxemia With Normal Heart and Respiratory Rate in Early-stage Coronavirus Disease 2019 Patients: The "Happy Hypoxemia Phenomenon".
    Clin Infect Dis. 2021 Feb 24. pii: 6149031. doi: 10.1093.
    >> Share

  669. DEN HARTOG G, Vos ERA, van den Hoogen LL, van Boven M, et al
    Persistence of antibodies to SARS-CoV-2 in relation to symptoms in a nationwide prospective study.
    Clin Infect Dis. 2021 Feb 24. pii: 6149064. doi: 10.1093.
    >> Share

  670. REIMER JR, Ahmed SM, Brintz B, Shah RU, et al
    Using a clinical prediction rule to prioritize diagnostic testing leads to reduced transmission and hospital burden: A modeling example of early SARS-CoV-2.
    Clin Infect Dis. 2021 Feb 23. pii: 6148743. doi: 10.1093.
    >> Share

  671. DAI CL, Kornilov SA, Roper RT, Cohen-Cline H, et al
    Characteristics and Factors Associated with COVID-19 Infection, Hospitalization, and Mortality Across Race and Ethnicity.
    Clin Infect Dis. 2021 Feb 20. pii: 6145124. doi: 10.1093.
    >> Share

  672. LEE JT, Hesse EM, Paulin HN, Datta D, et al
    Clinical and Laboratory Findings in Patients with Potential SARS-CoV-2 Reinfection, May-July 2020.
    Clin Infect Dis. 2021 Feb 18. pii: 6142945. doi: 10.1093.
    >> Share

  673. XU J, Zhou M, Luo P, Yin Z, et al
    Plasma metabolomic profiling of patients recovered from COVID-19 with pulmonary sequelae 3 months after discharge.
    Clin Infect Dis. 2021 Feb 17. pii: 6141511. doi: 10.1093.
    >> Share

  674. FOLEY DA, Yeoh DK, Minney-Smith CA, Martin AC, et al
    The Interseasonal Resurgence of Respiratory Syncytial Virus in Australian Children Following the Reduction of Coronavirus Disease 2019-Related Public Health Measures.
    Clin Infect Dis. 2021 Feb 17. pii: 6140790. doi: 10.1093/cid/ciaa1906.
    >> Share

  675. JACKSON ML, Starita L, Kiniry E, Phillips CH, et al
    Incidence of medically attended acute respiratory illnesses due to respiratory viruses across the life course during the 2018/19 influenza season.
    Clin Infect Dis. 2021 Feb 16. pii: 6137552. doi: 10.1093.
    >> Share

  676. KULKARNI O, Narreddy S, Zaveri L, Kalal IG, et al
    Evidence of SARS-CoV-2 reinfection without mutations in Spike protein.
    Clin Infect Dis. 2021 Feb 16. pii: 6137553. doi: 10.1093.
    >> Share

  677. WESTREICH D, Jenness SM, Marcus JL
    To Contact Tracing... and Beyond!
    Clin Infect Dis. 2021;72:724-725.
    >> Share

  678. SAM-AGUDU NA, Rabie H, Pipo MT, Byamungu LN, et al
    The Critical Need for Pooled Data on COVID-19 in African Children: An AFREhealth Call for Action through Multi-Country Research Collaboration.
    Clin Infect Dis. 2021 Feb 13. pii: 6134449. doi: 10.1093.
    >> Share

  679. BELL N, Bracchi M, Dalla Pria A, Nelson M, et al
    Indirect HIV morbidity and mortality due to COVID-19.
    Clin Infect Dis. 2021 Feb 13. pii: 6134310. doi: 10.1093.
    >> Share

  680. FELDMAN AG, O'Leary ST, Isakov LD
    The Risk of Resurgence in Vaccine Preventable Infections Due to COVID-Related Gaps in Immunization.
    Clin Infect Dis. 2021 Feb 13. pii: 6134309. doi: 10.1093.
    >> Share

  681. ZUCMAN N, Uhel F, Descamps D, Roux D, et al
    Severe reinfection with South African SARS-CoV-2 variant 501Y.V2: A case report.
    Clin Infect Dis. 2021 Feb 10. pii: 6132402. doi: 10.1093.
    >> Share

  682. SEE I, Paul P, Slayton RB, Steele MK, et al
    Modeling effectiveness of testing strategies to prevent COVID-19 in nursing homes -United States, 2020.
    Clin Infect Dis. 2021 Feb 10. pii: 6132104. doi: 10.1093.
    >> Share

  683. DUGDALE CM, Rubins DM, Lee H, McCluskey SM, et al
    COVID-19 Diagnostic Clinical Decision Support: a Pre-Post Implementation Study of CORAL (COvid Risk cALculator).
    Clin Infect Dis. 2021 Feb 10. pii: 6132091. doi: 10.1093.
    >> Share

  684. THOMPSON HA, Mousa A, Dighe A, Fu H, et al
    SARS-CoV-2 setting-specific transmission rates: a systematic review and meta-analysis.
    Clin Infect Dis. 2021 Feb 9. pii: 6131730. doi: 10.1093.
    >> Share

  685. MOMPLAISIR F, Haynes N, Nkwihoreze H, Nelson M, et al
    Understanding Drivers of COVID-19 Vaccine Hesitancy Among Blacks.
    Clin Infect Dis. 2021 Feb 9. pii: 6131729. doi: 10.1093.
    >> Share

  686. CROVETTO F, Crispi F, Llurba E, Pascal R, et al
    Impact of SARS-CoV-2 Infection on Pregnancy Outcomes: A Population-Based Study.
    Clin Infect Dis. 2021 Feb 8. pii: 6131375. doi: 10.1093.
    >> Share

  687. REBEIRO PF, Aronoff DM, Smith MK
    The Impact of State Mask-Wearing Requirements on the Growth of COVID-19 Cases in the United States.
    Clin Infect Dis. 2021 Feb 7. pii: 6129930. doi: 10.1093.
    >> Share

  688. JACOBSON KB, Rao M, Bonilla H, Subramanian A, et al
    Patients with uncomplicated COVID-19 have long-term persistent symptoms and functional impairment similar to patients with severe COVID-19: a cautionary tale during a global pandemic.
    Clin Infect Dis. 2021 Feb 7. pii: 6129932. doi: 10.1093.
    >> Share

  689. CONNORS JM, Iba T, Gandhi RT
    Thrombosis and COVID-19: Controversies and (Tentative) Conclusions.
    Clin Infect Dis. 2021 Feb 4. pii: 6128795. doi: 10.1093.
    >> Share

  690. ARNAOUT R, Lee RA, Lee GR, Callahan C, et al
    The Limit of Detection Matters: The Case for Benchmarking Severe Acute Respiratory Syndrome Coronavirus 2 Testing.
    Clin Infect Dis. 2021 Feb 3. pii: 6127024. doi: 10.1093/cid/ciaa1382.
    >> Share

  691. PATEL MR, Carroll D, Ussery E, Whitham H, et al
    Performance of Oropharyngeal Swab Testing Compared With Nasopharyngeal Swab Testing for Diagnosis of Coronavirus Disease 2019-United States, January 2020-February 2020.
    Clin Infect Dis. 2021;72:403-410.
    >> Share

  692. CANADAY DH, Gravenstein S
    On Setting Expectations for a Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine.
    Clin Infect Dis. 2021;72:513-514.
    >> Share

  693. KAO CM, Orenstein WA, Anderson EJ
    The Importance of Advancing Severe Acute Respiratory Syndrome Coronavirus 2 Vaccines in Children.
    Clin Infect Dis. 2021;72:515-518.
    >> Share

  694. MANDONNET E, Molina JM
    Household Coronavirus Disease 2019 (COVID-19) Prevalence.
    Clin Infect Dis. 2021;72:539.
    >> Share

  695. HAN L, Li N, Peng M, Yang L, et al
    Reply to Chen.
    Clin Infect Dis. 2021;72:538-539.
    >> Share

  696. CHEN HJ
    It Is Not a Case-control Study.
    Clin Infect Dis. 2021;72:538.
    >> Share

    January 2021
  697. LI C, Chen YX, Liu FF, Lee AC, et al
    Absence of vaccine-enhanced disease with unexpected positive protection against SARS-CoV-2 by inactivated vaccine given within three days of virus challenge in Syrian hamster model.
    Clin Infect Dis. 2021 Jan 30. pii: 6124512. doi: 10.1093.
    >> Share

  698. GOTTLIEB RL, Spak CW
    The Olympiad of SARS-CoV-2 vaccinology: Fundamentals to Complement Technical Frontiers.
    Clin Infect Dis. 2021 Jan 30. pii: 6124447. doi: 10.1093.
    >> Share

  699. RICHIER Q, Placais L, Lacombe K, Hermine O, et al
    Tocilizumab in COVID-19: Give it time!
    Clin Infect Dis. 2021 Jan 30. pii: 6124471. doi: 10.1093.
    >> Share

  700. MOGHADAS SM, Vilches TN, Zhang K, Wells CR, et al
    The impact of vaccination on COVID-19 outbreaks in the United States.
    Clin Infect Dis. 2021 Jan 30. pii: 6124429. doi: 10.1093.
    >> Share

  701. AKINBAMI LJ, Petersen LR, Sami S, Vuong N, et al
    COVID-19 symptoms and SARS-CoV-2 antibody positivity in a large survey of first responders and healthcare personnel, May-July 2020.
    Clin Infect Dis. 2021 Jan 30. pii: 6124470. doi: 10.1093.
    >> Share

  702. HENSLEY MK, Bain WG, Jacobs J, Nambulli S, et al
    Intractable COVID-19 and Prolonged SARS-CoV-2 Replication in a CAR-T-cell Therapy Recipient: A Case Study.
    Clin Infect Dis. 2021 Jan 28. pii: 6122591. doi: 10.1093.
    >> Share

  703. LANE MA, Brownsword EA, Babiker A, Ingersoll JM, et al
    Bioaerosol sampling for SARS-CoV-2 in a referral center with critically ill COVID-19 patients March-May 2020.
    Clin Infect Dis. 2021 Jan 28. pii: 6121685. doi: 10.1093/cid/ciaa1880.
    >> Share

  704. BIENIASZ P
    The case against delaying SARS-CoV-2 mRNA vaccine boosting doses.
    Clin Infect Dis. 2021 Jan 27. pii: 6121510. doi: 10.1093.
    >> Share

  705. LAPENNA D
    Antioxidant therapy in COVID-19: The crucial role of early treatment and antioxidant typology.
    Clin Infect Dis. 2021 Jan 27. pii: 6121547. doi: 10.1093.
    >> Share

  706. DIMEGLIO C, Herin F, Miedouge M, Martin-Blondel G, et al
    Protection of healthcare workers against SARS-CoV-2 reinfection.
    Clin Infect Dis. 2021 Jan 27. pii: 6121509. doi: 10.1093.
    >> Share

  707. PLOTKIN SA, Halsey N
    Accelerate COVID-19 Vaccine Rollout by Delaying the Second Dose of mRNA Vaccines.
    Clin Infect Dis. 2021 Jan 27. pii: 6121304. doi: 10.1093.
    >> Share

  708. FUNG M, Babik JM
    COVID-19 in Immunocompromised Hosts: What We Know So Far.
    Clin Infect Dis. 2021;72:340-350.
    >> Share

  709. ERIKSTRUP C, Hother CE, Pedersen OBV, Molbak K, et al
    Estimation of SARS-CoV-2 Infection Fatality Rate by Real-time Antibody Screening of Blood Donors.
    Clin Infect Dis. 2021;72:249-253.
    >> Share

  710. ANGOULVANT F, Ouldali N, Yang DD, Filser M, et al
    Coronavirus Disease 2019 Pandemic: Impact Caused by School Closure and National Lockdown on Pediatric Visits and Admissions for Viral and Nonviral Infections-a Time Series Analysis.
    Clin Infect Dis. 2021;72:319-322.
    >> Share

  711. NACHEGA JB, Grimwood A, Mahomed H, Fatti G, et al
    From Easing Lockdowns to Scaling Up Community-based Coronavirus Disease 2019 Screening, Testing, and Contact Tracing in Africa-Shared Approaches, Innovations, and Challenges to Minimize Morbidity and Mortality.
    Clin Infect Dis. 2021;72:327-331.
    >> Share

  712. SCHWIERZECK V, Konig JC, Kuhn J, Mellmann A, et al
    First Reported Nosocomial Outbreak of Severe Acute Respiratory Syndrome Coronavirus 2 in a Pediatric Dialysis Unit.
    Clin Infect Dis. 2021;72:265-270.
    >> Share

  713. CHAMILOS G, Lionakis MS, Kontoyiannis DP
    Are All Patients with Cancer at Heightened Risk for Severe Coronavirus Disease 2019 (COVID-19)?
    Clin Infect Dis. 2021;72:351-356.
    >> Share

  714. BUSCH MP, Stone M
    Serosurveillance for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Incidence Using Global Blood Donor Populations.
    Clin Infect Dis. 2021;72:254-256.
    >> Share

  715. CONTEJEAN A, Leporrier J, Canoui E, Alby-Laurent F, et al
    Comparing Dynamics and Determinants of Severe Acute Respiratory Syndrome Coronavirus 2 Transmissions Among Healthcare Workers of Adult and Pediatric Settings in Central Paris.
    Clin Infect Dis. 2021;72:257-264.
    >> Share

  716. LYNCH KL, Whitman JD, Lacanienta NP, Beckerdite EW, et al
    Magnitude and Kinetics of Anti-Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Responses and Their Relationship to Disease Severity.
    Clin Infect Dis. 2021;72:301-308.
    >> Share

  717. LONG DR, Gombar S, Hogan CA, Greninger AL, et al
    Occurrence and Timing of Subsequent Severe Acute Respiratory Syndrome Coronavirus 2 Reverse-transcription Polymerase Chain Reaction Positivity Among Initially Negative Patients.
    Clin Infect Dis. 2021;72:323-326.
    >> Share

  718. ZHOU L, Wu Z, Li Z, Zhang Y, et al
    One Hundred Days of Coronavirus Disease 2019 Prevention and Control in China.
    Clin Infect Dis. 2021;72:332-339.
    >> Share

  719. LYNCH KL, Whitman JD, Lacanienta NP, Beckerdite EW, et al
    Magnitude and Kinetics of Anti-Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Responses and Their Relationship to Disease Severity.
    Clin Infect Dis. 2021;72:301-308.
    >> Share

  720. ZHOU L, Wu Z, Li Z, Zhang Y, et al
    One Hundred Days of Coronavirus Disease 2019 Prevention and Control in China.
    Clin Infect Dis. 2021;72:332-339.
    >> Share

  721. CONTEJEAN A, Leporrier J, Canoui E, Alby-Laurent F, et al
    Comparing Dynamics and Determinants of Severe Acute Respiratory Syndrome Coronavirus 2 Transmissions Among Healthcare Workers of Adult and Pediatric Settings in Central Paris.
    Clin Infect Dis. 2021;72:257-264.
    >> Share

  722. BUSCH MP, Stone M
    Serosurveillance for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Incidence Using Global Blood Donor Populations.
    Clin Infect Dis. 2021;72:254-256.
    >> Share

  723. LONG DR, Gombar S, Hogan CA, Greninger AL, et al
    Occurrence and Timing of Subsequent Severe Acute Respiratory Syndrome Coronavirus 2 Reverse-transcription Polymerase Chain Reaction Positivity Among Initially Negative Patients.
    Clin Infect Dis. 2021;72:323-326.
    >> Share

  724. MAVES RC
    Making sense of contradictory evidence in Covid-19 trials.
    Clin Infect Dis. 2021 Jan 25. pii: 6119538. doi: 10.1093.
    >> Share

  725. SHAW J, Stewart T, Anderson KB, Hanley S, et al
    Assessment of U.S. health care personnel (HCP) attitudes towards COVID-19 vaccination in a large university health care system.
    Clin Infect Dis. 2021 Jan 25. pii: 6118651. doi: 10.1093.
    >> Share

  726. BRANCH-ELLIMAN W, Safdar N, Nelson R
    Economic Considerations in Infectious Diseases Emergency Response Preparedness: It's All About the Point of View.
    Clin Infect Dis. 2021;72:148-152.
    >> Share

  727. JI D, Qin E, Zhang D, Cheng G, et al
    Reply to Grifoni et al.
    Clin Infect Dis. 2021;72:183.
    >> Share

  728. HANSON KE, Caliendo AM, Arias CA, Hayden MK, et al
    The Infectious Diseases Society of America Guidelines on the Diagnosis of COVID-19: Molecular Diagnostic Testing.
    Clin Infect Dis. 2021 Jan 22. pii: 6106562. doi: 10.1093.
    >> Share

  729. PEKOSZ A, Parvu V, Li M, Andrews JC, et al
    Antigen-Based Testing but Not Real-Time Polymerase Chain Reaction Correlates With Severe Acute Respiratory Syndrome Coronavirus 2 Viral Culture.
    Clin Infect Dis. 2021 Jan 20. pii: 6105729. doi: 10.1093/cid/ciaa1706.
    >> Share

  730. GOYAL R, Hotchkiss J, Schooley RT, De Gruttola V, et al
    Evaluation of SARS-CoV-2 transmission mitigation strategies on a university campus using an agent-based network model.
    Clin Infect Dis. 2021 Jan 19. pii: 6104139. doi: 10.1093.
    >> Share

  731. SOMEKH I, Shohat T, Boker LK, Simoes EAF, et al
    Reopening Schools and the Dynamics of SARS-CoV-2 Infections in Israel: A Nationwide Study.
    Clin Infect Dis. 2021 Jan 18. pii: 6103916. doi: 10.1093.
    >> Share

  732. SAMET JM, Prather K, Benjamin G, Lakdawala S, et al
    Airborne Transmission of SARS-CoV-2: What We Know.
    Clin Infect Dis. 2021 Jan 18. pii: 6103221. doi: 10.1093.
    >> Share

  733. ALROY KA, Crossa A, Dominianni C, Sell J, et al
    Population-based Estimates of COVID-19-like Illness, COVID-19 Illness, and Rates of Case Ascertainment, Hospitalizations, and Deaths - Non-Institutionalized New York City Residents, March-April 2020.
    Clin Infect Dis. 2021 Jan 18. pii: 6103212. doi: 10.1093.
    >> Share

  734. HARRINGTON D, Kele B, Pereira S, Couto-Parada X, et al
    Confirmed Reinfection with SARS-CoV-2 Variant VOC-202012/01.
    Clin Infect Dis. 2021 Jan 9. pii: 6076528. doi: 10.1093.
    >> Share

  735. LEE M
    Lack of SARS-CoV2 neutralization by antibodies to seasonal coronaviruses: making sense of the COVID-19 pandemic.
    Clin Infect Dis. 2021 Jan 8. pii: 6071008. doi: 10.1093.
    >> Share

  736. BOYD S, Martin-Loeches I
    Rates of Aspergillus Co-infection in COVID patients in ICU not as high as previously reported.
    Clin Infect Dis. 2021 Jan 8. pii: 6071009. doi: 10.1093.
    >> Share

  737. ANDERSEN KM, Mehta HB, Palamuttam N, Ford D, et al
    Association Between Chronic Use of Immunosuppresive Drugs and Clinical Outcomes From Coronavirus Disease 2019 (COVID-19) Hospitalization: A Retrospective Cohort Study in a Large US Health System.
    Clin Infect Dis. 2021 Jan 7. pii: 6067567. doi: 10.1093/cid/ciaa1488.
    >> Share

  738. YANG B, Wu P, Lau EHY, Wong JY, et al
    Changing disparities in COVID-19 burden in the ethnically homogeneous population of Hong Kong through pandemic waves: an observational study.
    Clin Infect Dis. 2021 Jan 6. pii: 6066577. doi: 10.1093.
    >> Share

  739. LUMLEY SF, Wei J, O'Donnell D, Stoesser NE, et al
    The duration, dynamics and determinants of SARS-CoV-2 antibody responses in individual healthcare workers.
    Clin Infect Dis. 2021 Jan 6. pii: 6064824. doi: 10.1093.
    >> Share

  740. DALAGER-PEDERSEN M, Lund LC, Mariager T, Winther R, et al
    Venous thromboembolism and major bleeding in patients with COVID-19: A nationwide population-based cohort study.
    Clin Infect Dis. 2021 Jan 5. pii: 6064643. doi: 10.1093.
    >> Share

  741. PILOTTO A, Masciocchi S, Volonghi I, De Giuli V, et al
    SARS-CoV-2 encephalitis is a cytokine release syndrome: evidences from cerebrospinal fluid analyses.
    Clin Infect Dis. 2021 Jan 4. pii: 6062486. doi: 10.1093/cid/ciaa1933.
    >> Share

  742. TRIANT VA, Gandhi RT
    When Epidemics Collide: Why People with HIV May Have Worse COVID-19 Outcomes and Implications for Vaccination.
    Clin Infect Dis. 2021 Jan 4. pii: 6062462. doi: 10.1093/cid/ciaa1946.
    >> Share

  743. WEINBERGER T, Steffen J, Osterman A, Mueller TT, et al
    Prospective Longitudinal Serosurvey of Health Care Workers in the First Wave of the SARS-CoV-2 Pandemic in a Quaternary Care Hospital in Munich, Germany.
    Clin Infect Dis. 2021 Jan 3. pii: 6060065. doi: 10.1093/cid/ciaa1935.
    >> Share

  744. ZHANG Z, Guo L, Huang L, Zhang C, et al
    Distinct disease severity between children and older adults with COVID-19: Impacts of ACE2 expression, distribution, and lung progenitor cells.
    Clin Infect Dis. 2021 Jan 3. pii: 6059779. doi: 10.1093/cid/ciaa1911.
    >> Share

  745. HOEHL S, Kreutzer E, Schenk B, Westhaus S, et al
    Longitudinal testing for respiratory and gastrointestinal shedding of SARS-CoV-2 in day care centres in Hesse, Germany.
    Clin Infect Dis. 2021 Jan 3. pii: 6059778. doi: 10.1093/cid/ciaa1912.
    >> Share

  746. DAN J, Mehta S
    SARS-CoV-2 immunity and reinfection.
    Clin Infect Dis. 2021 Jan 2. pii: 6058751. doi: 10.1093/cid/ciaa1936.
    >> Share

    December 2020
  747. GRANICH R, Gupta S
    European Union, HIV, and Coronavirus Disease 2019 (COVID-19): Progress and Lessons Learned From the HIV Pandemic.
    Clin Infect Dis. 2020;71:2917-2919.
    >> Share

  748. TAYLOR SP, Kowalkowski MA, Beidas RS
    Where Is the Implementation Science? An Opportunity to Apply Principles During the COVID-19 Pandemic.
    Clin Infect Dis. 2020;71:2993-2995.
    >> Share

  749. SKURNIK D, Rybak A, Yang DD, Pons S, et al
    Unexpected lessons from the COVID-19 lockdowns in France: Low impact of school opening on common communicable pediatric airborne diseases.
    Clin Infect Dis. 2020 Dec 29. pii: 6054992. doi: 10.1093/cid/ciaa1899.
    >> Share

  750. KING LM, Lovegrove MC, Shehab N, Tsay S, et al
    Trends in U.S. outpatient antibiotic prescriptions during the COVID-19 pandemic.
    Clin Infect Dis. 2020 Dec 29. pii: 6054971. doi: 10.1093/cid/ciaa1896.
    >> Share

  751. SILVESTRE OM, Costa LR, Lopes BVR, Barbosa MR, et al
    Previous dengue infection and mortality in COVID-19.
    Clin Infect Dis. 2020 Dec 29. pii: 6054970. doi: 10.1093/cid/ciaa1895.
    >> Share

  752. PILAROWSKI G, Marquez C, Rubio L, Peng J, et al
    Field performance and public health response using the BinaxNOW TM Rapid SARS-CoV-2 antigen detection assay during community-based testing.
    Clin Infect Dis. 2020 Dec 26. pii: 6052342. doi: 10.1093/cid/ciaa1890.
    >> Share

  753. HIRSCHFELD G, von Glischinski M, Thiele C
    Optimal cycle thresholds for COVID-19 screening - ROC-based methods highlight between-study differences.
    Clin Infect Dis. 2020 Dec 23. pii: 6044731. doi: 10.1093/cid/ciaa1883.
    >> Share

  754. GILES ML, Wallace EM, Alpren C, Brady N, et al
    Suppression of SARS-CoV-2 after a second wave in Victoria, Australia.
    Clin Infect Dis. 2020 Dec 23. pii: 6044730. doi: 10.1093/cid/ciaa1882.
    >> Share

  755. KIES KD, Thomas AS, Binnicker MJ, Bashynski KL, et al
    Decrease in Enteroviral Meningitis - An Unexpected Benefit of COVID-19 Mitigation?
    Clin Infect Dis. 2020 Dec 23. pii: 6044729. doi: 10.1093/cid/ciaa1881.
    >> Share

  756. LIN DY, Zeng D, Mehrotra DV, Corey L, et al
    Evaluating the Efficacy of COVID-19 Vaccines.
    Clin Infect Dis. 2020 Dec 19. pii: 6042236. doi: 10.1093/cid/ciaa1863.
    >> Share

  757. GUARALDI G, Milic J, Martinez E, Kamarulzaman A, et al
    HIV care models during the COVID-19 era.
    Clin Infect Dis. 2020 Dec 19. pii: 6041857. doi: 10.1093/cid/ciaa1864.
    >> Share

  758. BOYCE RM, Shook-Sa BE, Aiello AE
    A tale of two studies: Study design and our understanding of SARS-CoV-2 seroprevalence.
    Clin Infect Dis. 2020 Dec 18. pii: 6041690. doi: 10.1093/cid/ciaa1868.
    >> Share

  759. COHEN JI, Burbelo PD
    Reinfection with SARS-CoV-2: Implications for Vaccines.
    Clin Infect Dis. 2020 Dec 18. pii: 6041697. doi: 10.1093/cid/ciaa1866.
    >> Share

  760. GOODMAN KE, Magder LS, Baghdadi JD, Pineles L, et al
    Impact of Sex and Metabolic Comorbidities on COVID-19 Mortality Risk Across Age Groups: 66,646 Inpatients Across 613 U.S. Hospitals.
    Clin Infect Dis. 2020 Dec 18. pii: 6041643. doi: 10.1093/cid/ciaa1787.
    >> Share

  761. HANSON KE, Azar MM, Banerjee R, Chou A, et al
    Molecular Testing for Acute Respiratory Tract Infections: Clinical and Diagnostic Recommendations From the IDSA's Diagnostics Committee.
    Clin Infect Dis. 2020;71:2744-2751.
    >> Share

  762. HUANG J, Liu F, Teng Z, Chen J, et al
    Care for the Psychological Status of Frontline Medical Staff Fighting Against Coronavirus Disease 2019 (COVID-19).
    Clin Infect Dis. 2020;71:3268-3269.
    >> Share

  763. MODY A, Pfeifauf K, Bradley C, Fox B, et al
    Understanding Drivers of COVID-19 Racial Disparities: A Population-Level Analysis of COVID-19 Testing among Black and White Populations.
    Clin Infect Dis. 2020 Dec 14. pii: 6033727. doi: 10.1093/cid/ciaa1848.
    >> Share

  764. PETTIT NN, Pisano J, Nguyen CT, Lew AK, et al
    Remdesivir Use in the Setting of Severe Renal Impairment: A Theoretical Concern or Real Risk?
    Clin Infect Dis. 2020 Dec 14. pii: 6033734. doi: 10.1093/cid/ciaa1851.
    >> Share

  765. ABU-RADDAD LJ, Chemaitelly H, Malek JA, Ahmed AA, et al
    Assessment of the risk of SARS-CoV-2 reinfection in an intense re-exposure setting.
    Clin Infect Dis. 2020 Dec 14. pii: 6033728. doi: 10.1093/cid/ciaa1846.
    >> Share

  766. SELHORST P, Van Ierssel S, Michiels J, Marien J, et al
    Symptomatic SARS-CoV-2 reinfection of a health care worker in a Belgian nosocomial outbreak despite primary neutralizing antibody response.
    Clin Infect Dis. 2020 Dec 14. pii: 6033730. doi: 10.1093/cid/ciaa1850.
    >> Share

  767. COSTA SF, Giavina-Bianchi P, Buss L, Mesquita Peres CH, et al
    SARS-CoV-2 seroprevalence and risk factors among oligo/asymptomatic healthcare workers(HCW): estimating the impact of community transmission.
    Clin Infect Dis. 2020 Dec 13. pii: 6032715. doi: 10.1093/cid/ciaa1845.
    >> Share

  768. MOEHRING RW, Holland TL
    Compiling Observational Research During a Pandemic: A Necessary Bridge.
    Clin Infect Dis. 2020 Dec 11. pii: 6030989. doi: 10.1093/cid/ciaa1705.
    >> Share

  769. COOK AR, Dickens BL, Wilder-Smith A
    Differential household attack rates mirror the ability to control Covid-19.
    Clin Infect Dis. 2020 Dec 11. pii: 6030927. doi: 10.1093/cid/ciaa1842.
    >> Share

  770. BAJEMA KL, Dahlgren FS, Lim TW, Bestul N, et al
    Comparison of Estimated SARS-CoV-2 Seroprevalence through Commercial Laboratory Residual Sera Testing and a Community Survey.
    Clin Infect Dis. 2020 Dec 10. pii: 6029296. doi: 10.1093/cid/ciaa1804.
    >> Share

  771. KAISER L, Vu-Cantero DL, Eberhardt CS
    Paradoxes and uncertainties of immunomodulatory treatments in the fight against COVID-19.
    Clin Infect Dis. 2020 Dec 8. pii: 6025515. doi: 10.1093/cid/ciaa1837.
    >> Share

  772. ZHU Y, Bloxham CJ, Hulme KD, Sinclair JE, et al
    A meta-analysis on the role of children in SARS-CoV-2 in household transmission clusters.
    Clin Infect Dis. 2020 Dec 6. pii: 6024998. doi: 10.1093/cid/ciaa1825.
    >> Share

  773. COVIN S, Rutherford GW
    Co-infection, SARS-CoV-2 and influenza: an evolving puzzle.
    Clin Infect Dis. 2020 Dec 5. pii: 6024509. doi: 10.1093/cid/ciaa1810.
    >> Share

  774. DOSHI P, Powers JH
    Determining the infectious potential of individuals with positive RT-PCR SARS-CoV-2 tests.
    Clin Infect Dis. 2020 Dec 4. pii: 6024448. doi: 10.1093/cid/ciaa1819.
    >> Share

  775. ZHANG N, Jia W, Lei H, Wang P, et al
    Effects of human behaviour changes during the COVID-19 pandemic on influenza spread in Hong Kong.
    Clin Infect Dis. 2020 Dec 4. pii: 6024447. doi: 10.1093/cid/ciaa1818.
    >> Share

  776. ROSENBERG ES, Bradley HM
    Improving surveillance estimates of COVID-19 incidence in the United States.
    Clin Infect Dis. 2020 Dec 4. pii: 6020000. doi: 10.1093/cid/ciaa1813.
    >> Share

  777. HOWARD LM
    Is there an association between SARS-CoV-2 and Streptococcus pneumoniae?
    Clin Infect Dis. 2020 Dec 4. pii: 6020002. doi: 10.1093/cid/ciaa1812.
    >> Share

  778. NEVES FS
    Dose-response effects of hydroxychloroquine on prophylaxis against SARS-CoV-2 / COVID-19 infection.
    Clin Infect Dis. 2020 Dec 3. pii: 6018203. doi: 10.1093/cid/ciaa1807.
    >> Share

  779. OWUSU D, Kim L, O'Halloran A, Whitaker M, et al
    Characteristics of Adults aged 18-49 Years without Underlying Conditions Hospitalized with Laboratory-Confirmed COVID-19 in the United States, COVID-NET - March-August 2020.
    Clin Infect Dis. 2020 Dec 3. pii: 6017811. doi: 10.1093/cid/ciaa1806.
    >> Share

  780. POSTON D, Weisblum Y, Wise H, Templeton K, et al
    Absence of SARS-CoV-2 neutralizing activity in pre-pandemic sera from individuals with recent seasonal coronavirus infection.
    Clin Infect Dis. 2020 Dec 3. pii: 6017810. doi: 10.1093/cid/ciaa1803.
    >> Share

  781. JEFFERSON T, Spencer EA, Brassey J, Heneghan C, et al
    Viral cultures for COVID-19 infectious potential assessment - a systematic review.
    Clin Infect Dis. 2020 Dec 3. pii: 6018217. doi: 10.1093/cid/ciaa1764.
    >> Share

  782. WADHWA A, Fisher KA, Silver R, Koh M, et al
    Identification of presymptomatic and asymptomatic cases using cohort-based testing approaches at a large correctional facility - Chicago, Illinois, USA, May 2020.
    Clin Infect Dis. 2020 Dec 3. pii: 6017809. doi: 10.1093/cid/ciaa1802.
    >> Share

  783. CHAN JF, Zhang AJ, Yuan S, Poon VK, et al
    Simulation of the Clinical and Pathological Manifestations of Coronavirus Disease 2019 (COVID-19) in a Golden Syrian Hamster Model: Implications for Disease Pathogenesis and Transmissibility.
    Clin Infect Dis. 2020;71:2428-2446.
    >> Share

  784. LEDNICKY JA
    A practical and economic approach for assessing potential SARS-CoV-2 transmission risk in COVID-19 patients.
    Clin Infect Dis. 2020 Dec 1. pii: 6015519. doi: 10.1093/cid/ciaa1789.
    >> Share

    November 2020
  785. PETERSEN MS, Kristiansen MF, Hanusson KD, Danielsen ME, et al
    Long COVID in the Faroe Islands - a longitudinal study among non-hospitalized patients.
    Clin Infect Dis. 2020 Nov 30. pii: 6012625. doi: 10.1093/cid/ciaa1792.
    >> Share

  786. BASAVARAJU SV, Patton ME, Grimm K, Rasheed MAU, et al
    Serologic testing of U.S. blood donations to identify SARS-CoV-2-reactive antibodies: December 2019-January 2020.
    Clin Infect Dis. 2020 Nov 30. pii: 6012472. doi: 10.1093/cid/ciaa1785.
    >> Share

  787. BRAUNSTEIN SL, Lazar R, Wahnich A, Daskalakis DC, et al
    COVID-19 infection among people with HIV in New York City: A population-level analysis of linked surveillance data.
    Clin Infect Dis. 2020 Nov 30. pii: 6012626. doi: 10.1093/cid/ciaa1793.
    >> Share

  788. KUIPER VP, Rosendaal FR, Kamerling IMC, Visser LG, et al
    Assessment of risks associated with SARS-CoV-2 experimental human infection studies.
    Clin Infect Dis. 2020 Nov 29. pii: 6009505. doi: 10.1093/cid/ciaa1784.
    >> Share

  789. PADMANABHAN S
    The COVID-19 Pan-Syndemic - will we ever learn?
    Clin Infect Dis. 2020 Nov 29. pii: 6009406. doi: 10.1093/cid/ciaa1797.
    >> Share

  790. NGUYEN TV, Frost SA
    Effect of steroids on Covid-19 mortality risk: a Bayesian interpretation.
    Clin Infect Dis. 2020 Nov 29. pii: 6009383. doi: 10.1093/cid/ciaa1783.
    >> Share

  791. JIA R, Wang H
    How Could In Vitro Antiviral Activity Be Applied to Optimize the Dosing Regimens of Candidates for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)?
    Clin Infect Dis. 2020 Nov 27. pii: 6007043. doi: 10.1093/cid/ciaa1325.
    >> Share

  792. HUGHES G, Merry C, Geary U, Noonan N, et al
    Changing Disease Epidemiology to Inform Expanded Coronavirus Disease 2019 Testing.
    Clin Infect Dis. 2020 Nov 26. pii: 6006321. doi: 10.1093/cid/ciaa1677.
    >> Share

  793. REESE H, Iuliano AD, Patel NN, Garg S, et al
    Estimated incidence of COVID-19 illness and hospitalization - United States, February-September, 2020.
    Clin Infect Dis. 2020 Nov 25. pii: 6000389. doi: 10.1093/cid/ciaa1780.
    >> Share

  794. VAN DEN BORST B, Peters JB, Brink M, Schoon Y, et al
    Comprehensive health assessment three months after recovery from acute COVID-19.
    Clin Infect Dis. 2020 Nov 21. pii: 5998118. doi: 10.1093/cid/ciaa1750.
    >> Share

  795. LEE JS, Kim SY, Kim TS, Hong KH, et al
    Evidence of Severe Acute Respiratory Syndrome Coronavirus 2 Reinfection After Recovery from Mild Coronavirus Disease 2019.
    Clin Infect Dis. 2020 Nov 21. pii: 5997517. doi: 10.1093/cid/ciaa1421.
    >> Share

  796. ZELNER J, Trangucci R, Naraharisetti R, Cao A, et al
    Racial disparities in COVID-19 mortality are driven by unequal infection risks.
    Clin Infect Dis. 2020 Nov 21. pii: 5998295. doi: 10.1093/cid/ciaa1723.
    >> Share

  797. BHATT PJ, Shiau S, Brunetti L, Xie Y, et al
    Risk Factors and Outcomes of Hospitalized Patients with Severe COVID-19 and Secondary Bloodstream Infections: A Multicenter, Case-Control Study.
    Clin Infect Dis. 2020 Nov 20. pii: 5995838. doi: 10.1093/cid/ciaa1748.
    >> Share

  798. MEYEROWITZ EA, Sen P, Schoenfeld SR, Neilan TG, et al
    Immunomodulation as Treatment for Severe COVID-19: a systematic review of current modalities and future directions.
    Clin Infect Dis. 2020 Nov 20. pii: 5996142. doi: 10.1093/cid/ciaa1759.
    >> Share

  799. ZHANG AJ, Lee AC, Chan JF, Liu F, et al
    Co-infection by severe acute respiratory syndrome coronavirus 2 and influenza A(H1N1)pdm09 virus enhances the severity of pneumonia in golden Syrian hamsters.
    Clin Infect Dis. 2020 Nov 20. pii: 5995847. doi: 10.1093/cid/ciaa1747.
    >> Share

  800. MCLAUGHLIN JM, Khan F, Pugh S, Angulo FJ, et al
    County-Level Predictors of COVID-19 Cases and Deaths in the United States: What Happened, and Where Do We Go from Here?
    Clin Infect Dis. 2020 Nov 19. pii: 5992242. doi: 10.1093/cid/ciaa1729.
    >> Share

  801. PELUSO MJ, Bakkour S, Busch MP, Deeks SG, et al
    A High Percentage of People with HIV on Antiretroviral Therapy Experience Detectable Low-Level Plasma HIV-1 RNA Following COVID-19.
    Clin Infect Dis. 2020 Nov 19. pii: 5991913. doi: 10.1093/cid/ciaa1754.
    >> Share

  802. SULLIVAN SG
    The Need for Robust Epidemiological Evidence During a Pandemic.
    Clin Infect Dis. 2020;71:2289-2290.
    >> Share

  803. LORENTZEN HF, Schmidt S, Benfield T
    PCR Test Caveats After Discharge Following COVID-19.
    Clin Infect Dis. 2020;71:2302-2303.
    >> Share

  804. JAIN MK, Rollins N, Jain R
    Access to Coronavirus Disease 2019 Clinical Trials by English and Non-English Speakers Is Needed.
    Clin Infect Dis. 2020;71:2298-2299.
    >> Share

  805. POLONI C, Tsoukas C
    Evaluating Immune Dysregulation in Patients With COVID-19 Requires a More Accurate Definition of the CD45RA+ T-cell Phenotype.
    Clin Infect Dis. 2020;71:2306-2307.
    >> Share

  806. DOAN T, Hinterwirth A, Arzika AM, Worden L, et al
    Reduction of Coronavirus Burden With Mass Azithromycin Distribution.
    Clin Infect Dis. 2020;71:2282-2284.
    >> Share

  807. POLLETT S, Rivers C
    Social Media and the New World of Scientific Communication During the COVID-19 Pandemic.
    Clin Infect Dis. 2020;71:2184-2186.
    >> Share

  808. OUYANG Y, Yin J, Wang W, Shi H, et al
    Downregulated Gene Expression Spectrum and Immune Responses Changed During the Disease Progression in Patients With COVID-19.
    Clin Infect Dis. 2020;71:2052-2060.
    >> Share

  809. LI N, Han L, Peng M, Lv Y, et al
    Maternal and Neonatal Outcomes of Pregnant Women With Coronavirus Disease 2019 (COVID-19) Pneumonia: A Case-Control Study.
    Clin Infect Dis. 2020;71:2035-2041.
    >> Share

  810. SANVILLE B, Corbett R, Pidcock W, Hardin K, et al
    A Community-transmitted Case of Severe Acute Respiratory Distress Syndrome (SARS) Due to SARS-CoV-2 in the United States.
    Clin Infect Dis. 2020;71:2222-2226.
    >> Share

  811. RUSSO A, Bellelli V, Ceccarelli G, Marincola Cattaneo F, et al
    Comparison between hospitalized patients affected or not by COVID-19 (RESILIENCY study).
    Clin Infect Dis. 2020 Nov 18. pii: 5989494. doi: 10.1093/cid/ciaa1745.
    >> Share

  812. STAPLETON JT
    SARS-CoV-2 Antibody Testing: Important but Imperfect.
    Clin Infect Dis. 2020 Nov 18. pii: 5989218. doi: 10.1093/cid/ciaa1755.
    >> Share

  813. TLEYJEH IM
    The misleading "pooled effect estimate" of crude data from observational studies at critical risk of bias: The case of Tocilizumab in COVID-19.
    Clin Infect Dis. 2020 Nov 17. pii: 5985641. doi: 10.1093/cid/ciaa1735.
    >> Share

  814. LADHANI SN, Andrews N, Aiano F, Baawuah F, et al
    Secondary attack rate and family clustering of SARS-CoV-2 infection in children of healthcare workers with confirmed COVID-19.
    Clin Infect Dis. 2020 Nov 17. pii: 5985642. doi: 10.1093/cid/ciaa1737.
    >> Share

  815. HUANG YT, Chao CM, Lai CC
    The impact of tocilizumab on the mortality of patients with COVID-19.
    Clin Infect Dis. 2020 Nov 17. pii: 5985678. doi: 10.1093/cid/ciaa1738.
    >> Share

  816. EMANUELS A, Heimonen J, O'Hanlon J, Kim AE, et al
    Remote Household Observation for Non-influenza Respiratory Viral Illness.
    Clin Infect Dis. 2020 Nov 17. pii: 5983780. doi: 10.1093/cid/ciaa1719.
    >> Share

  817. AMIN-CHOWDHURY Z, Aiano F, Mensah A, Sheppard C, et al
    Impact of the COVID-19 Pandemic on Invasive Pneumococcal Disease and Risk of Pneumococcal Coinfection with SARS-CoV-2: prospective national cohort study, England.
    Clin Infect Dis. 2020 Nov 16. pii: 5983410. doi: 10.1093/cid/ciaa1728.
    >> Share

  818. MARAIS BJ
    COVID-19 disease spectrum in children - first insights from Africa.
    Clin Infect Dis. 2020 Nov 14. pii: 5981678. doi: 10.1093/cid/ciaa1731.
    >> Share

  819. BROTONS P, Launes C, Buetas E, Fumado V, et al
    Susceptibility to Sars-COV-2 Infection Among Children And Adults: A Seroprevalence Study of Family Households in the Barcelona Metropolitan Region, Spain.
    Clin Infect Dis. 2020 Nov 12. pii: 5979490. doi: 10.1093/cid/ciaa1721.
    >> Share

  820. LUM BX, Liu EH, Archuleta S, Somani J, et al
    Establishing a New Normal for Hospital Care: A Whole of Hospital Approach to COVID-19.
    Clin Infect Dis. 2020 Nov 12. pii: 5974991. doi: 10.1093/cid/ciaa1722.
    >> Share

  821. VAN DER ZALM MM, Lishman J, Verhagen LM, Redfern A, et al
    Clinical experience with SARS CoV-2 related illness in children - hospital experience in Cape Town, South Africa.
    Clin Infect Dis. 2020 Nov 10. pii: 5973899. doi: 10.1093/cid/ciaa1666.
    >> Share

  822. CHE Y, Liu X, Pu Y, Zhou M, et al
    Randomized, double-blinded and placebo-controlled phase II trial of an inactivated SARS-CoV-2 vaccine in healthy adults.
    Clin Infect Dis. 2020 Nov 9. pii: 5962856. doi: 10.1093/cid/ciaa1703.
    >> Share

  823. COLLINS LF
    Persons with HIV and the COVID-19 Pandemic: A Viral Synergy of Biology and Sociology.
    Clin Infect Dis. 2020